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On behalf of the College of Veterinary Medicine, I would like to extend a warm welcome to 
you. The 2013 Minnesota Dairy Health Conference is part of the college’s commitment to 
offering current research in practical contexts to both practitioners and producers.  Your 
partnership in this educational process with us ensures improved management, healthy 
herds and a safer food supply.  
 
Last year I was standing before you and could report to you about $700,000 grant from the 
U.S. Department of Agriculture’s National Institute of Food and Agriculture that is sponsoring our National 
Center of Excellence in Dairy Production Medicine Education at the Dairy Education Center. The Center is 
located at the Davis Family Dairies’ New Sweden Dairy, LLC, Nicollet County, Minnesota and shows a 
unique collaboration across several Universities: the University of Minnesota, the University of Georgia, 
University of Illinois, and Kansas State University. As of now the first two groups of students from 5 
veterinary schools have successfully completed the intense 8 week curriculum.  
 
Additionally, as you might know, our colleague Dr. Paul Rapnicki has left us in the previous summer. 
However, I am happy to inform you that we found a fabulous replacement: Dr. Gerard Cramer, who 
specializes in dairy cattle lameness and stockmanship. Welcome Gerard!  
 
Today we are fortunate to offer a program featuring a group of leading dairy industry speakers from across 
North America.  Joining this roster of presenters is a group I am especially proud to call my colleagues.  Our 
dairy faculty and graduate students here at the University of Minnesota will further enrich the program by 
presenting their most current research.   
 
In addition, I want to thank the sponsors and exhibitors of this annual conference. Your support makes this 
educational exchange possible.  We especially appreciate the interest you take in our students’ research, 
education and careers. I am fortunate to see the high level of quality in students entering the field of food 
animal veterinary medicine today and your mentorship and support of these students is critical to the industry. 
And finally, a special thank you to Dr. Riki Sorge for her committee’s steadfast and visionary leadership of 
this conference.  The conference’s scientific program remains vibrant and timely due to the attention and 
involvement of our entire dairy faculty here at the University of Minnesota College of Veterinary Medicine. 
 
Thank you for joining us.  
Sincerely, 
 
Trevor R. Ames, D.V.M., M.S., Diplomate ACVIM 
Dean, College of Veterinary Medicine 
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Why Cows Die on Dairies 
 
Franklyn Garry DVM, MS and Craig McConnel DVM, PhD 
 Department of Clinical Sciences, Colorado State University 
300 West Drake Road 
Fort Collins, CO  80521 
 
Originally published in the AABP Proceedings: 
Garry F, McConnel C. Why cows die on dairies. Proc Am Assoc Bovine Pract 45th 
annual meeting, Montreal, Quebec, Canada, 2012, pp82-86. 
 
Abstract 
On-farm death of adult dairy cows is a significant problem for both economic and animal 
welfare reasons. Adult cow mortality losses on dairies have increased in recent years. 
These losses and their causes are not carefully monitored or evaluated on most dairies 
leaving producers and veterinarians without the information needed to manage them. The 
reasons cows die are multiple and complex, necessitating an improved approach to 
diagnosis, information management and analysis.  
 
Introduction 
Death losses have not been studied very intensively in the dairy industry.  Yet, mortality 
rates in the dairy industry are much higher than those in the cow calf or feedlot industries.  
Estimates of these death losses are variable.  Unless they focus on monitoring cow 
deaths, dairy producers may underestimate the amount of adult cow death loss on their 
operations. The USDA:APHIS:VS National Animal Health Monitoring System 
(NAHMS) Dairy 2007 survey reported that 5.7% of dairy cows die on-farm across the 
country each year, an increase from 4.8% of the January 2002 inventory, and 3.8% of the 
January 1996 inventory.14, 15  
 
Information from computerized dairy record systems suggests that mortality rates have 
continually increased over the last 10 years. In some states, adult cow mortality exceeds 
10% per year.2, 4  Few formal studies have focused on this issue, yet dairy cattle death 
losses are an extremely important problem. Not only are these losses an economic 
disaster, they also represent very substantial problems with animal well-being.  
 
Adult cow death loss is an issue that should be very important to producers and 
veterinarians. But rising rates of occurrence across the industry suggests that 
veterinarians and producers do not have the information required to manage the problem 
appropriately. The purpose of this presentation is to critique the information we have, 
consider what information we need, and suggest changes in information gathering for 
dairy herds that would help diminish losses. 
 
Why do dairy cows die? 
Most studies of dairy cow mortality have come from outside the United States.  Studies 
from the US on this issue have been primarily focused on culling and herd turnover rates 
rather than death losses per se.  The 2007 national survey of dairies in the US14 showed 
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that approximately 23.6% of dairy cows left herds permanently during 2007, and that 
approximately 5.5% of these cows were sold to other dairies, while 94% were culled (i.e. 
sold and not returned to milk production, sent for slaughter). The reasons cows were 
culled included reproductive failure (26.3% of culled cows), mastitis and udder problems 
(23%), lameness or injury (16%), other disease (3.7%), and poor milk production not 
related to these other problems (16%), while other miscellaneous reasons accounted for 
about 8% of culling. Therefore, on average, the overwhelming majority of dairy cows 
leaving farms are not fit for sale as dairy production animals, and approximately 50% of 
these cows leave because of disease or injury problems rather than being selectively 
removed because of low fertility or milk productivity. 
 
Adult cow death losses appear to be attributable to reasons similar to those for culling cows.  
A recent literature review identified 19 studies between the years 1965 and 2006 that focused 
on dairy cow mortality in countries with relatively intensive dairy production.13  While 10 of 
the 19 studies provided information about causes of death, none of the diagnoses were 
founded on necropsy evaluation.  Only a single study discriminated between cows that were 
euthanized or died unassisted.  The categories used to describe causes of death were 
relatively uniform across studies and were presented as:  accidents, calving disorders, 
digestive disorders, locomotor disorders, metabolic disorders, udder/teat disorders, other 
known reasons, and unknown reasons.  The NAHMS Dairy 2007 survey recorded causes of 
death similarly to those established through the literature review, documenting the percentage 
of cow deaths due to:  euthanasia due to lameness or injury (20.0%), mastitis (16.5%),  
calving problems (15.2%), respiratory problems (11.3%), scours, diarrhea, or other digestive 
problems (10.4%), lack of coordination or severe depression (1.0%), poison (0.4%), other 
known reasons (10.2%), and unknown reasons (15.0%).14 
 
Let's consider what the preceding information means. First it suggests that historically the 
careful tracking of causes of mortality on dairies has not been seen as a high priority. Such an 
attitude would make sense if deaths occur very infrequently and appear to have little to do 
with the health of the remaining herd. It makes a lot less sense when 5 to 10% of standing 
herd inventory is lost to death each year. This information also speaks to the diverse health 
challenges seen on dairies. Dairy cows are complex animals that go through multiple life 
stages in the course of their residence on a farm. This is very different than a beef feedlot 
where most of the animals are young and growing, somewhat equivalent to dairy heifers. In 
these populations infectious respiratory disease is far and away the number one health 
challenge that predisposes to euthanasia and death. For adult dairy cows there is no single 
predominant life-threatening disease. 
 
It is also worth noticing that the categorization systems used on dairies and reported in the 
literature are not very helpful when it comes to instituting corrective actions. For example if 
you consider the category of lameness as a cause of death, there are so many potential causes 
of lameness that it would be difficult to institute a specific corrective action that would 
decrease the numbers in this category. Similarly, consider the wide range of disease problems 
that could be categorized as digestive death. 
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How good is our information about cause of death? 
Cause of death entered in dairy record systems is usually based on producer assessment 
and diagnosis.  It appears that most dairy veterinarians are minimally involved in the 
diagnosis of cause of death, and relatively few U.S. dairy operations perform necropsies 
in an effort to determine the cause of cow death.  The NAHMS Dairy 2007 study 
reported that necropsies were performed on only 13% of operations and only 4.4% of 
cow deaths received a postmortem examination.14  Therefore, historically almost all 
studies of dairy cow mortality are based on producer assessment rather than veterinary 
diagnosis and the causes of death are described using broad categories that do not provide 
much information about specific cause.  
 
Dairy record systems appear to be an unreliable source of information concerning cause 
of death in individual animals. We have been studying the phenomenon of dairy cow 
mortality over the last several years. Our findings suggest that dairy producer assessment 
of the proximate cause of death is inaccurate approximately 50% of the time. Our results 
also validate that there are multiple causes of dairy cow death.9  It seems reasonable to 
suggest that numerous health problems in dairy cows are not recognized early enough or 
treated appropriately to promote an optimal outcome, but this type of information cannot 
be retrieved from record systems. Furthermore, without good descriptors and records of 
the reasons that cows die, preventive measures that should decrease disease and death are 
not modified or improved to address the problem. 
 
No specific reason has been identified for the increase in dairy cow death rates. In 
conversation with producers and veterinarians, some have questioned whether the federal 
regulations regarding down dairy cows and neurologic disease may have artificially 
increased recorded death rates. While this will contribute to recorded mortalities, death 
rates were increasing prior to the implementation of this rule.11 Furthermore, if 
euthanized down cows represent more than a small fraction of dairy mortalities we need 
to ask why there are so many down cows that need to be euthanized. Others have 
suggested that specific disease problems such as hemorrhagic bowel disease may be 
increasing death rates. This could certainly be true on an individual dairy but the 
increased mortality rates across the industry exceed the incidence of any specific disease 
problem.  
 
Any conjectures on the cause of increased mortality are difficult to validate without 
specific diagnoses. Determining the cause of death would provide invaluable information 
for preventing future deaths and improving herd health.7  The fact that very few dairy 
cow deaths are evaluated by necropsy leaves a serious information gap in any analysis of 
cow mortality. 
 
Epidemiological associations with dairy cow mortality 
Although record systems as they are currently designed and used are not particularly 
helpful in managing adult cow death losses, they do demonstrate associations between 
high death rates and herd health problems. Analyses of large data sets demonstrate that 
herds with high rates of disease and culling also have higher death rates.1, 3, 10  More 
specifically, high mortality in dairy herds is related to high rates of lameness and large 
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proportions of cows that are removed due to lameness or injury.   Mortalities tend to 
occur much more frequently in the early part of lactation, coincident with increases in 
other health problems.2  Death losses are  related to the occurrence of respiratory disease, 
diarrhea, and mastitis.10  These findings should not be surprising, as they suggest that 
herds that have poor ability to control lameness, injury, and infectious disease also have 
increased likelihood of cow death. It is important to recognize that these epidemiologic 
associations do not inform us of specific causes, and rather show that herds with certain 
types of problems also have higher rates of death. The problem for the producer and dairy 
consultant lies in how to determine specific actions that decrease disease prevalence and 
risk of death.  
 
What can be done to decrease dairy cow deaths? 
Most decisions in a low-cost production dairy model are made with input cost as the 
primary driving force, and potential negative impacts on the animals in the production 
system are seen as problems that must be managed as a consequence. For example, it is 
common that large scale expansion of a dairy will capture production cost efficiencies, 
but often with the caveat that expansions are accompanied by substantial problems with 
animal health. During the time that large numbers of animals are being imported to the 
herd it is routine that disease introduction is occurring. Numerous animal health problems 
are prevalent and even increase with time.5, 16  Because there are compelling reasons for 
dairies to expand, there is a real need for the dairy industry and dairy veterinarians to 
reevaluate dairy management systems with a focus on optimum animal health. 
 
An overview of the health challenges faced by dairy cows needs to recognize that some 
changes in the modern dairy industry may result in systematic problems with animal care. 
The labor force on most dairies is primarily composed of low wage workers without 
extensive, preexisting dairy cow management skills. The ability of dairy personnel to 
adequately identify disease in individual animals and respond with prompt individual 
animal attention is limited by the extent of their experience and training. The 
overwhelming majority of sick cows on dairies are identified, diagnosed, and treated by 
farm workers rather than veterinarians. Poor outcomes may be an issue of poor clinical 
disease management in addition to any preexisting problems with cow physiology.  
 
Farm necropsy examinations should be an invaluable tool to help assess cause of adult 
cow death.7  Necropsy of dead animals to assess and monitor cause of death is rarely 
performed on dairies.14  This is in sharp contrast to other intensive livestock management 
systems, including poultry, swine, and feedlot enterprises where necropsy monitoring is 
routine. Most dairy veterinarians focus considerable effort on dairy reproduction, or 
udder health and milk quality, but little time on mortality evaluation. This presents a very 
significant liability to the dairy industry because efforts to effectively decrease mortality 
losses are hampered by a lack of monitoring and information necessary to accurately 
assess the problem.  
 
We believe that dairy workers could be trained to more effectively monitor death losses, 
and to perform on-farm necropsy examinations in consultation with veterinarians when 
the veterinarian cannot be present to perform the examination on a freshly dead carcass. 
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We have presented this recommendation to producer groups and produced an on-line 
training program for that purpose on our website.12  Very few producers or veterinarians 
have pursued this approach, attesting to the notion that monitoring actual cause of death 
has not been seen as a valuable pursuit.  
 
Necropsy examinations provide good information, but we also need to develop new 
recording systems that allow the necropsy results to be recorded as usable information. 
On their own, necropsy diagnoses provide great detail about the specific cause of death, 
but do not necessarily provide information about why that specific cause occurred. 
Therefore necropsy information needs to be combined with other historical information 
about the affected animals to help direct management changes.8  Our studies suggest that 
more than 50% of cow death losses are attributable to causes that could be mitigated with 
proper management.8  
 
Because of the complex nature of dairy management systems a variety of causes are 
responsible for high disease and mortality rates, with different rates of occurrence on 
different operations.  The wide range of lactational incidence risk for common diseases (milk 
fever: 0.03%-22.3%, RP: 1.3 – 39.2%, metritis: 2.2-37.3%, ketosis: 1.3-18.3%, LDA: 0.3-
6.3, lameness: 1.8-30%) attests to the complexity of dairy systems.6  To adequately address 
such complexity requires more accurate information about current losses, followed by 
management alterations that address the underlying problems. This will require changing the 
nature of information used in dairy management systems. An example of mastitis prevalence 
can illustrate this point. The specific infectious organism that causes a clinical mastitis 
episode can have a dramatic impact on outcome, and appropriate preventative or therapeutic 
measures need to be tailored to the specific cause, e.g. gram negative vs. gram positive, 
environmental vs. contagious, Escherichia coli vs. Staphylococcus aureus.  Assessments and 
record systems that track “mastitis” without identifying other specific details provide less 
information than needed to establish effective interventions. Similarly, monitoring death 
losses with generic terms such as “lameness” or “mastitis” and performing this monitoring on 
the basis of presumption will not allow correction of management problems that may 
underlie the death.  
 
 
Specific recommendations to decrease death losses 
We have proposed an approach to monitoring death losses that should help producers 
identify management changes to improve cow health and survival.8  The first step is to 
identify the magnitude of the problem on a dairy and commit to improving outcomes. 
Like any other substantial management change on a dairy, if the owner or manager is not 
committed to change it will not actually happen. Therefore simple analysis of the 
incidence of on-farm death and an assessment of its importance to the dairy and the well-
being of the cows is critical. 
 
Second, we recommend performing necropsy examinations to identify specific causes of 
death. This information needs to be considered along with other cow information such as 
preceding health problems, treatments, and individual cow circumstances as part of a 
complete post mortem evaluation. It is unrealistic to assume that 100% of all dead cows 
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will be examined by necropsy. Our experience suggests that routine necropsy 
examination is important but that targeting cases is useful. For animals euthanized due to 
obvious trauma, or where the cause of death is obvious based on priority veterinary 
assessment, necropsy examination usually will not provide much more information. 
Alternatively, for unexpected deaths or animals without simple specific antemortem 
diagnoses, necropsy can help not only define the cause of death but also inform farm 
workers about the types of problems that occur on the farm. 
 
We have developed a conceptual model to help assign cause of death to categories that 
have more meaning than those simple categories that assign cause of death to an organ 
system that the owner perceives was affected by disease. Necropsy is a key tool for 
assigning cause of death, if the information obtained is also matched with other animal 
information. Dairy workers who are involved in animal care should be included in the 
discussion of the necropsy and cause of death. The monitoring and focus on cause of 
death as an important component of dairy animal monitoring increases owner and worker 
focus on the actions needed to prevent future death losses.  
 
We recommend maintaining hard copy records of each case of death. When a particular 
category of death is seen to be problematic the details of the individuals in that category 
can be reviewed. As with all records, they need to be used to inform management if they 
are to be any use at all. Therefore we recommend periodic meetings between farm 
managers and veterinarians to consider death losses and what can be done to improve 
outcomes. 
 
More focus needs to be placed on evaluating subclinical disease problems. One of the 
problems with current record systems is that health events are only entered when they are 
obvious and prompt a treatment. Subclinical disease does not fit this category and 
therefore information about subclinical cow problems cannot be retrieved to be compared 
with assessment of death losses. Consider for example the assessment of lameness on 
dairies. As noted above, high rates of lameness are strongly associated with high rates of 
death losses. However, most records systems monitor lameness only when cows receive 
specific treatment. It is unusual for dairies to do routine locomotion scoring that detects 
cows with more modest degrees of lameness. It is likely that management changes 
targeted to improving overall cow locomotion will also improve other aspects of cow 
health and ultimately lead to decrease death losses. 
 
Conclusions 
There will not be a single simple answer to the problem of high mortality on dairies. 
Steps toward managing this challenge will require recognizing and defining the problem, 
improving information systems to provide details necessary to take action, and 
monitoring appropriate metrics that promote ongoing attention to management 
corrections.  
 
 
7 
 
Literature Cited 
 
1.  Bascom SS, Young AJ: A summary of the reasons why farmers cull cows.  J Dairy 
Sci. 81(8): 2299-2305, 1998. 
2.  Dechow CD, Goodling RC: Mortality, culling by sixty days in milk, and production 
profiles in high- and low-survival Pennsylvania herds  J Dairy Sci. 91(12): 4630-9, 2008. 
3.  Dechow CD, Smith EA, Goodling RC: The effect of management system on mortality 
and other welfare indicators in Pennsylvania dairy herds  Animal Welfare. 20(2): 145-
158, 2011. 
4.  DHI Computing Services, Inc. P.O. Box 51427, Provo Utah 84605-1427, 800-453-
9400. 2010. 
5.  Faust MA, Kinsel ML, Kirkpatrick MA: Characterizing biosecurity, health, and 
culling during dairy herd expansions  J Dairy Sci. 84(4): 955-65, 2001. 
6.  Kelton DF, Lissemore KD, Martin RE: Recommendations for recording and 
calculating the incidence of selected clinical diseases of dairy cattle  J Dairy Sci. 81(9): 
2502-2509, 1998. 
7.  Mason GL, Madden DJ: Performing the field necropsy examination  Vet Clin North 
Am Food Anim Pract. 23(3): 503-526, 2007. 
8.  McConnel CS, Garry FB, Hill AE, Lombard JE, and Gould DH: Conceptual modeling 
of postmortem evaluation findings to describe dairy cow deaths  J Dairy Sci. 93(1): 373-
386, 2010. 
9.  McConnel CS, Garry FB, Lombard JE, Kidd JA, Hill AE, and Gould DH: A necropsy-
based descriptive study of dairy cow deaths on a Colorado dairy  J Dairy Sci. 92(5): 
1954-1962, 2009. 
10.  McConnel CS, Lombard JE, Wagner BA, and Garry FB: Evaluation of factors 
associated with increased dairy cow mortality on United States dairy operations  J Dairy 
Sci. 91(4): 1423-32, 2008. 
11.  Miller RH, Kuhn MT, Norman HD, and Wright JR: Death losses for lactating dairy 
cows in herds enrolled in dairy herd improvement test plans  J Dairy Sci. 91(9): 3710-
3715, 2008. 
12.  Severidt JA, Madden DJ, Mason GL, Garry FB, and Gould DH. 2002; Available 
from: http://www.cvmbs.colostate.edu/ilm/proinfo/necropsy/notes/index.html. Integrated 
Livestock Management, Colorado State University 
13.  Thomsen PT, Houe H: Dairy cow mortality.  A review  Vet Q. 28(4): 122-129, 2006. 
14.  USDA. 2007. Dairy 2007, Part 1:  Reference of Dairy Cattle Health and 
Management Practices in the United States, 2007. USDA-APHIS-VS, CEAH, Fort 
Collins, CO. 
15.  USDA. 2007. Dairy 2007, Part II:  Changes in the U.S. Dairy Cattle Industry, 1991-
2007. USDA-APHIS-VS, CEAH, Fort Collins, CO. 
16.  Weigel KA, Palmer RW, Caraviello DZ: Investigation of factors affecting voluntary 
and involuntary culling in expanding dairy herds in Wisconsin using survival analysis  J 
Dairy Sci. 86(4): 1482-6, 2003. 
 
 








16 
 
Euthanasia Guidelines for Cattle 
Jan K. Shearer1, Dee Griffin2, James P. Reynolds3 and Glen T. Johnson4  
 
1Iowa State University, Ames, IA, jks@iastate.edu  
2University of Nebraska –GPVEC, Clay Center, NE, DGriffin@GPVEC.UNL.EDU  
3Western University College of Veterinary Medicine, Pomona, CA, jreynolds@westernu.edu  
4Reedsburg Veterinary Clinic, Inc., Reedsburg, WI, gjohnson@rucls.ne  
 
 
AVMA Guidelines for the Euthanasia of Animals: 2013 Edition 
 
The newest version of the AVMA Guidelines on Euthanasia may be found at: 
https://www.avma.org/KB/Policies/Documents/euthanasia.pdf .  The revised version is more 
comprehensive than previous editions and intended to be a “living document”; that is, to ensure 
the Guidelines remain as up-to-date as possible, interim revisions and other editorial corrections 
(e.g., typographical errors, updating of website addresses) will be made as necessary.  A number 
will be given to each revision so that users will know if they are viewing the most recent version 
of the Guidelines.   
 
Other changes relative to the 2012 Guidelines include the development of separate documents 
for Mass Depopulation and Humane Slaughter.  The Panel determined that it was necessary to 
develop separate documents for these topics since the techniques applicable to mass 
depopulation and humane slaughter do not always fit the definition of euthanasia.  
 
Introduction 
 
In the following we have attempted to summarize the salient features of the AVMA Guidelines 
for euthanasia of cattle, including recent studies that did not make the deadline for inclusion in 
the revised version.  One of these by Dr. JN Gilliam et al. is particularly noteworthy since the 
information presented in this paper represents a significant shift in current thinking on 
anatomical site selection for conducting euthanasia in cattle.  A second study is that reported Dr. 
B. Wileman, et al. on firearm and munitions selection which supports observations from an 
earlier Canadian study indicating that the .22 LR loaded with a hollow point bullet lacks 
sufficient muzzle energy and physical characteristics to provide consistent results when used for 
the euthanasia of cattle.  
 
In addition to proper application of euthanasia techniques, persons conducting euthanasia 
procedures need to understand the visual indicators of unconsciousness and the physical 
parameters that confirm death.  Careful observation of these responses helps provide clues to the 
effectiveness of the euthanasia procedure and the possibility or likelihood of a return to 
sensibility.  Proper interpretation of these responses is essential to assuring the welfare of 
animals that must undergo euthanasia.    
 
There are many ways to induce death, but not all are humane nor would they fit the definition of 
euthanasia.  Sometimes people resort to unapproved or unacceptable methods out of convenience 
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and/or a failure to understand that the particular method applied does not induce a humane death. 
It is imperative upon all who work with livestock to be prepared for situations that might require 
euthanasia of an animal. But, having the right equipment and a thorough understanding of the 
technique does not assure humane euthanasia.  Too many animals still experience horrible deaths 
simply because of inertia and indecision. We discuss just a few of the causes of euthanasia 
delays.  Once the decision is made, euthanasia should be conducted with as little stress to the 
animal as possible. This can be challenging as well as dangerous in some venues requiring 
tranquilization of some animals.     
 
We conclude with a brief discussion of options for carcass disposal. This is no small concern as 
options for the disposal of carcasses have decreased markedly in many areas.    
 
AVMA Guidelines on Euthanasia 
 
Euthanasia means a “good death” whereby the methods applied to cause death induce an 
immediate loss of consciousness followed by cardiac and respiratory arrest and death without a 
return to consciousness.  In the updated version of the AVMA Guidelines, euthanasia techniques 
are classified as 1) Acceptable, 2) Acceptable with Conditions, 3) Adjunctive, and 4) 
Unacceptable.  Methods deemed “Acceptable” are those that consistently produce a humane 
death when used as the sole means of euthanasia. Those methods classified as “Acceptable with 
Conditions” are those that require certain conditions to be met in order to consistently produce a 
humane death. For example, techniques in this latter category might have greater potential for 
human error or injury and/or may require a secondary (adjunctive) step to ensure death.  
Although the “with conditions” qualifier suggests that these methods are less humane or not as 
suitable as those listed as “Acceptable”, in fact they are considered to be equivalent to those 
listed under the “Acceptable” category.  
 
Methods classified as “Adjunctive” are those that should not be used as the sole method of 
euthanasia; rather they are to be used in conjunction with others to ensure death in animals 
previously rendered unconscious.  And finally, methods classified as “Unacceptable” are those 
that are considered to be inhumane under any conditions.   
 
Methods of Euthanasia in Adult Cattle 
 
Methods recognized as appropriate for euthanasia of cattle are: 1) barbiturates and barbituric acid 
derivatives (“Acceptable”), gunshot and penetrating captive bolt (“Acceptable with Conditions”). 
Penetrating and non-penetrating captive bolt are suitable for euthanasia of calves.  Whether used 
in mature animals or in calves penetrating captive bolt requires an “Adjunctive” method to assure 
death.  These are described in greater detail below.     
 
“Acceptable” Methods 
  
Barbiturates and barbituric acid derivatives—Barbiturates are preferred by some because of 
their rapid action and ability to induce a smooth transition from consciousness to 
unconsciousness and death. Drawbacks to the use of these agents for euthanasia include: cost, the 
need for restraint to deliver the drug, necessity to maintain a careful accounting of amounts used, 
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requirements that these agents be administered only by a veterinarian or personnel who are 
registered with the US Drug Enforcement Administration and finally, residues that limit carcass 
disposal options.   
 
A question that frequently arises is: “What happens to the fetus in pregnant animals euthanized 
by an overdose of pentobarbital”?  Research and clinical observation shows that barbiturates 
readily cross the placenta resulting in fetal depression; however death of the dam precedes death 
of the fetus by as much as 20-25 minutes.  Fetal welfare is preserved by the fact that while in 
utero, the fetus is maintained in sleep-like state of unconscious.  On the other hand, if removed 
from the uterus prior to 20-25 minutes post death of the dam, the fetus may regain consciousness.  
In cases involving euthanasia, any fetus removed from uterus prior to the amount of time 
required to cause death should be carefully observed for evidence of life and immediately 
euthanized if there is any doubt.   
 
“Conditionally Acceptable” Methods 
 
“Free Bullet” from Gunshot   A 2008 study by Fulwider found that gunshot is the most common 
method used for on-farm euthanasia of cattle. Death by means of a “free bullet” is caused by 
massive destruction of brain tissue. Despite its popularity and effectiveness for the purpose of 
euthanasia, those who are less familiar with firearms often find gunshot violent and 
objectionable. However, as stated in a previous edition of the Guidelines:   
 
“Properly applied, “euthanasia by either gunshot or penetrating captive bolt, causes less fear 
and anxiety and induces a more rapid, painless, and humane death than can be achieved by most 
other methods.”   
 
Penetrating captive bolt is also used for euthanasia of mature cattle in field situations.  Unlike 
euthanasia with firearms, once the animal is rendered unconscious, an adjunctive method to 
insure death must be applied.  Styles of penetrating captive bolt include an in-line (cylindrical) 
and pistol grip (resembling a handgun) versions. Pneumatic captive bolt guns (air powered) are 
limited to use in slaughter plant environments.  Models using gunpowder charges are more often 
used in farm environments.  Depending upon model, the bolt may automatically retract or require 
manual placement back into the barrel through the muzzle. Accurate placement of the captive 
bolt over the ideal anatomical site, energy (i.e. bolt velocity) and depth of penetration of the bolt 
determine effectiveness of the device to cause a loss of consciousness and death.  Bolt velocity is 
dependent on maintenance, in particular cleaning and storage of the cartridge charges.  Captive 
bolt guns should be cleaned regularly using the same or similar solvents used in the cleaning of 
firearms.  Powder charges for the captive bolt should be stored in air tight containers to prevent 
damage from moisture in hot and humid conditions.  
 
Non-penetrating captive bolt is not recommended for euthanasia of adult cattle.  On the other 
hand, non-penetrating captive bolt is appropriate for euthanasia of calves when followed by the 
use of an adjunctive (secondary step) method to assure death. 
 
Research on Firearm Use for Euthanasia of Cattle 
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Although the .22 LR is a popular caliber of firearm, results of a Canadian study suggest that it 
may not be the best choice for euthanasia of adult cattle because of poor penetration, deflection 
and fragmentation of the bullet.  Standard and high velocity bullets fired from a .22 caliber rifle 
at a range of 25 meters (82 feet) failed to penetrate skulls of steers and heifers studied.  These 
observations are corroborated by the results of a Kansas State University study by Wileman et al, 
designed to evaluate the characteristics of bullet penetration and brain tissue destruction using 
different calibers of firearms.  In this study, researchers assigned disembodied heads of feedlot 
cattle to one of seven treatments:  1) .22 LR with a solid point bullet (160 ft. lbs. or 217 Joules), 
2) .22 LR with a hollow point bullet (160 ft. lbs. or 217 Joules), 3) .223 rifle (1183 ft. lbs. or 
1604 Joules), 4) 9 mm handgun (316 ft. lbs. or 428 Joules), 5) .45 caliber handgun (551 ft. lbs. 
or 747 Joules), 6) 12 gauge shotgun with # 4 shot (1769 ft. lbs. or 2398 Joules) and 7) 12 gauge 
loaded with a 1 oz. slug (4095 ft. lbs. or 5552 Joules).  Cadaver skulls were shot from a fixed 
distance of 3 meters (approximately 10 feet).  The anatomical site used was on the intersection of 
two lines each drawn from the medial canthus of the eye to the base of the opposite ear with the 
firearm directed toward the foramen magnum. Damage to the brain was determined by computed 
tomography (CT) using serial coronal scans at 3 mm intervals which were reconstructed at 1.5 
mm intervals.   
 
Results demonstrated that the .22 LR hollow point bullet had the poorest depth of penetration 
(107.5 mm) compared with other treatment groups which had a penetration depths of 150 mm.  
Only 33% of the 9 mm bullets caused damage to brain tissues sufficient to cause death.  Greatest 
destruction of brain tissue occurred with the 12 gauge shotgun with #4 shot and the 1 oz. slug.  
Researchers concluded that the .22 LR with a hollow point bullet and the 9mm pistol could not 
be recommended based on this study.   
 
A couple of points worthy of mention in regard to the above studies; first, when gunshot is used 
for the purposes of euthanasia, whenever possible the firearm should be held perpendicular to the 
skull and at a distance of no more than 2 to 3 feet away from the intended target.  Reasons for 
these recommendations are to avoid ricochet and to take full advantage of the bullet’s maximum 
muzzle energy.  Obviously, this is not possible for an animal that is standing or mobile which is 
frequently the circumstance in feedlot conditions.  In the studies cited above the distance of the 
shooters from their targets were 25 and 3 meters for the Canadian and US studies, respectively.  
As the distance away from the target increases so do the challenges for accurate shot placement, 
potential for ricochet and ability to maintain sufficient muzzle energy particularly when lower 
caliber firearms are used.     
 
Recommendations on Firearms for Euthanasia  
 
Handguns   Handguns or pistols are short-barreled firearms that may be fired with one hand.  For 
the purposes of euthanasia, handguns are limited to close-range shooting (within 1 to 2 feet or 30 
to 60 cm) of the intended target. Calibers ranging from .32 to .45 are recommended for 
euthanasia of cattle.  Solid-point lead bullets are recommended over hollow points because they 
are more likely traverse the skull.  Hollow point bullets are designed to expand and fragment on 
impact with their targets which reduces the depth of penetration. The .22 caliber handgun is not 
recommended for routine euthanasia of adult cattle regardless of the type of bullet used, because 
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of the inability to consistently achieve desirable muzzle energies with standard commercial 
loads.   
 
Rifles   A rifle is a long barreled firearm that is usually fired from the shoulder.  Unlike the barrel 
of a shotgun which has a smooth bore for shot shells, the bore of a rifle barrel contains a series of 
helical grooves (called rifling) that cause the bullet to spin as it travels through the barrel.  
Rifling imparts stability to the bullet and improves accuracy.  For this reason, rifles are the 
preferred firearm for euthanasia when it is necessary to shoot from a distance. Rifles are capable 
of delivering bullets at much higher muzzle velocities and energies and are therefore not the 
ideal choice for euthanasia of animals in indoor or short range conditions. General 
recommendations on rifle selection for use in euthanasia of cattle include; .22 magnum, .223, 
.243, .270 and .308 and others.   
 
Shotguns   Shotguns 
loaded with birdshot 
(lead or steel BBs) or 
slugs (solid lead 
projectiles specifically 
designed for shotguns) 
are appropriate from a 
distance of 1 to 2 yards 
(.9 to 1.8 meters). 
Although all shotguns 
are lethal at close range, 
the preferred gauges for 
euthanasia of mature 
cattle are 20, 16, or 12. 
Number 6 or larger 
birdshot or shotgun slugs 
are the best choices for 
euthanasia of cattle. Birdshot begins to disperse as it leaves the end of the gun barrel; however, if 
the operator stays within short range of the intended anatomic site, the birdshot will strike the 
skull as a compact bolus or mass of BBs with ballistic characteristics on impact and entry that 
are similar to a solid lead bullet.  At close range penetration of the skull is assured with massive 
destruction of brain tissue from the dispersion of birdshot into the brain that results in immediate 
loss of consciousness and rapid death.   
 
One advantage of euthanasia using a shotgun is that within close range and when properly 
directed, birdshot has sufficient energy to penetrate the skull, but is unlikely to exit the skull. In 
the case of a free bullet or shotgun slug there is always the possibility of the bullet or slug exiting 
the skull creating an injury risk for the operator or by-standers.  For safety reasons it is important 
that the muzzle of a shotgun (or any other firearm) never be held directly against the animal’s 
head.  Discharge of the firearm results in the development of enormous pressure within the barrel 
that can result in explosion of the barrel and potential for injury of the operator and by-standers if 
the muzzle end is obstructed or blocked.     
 
Figure 1. Shotguns are a good choice for euthanasia using a firearm.  A 20, 16 or 12 gauge 
are recommended for euthanasia of adult bovines.  One may use birdshot (number 6 or 
larger BBs, or slugs.  
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Captive Bolt 
 
Penetrating captive bolt   In general, captive bolt guns, whether penetrating or non-penetrating, 
induce immediate loss of consciousness, but death is not always assured with the use of this 
device alone. Therefore, an adjunctive method such as a second shot, exsanguination, pithing or 
the intravenous injection of a saturated solution of potassium chloride (KCl) is recommended to 
ensure death when penetrating captive bolt is used. A newer version of penetrating captive bolt 
has emerged in recent years. This device is equipped with an extended bolt with sufficient length 
and cartridge power to increase damage to the brain including the brainstem. If studies prove this 
to be an effective 1-step euthanasia method, it will eliminate the need for an adjunctive method. 
Unlike techniques described for gunshot, the animal must be restrained for accurate placement of 
the captive bolt. And, unlike use of a firearm, proper use of the captive bolt requires that the 
muzzle of the device be held firmly against the animal’s head. Once the animal is restrained, 
discharge of the captive bolt should occur with little or no delay so that animal distress is 
minimized. Adjunctive methods should be implemented as soon as the animal is rendered 
unconscious to avoid a possible return to sensibility. Thus, when conducting euthanasia by 
captive bolt, pre-planning and preparation is necessary to achieve the desired results.      
 
Visual indicators that an animal has been rendered unconscious from captive bolt or gunshot 
include the following:  immediate collapse; brief tetanic spasms followed by uncoordinated hind 
limb movements; immediate and sustained cessation of rhythmic breathing; lack of coordinated 
attempts to rise; absence of vocalization; glazed or glassy appearance to the eyes; centralized eye 
position with a dilated pupil; and absence of eye reflexes.  Nervous system control of the blink or 
corneal reflex is located in the brain stem; therefore, the presence of a corneal reflex is highly 
suggestive that an animal is still conscious.   
 
Anatomical Landmarks for Euthanasia of Cattle 
 
The objective in 
euthanasia is to 
cause sufficient 
damage to the brain 
to result in 
immediate loss of 
consciousness and 
death.  
Accomplishment of 
this objective 
requires the 
accurate delivery of 
a bullet or captive 
bolt at an 
anatomical site that is most likely to cause damage to the brainstem.  In the past, most 
recommendations suggested that the ideal site was on the intersection of two lines each drawn 
from the medial canthus of the eye to the base of the opposite horn or top of the ear in polled 
cattle.   
Figure 2.  Cadaver skull form an adult Holstein cow shot with a penetrating captive bolt. The shot was 
placed on the intersection of 2 lines each from the medial canthus (inside corner) of the eye to the opposite 
horn or top of the opposite ear (black arrow). Note that the bolt failed to enter the cranial vault (white 
arrow).  Path of the bolt is rostral to the brain (Gilliam et al., 2012). 
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As early as 2008, Gilliam and others suggested 
that this site was in fact too rostral (i.e. toward the 
nasal region or muzzle) and unlikely to damage 
the brainstem (See Figure 1).  In order to confirm 
this observation, Gilliam instituted a study to 
evaluate the likelihood of brainstem damage using 
penetrating captive bolt at two anatomical 
locations.  Cadaver skulls from 15 cattle were 
divided into one of two groups.  Group 1 was shot 
with the penetrating captive bolt on the 
intersection of two lines each drawn from the 
medial canthus of the eye to the opposite horn or 
top of the opposite ear.  Group 2 was shot at the 
intersection of two lines each drawn from the 
lateral canthus of the eye to the opposite horn or 
top of the opposite ear.  The actual tract (or path) 
of the bolt for each respective location was 
determined by computed tomography and 
physical observation of the brain and brainstem.  
Evaluation of the skulls from Group 1 
demonstrated that the bolt failed to make contact 
with the brainstem in all skulls studied (See 
Figure 2).  In Group 2, the bolt was observed to 
cause significant damage to the brainstem in 6 of 
8 skulls studied (See Figure 3).  These results, 
although preliminary, indicate that the higher 
anatomical site improves the likelihood of causing 
damage to the brainstem.  However, these data 
also suggest that some adjustment of this site is 
still necessary to achieve consistent results. This 
study is continuing with plans to assess age and 
breed differences for determination of the best 
anatomical site for conducting euthanasia in 
cattle.   
 
Anatomic landmarks for use of the penetrating captive bolt and gunshot   Based upon current 
information in cattle, we suggest that the point of entry of the projectile should be at (or slightly 
above) the intersection of two imaginary lines, each drawn from the outside corner (lateral 
canthus) of the eye to the center of the base of the opposite horn. If a firearm is used it should be 
used within 3 feet of the target when possible and positioned so that the muzzle is perpendicular 
to the skull to avoid ricochet.  When using penetrating captive bolt, operators are advised to 
restrain the head so that the captive bolt may be held flush with the skull.   
 
In all cases, proper positioning of the firearm or penetrating captive bolt is necessary to achieve 
the desired results.  As suggested earlier, persons using captive bolt are advised to prepare for the 
Figure 4.  Computed tomography image of a bovine skull shot 
with a penetrating captive bolt showing the bolt path (white 
arrow) too far rostral to disrupt the brainstem (Gilliam et al. 
2012). 
Figure 3.  Computed tomography image of a bovine skull shot 
with a penetrating captive bolt showing the bolt path (white 
arrow) disrupting both the cerebral cortex and brainstem (i.e. 
bolt path is indicated  by bone fragments pushed into the brain, 
Gilliam et al 2012). 
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application of adjunctive methods to assure death as soon as possible following confirmation that 
the animal is unconscious.  It is also important to consider positioning of the captive bolt device.  
Directing the bolt toward the foramen magnum will likely improve results particularly when 
placement of the device is slightly rostral.       
 
Figure 4—Anatomic site for gunshot or placement of a captive bolt and desired path of the 
projectile in bovids.    
 
 
 
Poll Stunning  
 
Many people assume the poll (the highest point on the skull) is a proper site for conducting 
euthanasia procedures with either gunshot or penetrating captive bolt.  In fact, this site is not 
advised since studies indicate that the depth of concussion in this region is less than that 
observed with frontal sites. Furthermore, research indicates that the use of penetrating captive 
bolt at the poll is more prone to operator error and misdirection of the bolt into the spinal cord 
instead of the brain. Conversely, for large bulls and water buffalo use of the frontal site is not 
always effective because of the thickness of the hide and skull in this region. Use of the poll 
position can be effective if the appropriate captive bolt gun is used and when the muzzle is 
directed so that the discharged bolt will enter the brain; but this site is not recommended for 
routine use.   
 
Unacceptable Methods  
 
The methods of euthanasia deemed unacceptable include: 1) manually applied blunt force trauma 
(as with a large hammer), 2) injection of chemical agents or other substances not specifically 
designed or labeled for euthanasia (i.e. disinfectants, cleaning solutions, etc.), 3) air injection into 
the vein, 4) electrocution as with a 120 volt electrical cord, 5) drowning, 6) exsanguination of 
conscious animals, and 7) deep tranquilization as with xylazine or other alpha-2 agonist followed 
by potassium chloride or magnesium sulfate. While some have been forced out of desperation to 
resort to one or more of these methods, readers are strongly advised against their use. Several of 
these methods are known to result in a less than humane death and for others the level of pain or 
distress associated with these methods is unknown.  For example, use of xylazine to create a 
deep state of tranquilization followed by the rapid administration of KCl is used by some 
veterinarians.  The position of the AVMA is as that stated in Goodman and Gilman’s 
Pharmacological Basis of Therapeutics, 11th Edition:  “Although large doses of alpha-2 agonists 
can produce a state resembling general anesthesia, they are recognized as being unreliable for 
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that purpose.”  Therefore, until such time as we have better information on this method in terms 
of its ability to cause a humane death, it is best to utilize alternate techniques.      
 
Confirmation of Death 
 
Regardless of method used for conducting euthanasia procedures it is important to confirm death. 
It is sometimes more easily said than done.  However, the most reliable criteria include lack of 
pulse, breathing, corneal reflex and response to firm toe pinch, inability to hear respiratory 
sounds and heart beat by use of a stethoscope, graying of the mucous membranes, and rigor 
mortis. None of these signs alone, with exception of rigor mortis, confirms death.   
 
The Impediments to Timely Euthanasia 
 
No one enjoys the task of euthanasia or really wants to do it.  This is especially so for a livestock 
owner faced with the task of euthanizing his/her own animal. Employees face similar problems 
in conducting these procedures and for the same reasons. Some develop close attachments for the 
animals within their care. The physical methods of gunshot and penetrating captive bolt are 
inherently violent. While this is a significant deterrent in itself; in addition, many people are 
unfamiliar with the proper use of firearms, let alone captive bolt. Sometimes the question that 
prevents moving forward with timely euthanasia is related to an uncertain prognosis. Diseased 
and/or injured animals often exhibit conflicting signs; it’s not always a black or white decision as 
to whether or not euthanasia is indicated. The opportunity to error on the side of waiting too long 
looms large.  
 
The consequence of early euthanasia is largely economic and delaying it prolongs animal 
suffering. Veterinarians play a key role in assisting folks with these decisions and should be 
consulted whenever there are doubts as to whether euthanasia is warranted. When necessary or 
desired, veterinarians can intervene and relieve their clients of the burden of conducting the task 
on an animal to which they are emotionally attached. Euthanasia decisions can be complicated 
and some will undoubtedly be haunted by those lingering questions for which some might find 
consolation in the words of Dr. Bernard Rollin, Professor of Philosophy and Bioethics at 
Colorado State University, “Better a week too early than a day too late”. 
 
Considerations for Conducting the Procedure 
 
Persons conducting euthanasia procedures should attempt to minimize animal distress. If animals 
are accustomed to human contact the presence of a familiar person may be reassuring and reduce 
anxiety. For animals that are not accustomed to human contact, gunshot may be the best option 
for euthanasia simply because it can be delivered with the least amount of human contact. In 
some cases tranquilization may be necessary to quiet a frightened or anxious animal.  
 
Cattle should be approached quietly and restrained only as necessary to properly conduct the 
procedure. If the animal is ambulatory and able to be moved without causing distress, discomfort 
or pain, it may be relocated to an area where the carcass may be more easily reached by removal 
equipment. Dragging of non-ambulatory animals is unacceptable. In cases where movement of a 
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down animal would increase distress or animal suffering, the animal should be euthanized first, 
and then moved following confirmation of death.    
 
Euthanasia of Injured or Recumbent Cattle on Enclosed Trailers 
 
Not all cattle requiring euthanasia are found in the farm or ranch setting.  Some are the 
consequence of livestock truck roll-over accidents or cattle injured in the process of hauling to a 
market or packing plant. Whenever an animal is down and unable to voluntarily walk off of a 
trailer, it may become necessary to euthanize the animal prior to removal. Since entering the 
trailer with a fractious animal (dairy bull or beef animal) might put a person at considerable risk, 
and gunshot is unsafe and possibly restricted by local ordinances, tranquilization of the animal is 
necessary.  This can be accomplished by a veterinarian with a medicated dart from either a pistol 
or rifle, or by use of a “pole syringe” of sufficient length to deliver the tranquilizer from across a 
barrier between the operator and the agitated animal. Xylazine dosed at 0.3 to 0.5 mg/lb. (3 to 5 
CC of 100mg/Ml /1000 lbs.) is usually sufficient to render the animal safe to approach.  
 
Readers are cautioned that although this is a larger dose than that one would normally use, the 
combination of administering the drug to an anxious animal plus delivery via a dart or pole 
syringe makes the end result less predictable. Following administration of the xylazine, leave the 
animal undisturbed for the 15 to 20 minutes required for the xylazine to take full effect.  Once 
the animal is sufficiently tranquilized it may be approached for application of the penetrating 
captive bolt with adjunctive procedures to ensure death.  The primary concerns in these 
situations are human, animal and food safety.   
 
Carcass Disposal 
 
Euthanasia presents another issue that people frequently fail to consider – disposal of the carcass.  
In North America, there are plenty of coyotes, buzzards and other scavenging animals willing to 
assist with carcass removal.  This seems a natural way to dispose of an animal carcass; it serves 
the purpose of disposing of the carcass and provides food for the scavengers.  This practice may 
be acceptable on large acreages, especially those without nearby neighbors and areas containing 
upland woods and brush.  However, this natural method isn’t permitted in most areas, and some 
scavengers become predators when carcasses are less available.  This places newborn calves and 
other animals weakened by disease or other maladies at risk of predation.  Most cattle producers 
are well aware that coyotes can take a significant toll on newborns.  In dairy operations, calves 
may be attacked at birth or later when confined to a small pen or hutch.  In either situation, they 
are easy prey for a coyote.  Furthermore, a proper method of carcass disposal is needed to 
prevent the spread of infectious and/or contagious disease.  Finally, as described earlier, when 
barbiturates are used for euthanasia wildlife may be at risk from the consumption of carcasses 
with drug residue that may be deadly. Penalties for the accidental killing of endangered animals 
are severe and include incarceration as well as huge fines for persons convicted of the offense.     
 
The problem is that socially, economically and environmentally acceptable methods of carcass 
disposal have become increasingly difficult to find.  In the United States the disposal of animal 
carcasses is regulated by state and local laws that vary widely according to animal species.  The 
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most common methods for disposal of animal carcasses are burial, composting, incineration and 
rendering. Less common methods would include landfills and tissue digestion.  
 
Advances in analytical chemistry have led to increasingly sensitive assays for multiple drugs and 
antimicrobials. The ability of these technologies to identify residue at extremely low levels has 
also continued to increase the scrutiny of rendered product end users.  Today, acceptable levels 
are no longer acceptable, for many if not most, only zero tolerance will do. The result is a 
rendering industry that is much less accepting of the carcasses of animals euthanized by 
barbiturates. Therefore, the first choice recommendation for carcass disposal of animals 
euthanized by pentobarbital overdose is incineration or cremation; but cost precludes this from 
being an economically viable consideration for carcass disposal in most of today’s commercial 
farm operations. The next best option is burial of the animal sufficiently deep to avoid being 
exhumed by scavengers.  This must be conducted in accordance with State and local laws to 
assure no contamination of ground water sources. When the ground is frozen, carcasses must be 
carefully covered and stored until such time as burial may be possible.   
 
Composting is another means of carcass disposal that is becoming increasingly more common. 
Although studies are few, most report the persistence of barbiturate residues in composted 
material.  For these reasons, the physical methods of gunshot and captive bolt are far more 
attractive for euthanasia of livestock. Even when adjunctive methods such as the rapid 
intravenous administration of potassium chloride are used to assure death there are no worries for 
rendering or composting.  In short, while there are many within the veterinary profession that 
find gunshot and penetrating captive bolt violent methods and therefore less desirable, when they 
are properly conducted they are very humane, cost-effective and do not pose residue risks.  
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 Take Home Messages 
 The most dramatic physiological changes occur during birth and death. 
 Calves born without assistance experience hypoxia (low arterial blood oxygen), 
acidosis, and frequently hypothermia. Dystocia calves experience the same changes but 
to a greater degree. 
 Dystocia has an immediate and prolonged effect on the health and productivity of 
calves.  
 Perinatal mortality due to dystocia accounts for about half of all calf deaths 
through weaning and is not due to infectious disease.  
 Simple interventions such as providing calves with mechanical breathing 
assistance, oxygen, colostrum, and a warm environment for the first few hours after birth 
can make the difference between life and death.  
 Dystocia monitoring should be implemented on every dairy farm.  
 Dystocia and subsequent perinatal mortality are major animal-welfare issues for 
the dairy industry. 
 
Prevalence and effects of dystocia 
Dystocia is defined as delayed or difficult parturition. There are three general categories 
of dystocia: fetal-maternal size mismatch (e.g. oversized calf or small maternal pelvis), 
fetal malpresentation (e.g. breech presentation), and maternal causes (e.g. hypocalcemia) 
(Arthur et al., 1989). 
The prevalence and effects of dystocia can be reduced in three ways: 
  
1. Prebreeding management: select sires for calving ease and dams for adequate pelvic 
size (dam selection has never been done in the dairy industry), breed heifers of 
recommended height and weight, and provide optimal nutrition during pregnancy.  
 
2. Calving time: ensure that calving areas are comfortable and as stress free as possible, 
and provide assistance when needed using proper techniques and procedures. 
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3. Neonatal assistance: provide maternal and additional care as needed.  
 
While all three of these methods are important, this paper focuses on neonatal assistance. 
  
Most dairy farms likely don’t know the impact of dystocia because it isn’t well 
monitored. The first step in reducing dystocia and improving the outcome for calves is to 
implement a monitoring plan. The plan can be relatively simple. For instance, the first 
step would be recording the number of calvings using a three-point dystocia scale in 
which ‘1’ is an unassisted birth, ‘2’ is a relatively easy pull, and ‘3’ is a hard pull or 
surgical extraction. Each calving should be assigned a dystocia score using the above 
criteria. In addition, record live and dead births, gender, time to stand, time to colostrum, 
and time to suckle. Specific interventions are discussed later in this paper and can also be 
recorded.   
These basic measures can be used to evaluate the effect of dystocia and suggest 
interventions to decrease its impact. Evaluated over time, these measures can indicate 
whether or not management changes have reduced the occurrence and impact of dystocia. 
For instance, a comparison could be made between the incidence of dystocia and the 
number of stillbirths by the level of dystocia before and after the implementation of 
specific practices, such as using a new sire, worker training, or additional care provided 
to dystocial calves.      
The prevalence of dystocia varies based on the type of cattle (beef versus dairy breeds), 
parity, and across studies. Data collected from U.S. dairy farms participating in the Dairy 
Herd Improvement Association indicated that 28.6% of primiparous (first-calf heifers) 
and 10.7% of multiparous cows experienced dystocia (Meyer et al., 2001). Other 
producer-collected data suggest a much lower rate or, more likely, reduced recognition of 
dystocia. These data indicate that only 4.6% of cows experienced reproductive problems, 
including dystocia (NAHMS 2007).  A study involving three large U.S. dairies reported 
an overall dystocia rate of 36.6% (Lombard et al., 2007), with 48.8% of primiparous 
dams experiencing dystocia compared with 29.4% of multiparous dams. Holsteins,   the 
predominant dairy breed in the United States, have a higher prevalence of dystocia than 
Jerseys or Jersey crosses (Dhakal et al., 2013). Regardless of breed, twins, bull calves, 
and heavier calves have an increased risk of experiencing dystocia (Johanson and Berger, 
2003; Dhakal et al., 2013).  
Multiple studies have demonstrated the adverse effect dystocia has on the survival, 
health, and production of calves and dams.  (Lombard et al., 2007; Barrier et al., 2012 
JDS; Barrier et al. 2012 TVJ; Tenhagen et al., 2007). A 13-month study evaluating 7,380 
calvings on three Colorado Holstein dairy farms (Lombard et al., 2007)  used a three-
level dystocia scoring system with 1 indicating a normal, unassisted delivery; 2 indicating 
assistance by one person not using mechanical means; and 3 indicating that two or more 
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people were required, and mechanical or surgical assistance was required. In this study, 
the percentage of stillbirth calves (more correctly perinatal mortality) increased as the 
dystocia score increased. Only 3.2% of unassisted calves (score of 1) were stillborn 
compared with 8.4% of calves with a score of 2, and 37.2% of calves with a score of 3. 
Overall, 8.2% of calves were stillborn, which is similar to a review of perinatal mortality 
reported by Mee (WCDS, 2012). 
Studies of both dairy and beef calves have also shown increased morbidity and mortality 
through the preweaning period for calves experiencing dystocia (Lombard et al., 2007; 
Wittum et al., 1994). Dystocial calves in the Lombard study had significantly increased 
odds of experiencing respiratory or digestive disease compared with calves born 
unassisted. A similar finding of increased odds for general morbidity was reported in beef 
calves experiencing dystocia in the Wittum study. Based on the findings from these 
studies, dystocia has both an immediate and prolonged effect on the health and survival 
of calves. Obviously, based on the frequency of occurrence and the impact, dystocia 
should be an area of great concern for the dairy industry. 
To address the impact of dystocia on calves, it is helpful to understand the complex and 
dramatic physiological changes that must occur for calves to successfully adapt to 
extrauterine life. 
Normal fetal physiology 
During normal extrauterine circulation in calves, the right side of the heart receives 
deoxygenated (relatively low oxygen and high carbon dioxide) blood from the body and 
pumps it to the lungs where oxygen is taken up by hemoglobin in the red blood cells and 
carbon dioxide is removed. The oxygenated (relatively high oxygen and low carbon 
dioxide) blood then flows to the left side of the heart where it is pumped to the rest of the 
body. Blood pressure in the right side of the heart is lower than in the left side 
(Cunningham and Klein, 2007).  
The lungs of the fetus in utero are not functional. Until birth, the placenta serves as ‘fetal 
lungs,’ providing gas exchange and acting as the source of nutrients. The placenta also 
eliminates waste products such as carbon dioxide from fetal blood. In turn, diseases or 
disorders affecting the placenta can have serious consequences for calves. Fetal blood 
circulation bypasses the lungs, for the most part, since blood is not oxygenated in utero. 
Fetal blood travels through two structures (referred to as fetal shunts) to bypass the lungs. 
The foramen ovale is a connection between the right and left atria of the heart and 
prevents some blood from being pushed through the lungs. The ductus arteriosis connects 
the pulmonary artery to the aorta and also shunts blood away from the pulmonary 
circulation (Kasari 1994).  
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During pregnancy and immediately after birth, calves have low blood oxygen levels and 
relatively high carbon dioxide levels compared with calves just a few hours old. Fetuses 
do fine at lower oxygen levels in utero because of the reduced oxygen consumption 
associated with low physical activity and living in a controlled environment in which the 
dam is responsible for providing nutrients and removing waste products. 
Changes at parturition 
Parturition results in dramatic physiological changes and has a negative impact on fetal 
oxygen concentration. As delivery progresses, uterine and abdominal contractions can 
impede or stop blood flow through the placenta. Bluel et al., (2008) showed that during 
delivery a fetus’s blood oxygen saturation drops from about 20% to less than 5%. During 
the calving process, the fetus experiences neonatal asphyxia: low blood oxygen levels 
and areas of decreased blood flow, or ischemia. Hypoxia can progress to anoxia (no 
oxygen in the blood).  Prolonged anoxia, such as occurs during continuous uterine 
contractions, will result in fetal death within six minutes. 
After delivery, the calf must begin breathing by inflating the lungs and initiating gas 
exchange. Lung expansion reduces blood pressure on the right side of the heart, causing a 
reversal of blood flow through fetal shunts, and functionally occludes the foramen ovale, 
usually within 5 to 20 minutes after birth. Due to respiration, oxygen tension in the blood 
going to the left side of the heart increases, causing the ductus arteriosus to close, usually 
within 5 minutes after birth (Kasari 1994). If the foramen ovale or ductus arteriosis do not 
close normally, the resulting turbulent blood flow may be detected as a heart murmur.  
Increased blood levels of carbon dioxide result in a respiratory acidosis and play a critical 
role in stimulating respiration. During dystocia, a more pronounced respiratory acidosis 
may occur. In addition to respiratory acidosis, the reduced oxygen content of the blood 
leads to anaerobic metabolism within tissues, resulting in a metabolic acidosis (lactic 
acidosis). The major clinical effect of acidosis is central nervous system depression, 
sometimes referred to as ‘weak calf syndrome’ or ‘dummy calf syndrome’. Maximizing 
lung function is key to resolving respiratory acidosis in newborn calves. Once the lungs 
are expanded, carbon dioxide is quickly removed via respiration. Resolution of the 
metabolic acidosis usually occurs within 2 hours of birth, while respiratory acidosis may 
persist for 24 to 48 hours (Ravary-Plumioën, RMV 2009).  
After parturition, the neonate moves from the controlled environment of the uterus to the 
ambient environment, which always results in heat loss. Minimizing heat loss by drying 
the hair coat and placing calves in a protected and warmed environment will increase the 
calves’ body temperature. Calves also begin to generate body heat after birth.  Heat is 
generated by three mechanisms: shivering thermogenesis, non-shivering thermogenesis, 
and physical activity. Shivering thermogenesis involves involuntary, periodic skeletal 
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muscle contractions, while nonshivering thermogenesis involves the metabolism of 
brown adipose tissue (brown fat).  Physical activity is the voluntary movements of 
skeletal muscles and is responsible for the greatest heat generation (Carstens, 1994). All 
of these mechanisms require good blood oxygen levels; hypoxemic calves have reduced 
ability to generate heat. 
Effects of dystocia 
Dystocia results in a more severe acidosis than a normal, unassisted birth due to the 
increased time of hypoxia and anoxia during parturition. The longer calves are in the 
transition between the uterine and extrauterine environment, the greater the probability of 
anoxia, resulting in a more severe acidosis. The acidosis starts a cascade of events that 
make the successful transition to extrauterine life much more difficult. Dystocial calves 
frequently have a depressed central nervous system, which reduces the stimulation for 
respiration. This depression also results in decreased physical activity and might prevent 
calves from standing or taking longer than normal to stand. In addition, decreased 
physical activity and reduced shivering results in more heat loss and hypothermia. In this 
case, suckling and the consumption of colostrum may not occur and, if it does, calves 
may not efficiently absorb the immunoglobulins necessary to protect against disease. 
Hypothermia and the lack of activity result in not only a failure to resolve the acidosis, 
but it commonly gets more severe and these calves frequently die (Kasari, 1994). 
Calving assistance 
Assistance should always be provided by a trained, competent person. Information on 
diagnosing and treating dystocia has been published elsewhere (Roberts, 1986). In 
addition to knowing the techniques involved in delivery, it is important to implement the 
proper use of hygienic procedures, lubrication, chains, and other extraction equipment, 
which should result in a successful outcome for calves and dams.  Farms should have 
guidelines available that provide specific instructions on when and how to proceed during 
a dystocia event. In addition, dystocia training for employees can help decrease the 
effects of dystocia. Improper or aggressive methods used by untrained personnel are 
likely to cause physical harm to calves, including fractures and crushing injuries (Nagy, 
2009).  In a study by Schuenemann et al., (2011) employees underwent a comprehensive 
educational program designed to improve calving management, practices of calving 
personnel, and communication within the farm team. One herd was evaluated for 
stillbirths before and after the training; the stillbirth percentage on this farm dropped from 
15.5 to 6.5% after training, representing a 60% decrease in stillbirths. Similar reductions 
due to employee training have been observed by the authors. 
 
In order to know when and when not to intervene, the calving process must be thoroughly 
understood. Although the normal calving process is classified into three stages, the 
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process is continuous and proceeds gradually from one stage to the next. Stage 1 is 
characterized by cervical dilation and uterine contractions that are usually not evident as 
abdominal contractions. During this stage, cattle might be restless/off feed because of the 
discomfort caused by uterine contractions. Stage 1 usually lasts 2 to 6 hours but may be 
longer in heifers. During stage 2, uterine contractions continue and abdominal 
contractions become evident. Stage 2 ends in the delivery of the fetus(es) and usually 
takes less than 2 hours for mature cows but up to 4 hours for heifers. In stage 3, the fetal 
membranes (placenta) are expelled as the uterus continues to contract. The duration of 
stage 3 can be minutes, even days if the placenta is retained (Arthur et al., 1989).  
 
Frequently observing cows close to calving is key in determining how labor is 
progressing, how much time has elapsed since labor began, and whether or not 
intervention is necessary. About half of U.S. dairy producers reported observing cattle 
close to calving about every 3 hours during the day but only about every 5 hours during 
the night (NAHMS, 2007). When calving was imminent and the heifer or cow was 
restless/off feed but not straining, about half of producers would examine heifers and 
cows within 3 to 5 hours; however, more than one-fourth of producers waited 7 or more 
hours before examining cattle in labor. Once heifers or cows began straining, almost 90% 
of producers examined the animals within 3 hours if labor was not progressing. Producers 
that call a veterinarian for assistance should consider the time it takes the veterinarian to 
arrive on site to avoid increasing the time to delivery and the possibility of a dystocia 
related stillbirth. The results of the NAHMS study indicate that many producers should 
observe cattle in labor more frequently and potentially intervene earlier in the calving 
process. 
  
Neonate assistance 
Based on the many physiological changes that occur during and after birth, most 
neonates, especially those experiencing dystocia, can benefit from relatively simple 
interventions. The three goals of intervention are to: 
1) Stimulate respiration  
2) Maintain body temperature (thermoregulation)  
 3) Increase blood volume via colostrum  
 Stimulate Respiration 
As mentioned earlier, calves are born with increased levels of carbon dioxide in their 
blood, which stimulate respiration; however, sometimes calves still need assistance 
breathing. To help calves breathe, mucus in the upper airway should be removed via 
suction or positive pressure ventilation. Some farms suspend calves from their rear legs 
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immediately after birth to help clear fluid from the upper airway and lungs. Research has 
shown that calves delivered by caesarean section have improved gas exchange and 
acidosis correction when they are suspended for 90 seconds or less or placed in sternal 
recumbeny compared with calves placed in lateral recumbency (Uysterpruyst et al., 
2002).  Although suspending newly born calves might be beneficial if done for a very 
short period, research has shown that most of the expelled fluids originate in the calves’ 
abomasum, not in the lungs. Additionally, the weight of the digestive tract on the 
diaphragm when calves are suspended makes it more difficult for calves to breathe. 
Rather than suspending calves upside down, we prefer to place calves in sternal 
recumbency immediately after birth.  
Lungs must inflate with air and expand in order for respiration to occur. The initial 
expansion of the lungs is similar to blowing up a balloon; expansion is difficult initially 
but gets easier as more air enters the lungs. Increased blood levels of carbon dioxide and 
the additional stimuli of the extrauterine environment, including temperature changes, 
promotes respiration in calves. Additional stimulation and respiration assistance can be 
performed in multiple ways, including stimulating the nostril with a piece of straw or 
similar material, vigorously rubbing the calves, pouring cold water on the calves’ head or 
in their ears, using an Ambu bag or similar device, or endotracheal tube for positive 
pressure ventilation, drugs such as doxopram, and the administration of oxygen. We 
recommend stimulation, positive pressure ventilation, and the administration of oxygen, 
for calves experiencing dystocia. We don’t recommend pouring cold water on newborn 
calves because of hypothermia concerns. 
Positive pressure ventilation forces air through the upper airway or trachea and into the 
lungs using mechanical means. Devices such as the Ambu bag have pressure relief valves 
that prevent over inflation and damage to the lungs. When using an Ambu bag with a 
mask for positive pressure ventilation, the esophagus must be occluded to prevent 
inflation of the abomasum (Kasari 1994). Occluding the esophagus can usually be 
accomplished by extending the neck and applying pressure around the trachea. Some 
calves may need only a few “mechanical” breaths to inflate their lungs, while others may 
need more prolonged assistance. Endotracheal tubes can also be used, but they frequently 
require a laryngoscope to place within the trachea and are not as simple and convenient to 
use as the Ambu bag with a mask.  
The direct administration of oxygen via nasal insufflation can be accomplished using a 
small rubber catheter placed in the nose or integrated into the ventilation provided with 
the Ambu bag. The recommended oxygen flow rate varies, but 2 to 4 L/min is probably 
adequate for most calves (Bleul 2008; Nagy 2009). The length of time that oxygen should 
be administered is based on the response of the individual calf. If the calf appears to be 
doing well, oxygen administration can be discontinued and the calf monitored to 
determine if oxygen therapy should be reinstituted. 
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 Thermoregulation 
Newborn calves regulate their body temperature (i.e. generate heat) by the catabolism of 
brown fat and by activity. Hypothermia, or body temperatures below 98.6°F, occurs in up 
to 25% of calves at birth (Mee, 2008).  Calves that can thermoregulate shouldn’t have a 
body temperature less than 101°F. Heat loss in calves occurs in multiple ways. In most 
instances, the ambient temperature is lower than the calves’ body temperature, resulting 
in heat loss through convection. Calves will also lose body heat when lying on cold 
surfaces via conduction. The other common form of heat loss occurs via evaporation 
from wet calves. Dystocial calves have increased heat loss and lower body temperatures 
due to their acidosis and decreased activity. It is relatively easy to assist calves in 
thermoregulation by drying them immediately after birth. Drying calves not only 
stimulates respiration but also reduces evaporative heat losses. Providing straw or other 
bedding also reduces conductive heat loss. Increasing the ambient temperature using a 
heater, providing heat via a hot water bottle, or immersing the calves in hot water helps 
prevent and treat hypothermia. Calves may need heat sources for up to 24 hours after 
birth. 
 Administer Colostrum 
Once calves are breathing normally, administering high quality colostrum is one of the 
most important practices to increase calves’ survival and productivity. There are 
numerous papers on the importance of colostrum administration for preventing failure of 
passive transfer and subsequent health and productivity of heifers.  Colostrum also 
provides essential fluids that are absorbed by the calves, increasing blood volume, 
thereby improving circulation and resolution of acidosis. Colostrum is also an important 
source of energy. This energy and the fact that colostrum is given to calves at 100F helps 
calves regulate their body temperature.   
Conclusion 
There have been large field studies evaluating the negative effects of dystocia. These 
effects are numerous, consistent, and have a negative impact on the health and welfare of 
calves and dams. Since dystocia is associated with 50% of preweaned calf losses, every 
dairy should implement a dystocia monitoring program and employ management 
practices that limit the occurrence and impact of dystocia. 
 
 
 
 
 
 
38 
 
References 
 
Arthur, G. H., D. E. Noakes, and H. Pearson. 1989. Veterinary Reproduction and 
Obstetrics. Pages 178-79 in Part III: Dystocia and Other Disorders Associated with 
Parturition.  General Considerations. Types of Dystocia Within the Species. 6th ed. 
Bailliere Tindall, London, UK. 
 
Meyer, C. L., P. J. Berger, K. J. Koehler, J. R. Thompson, and C. G. Sattler. 2001. 
Phenotypic trends in incidence of stillbirth for Holsteins in the United States. J. Dairy 
Sci. 84:515-523. 
 
Lombard JE, Garry FB, Tomlinson SM, Garber LP. Impacts of dystocia on health and 
survival of dairy calves. J Dairy Sci. 2007 Apr;90(4):1751-60.  
 
Dhakal K, Maltecca C, Cassady JP, Baloche G, Williams CM, Washburn SP. Calf birth 
weight, gestation length, calving ease, and neonatal calf mortality in 
Holstein, Jersey, and crossbred cows in a pasture system. J Dairy Sci. 2012 Oct 18. 
doi:pii: S0022-0302(12)00773-4. 10.3168/jds.2012-5817. [Epub ahead of print]. 
 
Johanson JM, Berger PJ. Birth weight as a predictor of calving ease and 
perinatal mortality in Holstein cattle. J Dairy Sci. 2003 Nov;86(11):3745-55. 
 
Barrier AC, Dwyer CM, Macrae AI, Haskell MJ. Short communication: Survival, growth 
to weaning, and subsequent fertility of live-born dairy heifers after a difficult birth. J 
Dairy Sci. 2012 Nov;95(11):6750-4. doi: 10.3168/jds.2012-5343. Epub 2012 Aug 29.  
 
Barrier AC, Haskell MJ, Birch S, Bagnall A, Bell DJ, Dickinson J, Macrae AI, 
Dwyer CM. The impact of dystocia on dairy calf health, welfare, performance and 
survival. Vet J. 2012 Sep 14. doi:pii: S1090-0233(12)00341-3. 
10.1016/j.tvjl.2012.07.031. [Epub ahead of print]  
 
Tenhagen BA, Helmbold A, Heuwieser W. Effect of various degrees of dystocia in dairy 
cattle on calf viability, milk production, fertility and culling. J Vet Med 
A Physiol Pathol Clin Med. 2007 Mar;54(2):98-102.  
 
Mee JF. Bovine neonatal survival – is improvement possible? WCDS Advances in Dairy 
Technology 2012 24:161-174 
 
39 
 
Wittum TE, Salman MD, King ME, Mortimer RG, Odde KG, Morris DL. Individual 
animal and maternal risk factors for morbidity and mortality of neonatal beef calves in 
Colorado, USA. Prev Vet Med. 1994 19:1-13. 
 
Cunningham JC, Klein BG, 2007. Fetal and Neonatal Oxygen Transport. In: Textbook of 
Veterinary Physiology, Fourth Ed. Saunders Elsevier, St. Louis, MO, USA, pp. 620-626 
  
Kasari TR. Physiologic mechanisms of adaptation in the fetal calf at birth. 
Vet Clin North Am Food Anim Pract. 1994 Mar;10(1):127-36.  
 
Kasari TR. Weakness in the newborn calf. Vet Clin North Am Food Anim Pract. 1994 
Mar;10(1):167-80.  
 
Schuenemann GM, Bas S, Gordon E, Workman J. Dairy calving management: 
Assessment of a comprehensive program for dairy personnel. J. Dairy Sci. 2011 vol. 94 
E-suppl. 1 pg 483. 
 
USDA. Dairy 2007, Part IV: Reference of Dairy Cattle Health and Management Practices 
in the United States, 2007. 2009.USDA:APHIS:VS:CEAH, NAHMS. Fort Collins, CO 
#N494.0209. 
 
Ravary-Plumioën B. Resuscitation procedures and life support of the newborn calf. 
Revue Méd. Vét., 2009, 160, 8-9, 410-419. 
 
Uystepruyst C, Coghe J, Dorts T, Harmegnies N, Delsemme MH, Art T, Lekeux P. 
Sternal recumbency or suspension by the hind legs immediately after delivery improves 
respiratory and metabolic adaptation to extra uterine life in newborn calves delivered by 
caesarean section. Vet Res. 2002 Nov-Dec;33(6):709-24.  
 
Bleul UT, Bircher BM, Kähn WK. Effect of intranasal oxygen administration on blood 
gas variables and outcome in neonatal calves with respiratory distress syndrome: 20 cases 
(2004-2006). J Am Vet Med Assoc. 2008 Jul 15;233(2):289-93.  
 
Nagy DW. Resuscitation and critical care of neonatal calves. Vet Clin North 
Am Food Anim Pract. 2009 Mar;25(1):1-11, xi.  
 
Bleul U, Kähn W. Monitoring the bovine fetus during stage II of parturition 
using pulse oximetry. Theriogenology. 2008 Feb;69(3):302-11. Epub 2007 Oct 31.  
 
40 
 
Uystepruyst CH, Coghe J, Bureau F, Lekeux P. Evaluation of accuracy of pulse oximetry 
in newborn calves. Vet J. 2000 Jan;159(1):71-6.  
 
Mee JF. Managing the calf at calving time, AABP Proceedings 2008 41:46-53. 
 
Carstens GE. Cold thermoregulation in the newborn calf. Vet Clin North Am Food Anim 
Pract. 1994 Mar;10(1):69-106. 
 
Roberts SJ, 1986. Diagnosis and treatment of various types of dystocia. In: Veterinary 
obstetrics and genital diseases theriogenology, Third Ed. SJ Roberts, Woodstock, VT, 
USA, pp. 326-352 
 
 
 
41 
 
Digital dermatitis in cattle 
 
J.K. Shearer, DVM, MS 
 
Professor and Extension Veterinarian 
Department of Veterinary Diagnostic and Production Animal Medicine 
College of Veterinary Medicine 
Iowa State University 
JKS@iastate.edu  
 
 
Digital dermatitis is the number 1 cause of lameness in dairy cattle and rapidly emerging 
as a major cause of lameness in feedlot cattle. Predisposing factors include: purchasing 
or raising replacements off-site, large herd size, muddy corrals (wet manure covered 
feet),use of a hoof trimmer that trims feet on other dairies, failure to wash or disinfect 
hoof care equipment between farms, facilities with grooved concrete, use of a footbath, 
herds with Holstein cows versus other breeds and more.  Organisms from the genus 
Treponema sp. are consistently isolated from lesions of digital dermatitis; but most 
researchers are reluctant to believe that these organisms are acting alone in the 
pathogenesis of this disease.  Treatment and control remains limited to topical spray 
treatment, footbaths and topical antibiotics with or without a bandage.      
 
Digital Dermatitis (Footwarts, Hairy Heel Warts, etc.)  
 
Discovery of the Disease  
 
Italian researchers, Drs. Cheli and Mortellaro are credited with being the first to describe 
this disease in Italy in 1974. However, a report by Lindley in 1974, describing a similar 
raised wart-like lesion in bulls he termed “malignant verrucae” suggests that digital 
dermatitis was quite likely present during this time in the US as well. A better known 
report from outbreaks of DD in New York dairy herds was published in 1980. Since that 
time DD has become worldwide in occurrence.   
 
Multiple Names    
 
Digital dermatitis is known by a number of terms: footwarts, hairy heel warts, digital 
warts, strawberry foot, raspberry heel, verrucose dermatitis, Mortellaro or Mortellaro’s 
disease (after Dr. Carlo Mortellaro), papillomatous digital dermatitis (PDD) or simply, 
digital dermatitis (DD), which is likely the most accurate terminology for this disease.  
Digital refers to the digit or claw and dermatitis simply means inflammation of the skin.  
Thus, “digital dermatitis” is a very descriptive name. 
 
The Cause or Causes 
 
Despite its known existence for nearly 40 years, the precise organisms responsible for 
this disease are not entirely known. Early reports of digital dermatitis suggested a viral 
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etiology because of the wart-like appearance of lesions. However, no one has been 
able to detect viruses associated with DD.  Further evidence of a non-viral cause is the 
favorable response observed following antibiotic treatment. Lesions, lameness and pain 
all regress rapidly following treatment with antibiotics. If the cause were a virus this 
would not occur.   
 
Investigations in the US and Europe consistently identify bacterial spirochetes (spiral-
shaped bacteria) in properly stained sections of DD tissue. The question is do these 
organisms initiate the disease or infect the lesions secondary to other invaders.  The 
problem is further complicated by the fact that there are many types of bacteria present 
in DD lesions. Sorting them out and determining their significance is an extremely 
complex process. Finally, assuming we find the precise causes, will we be able to 
construct a vaccine or more effective treatment strategy?  There are many questions to 
be answered in the process of finding permanent solutions for this disease.   
 
Characteristics of the Lesion 
 
The lesions of DD typically occur on the skin of 
the plantar aspect of the rear foot adjacent to the 
interdigital cleft, or at the skin-horn junction of the 
heel bulbs.  On front feet lesions are often found 
adjacent to the dew claws or bordering the dorsal 
(front) interdigital cleft.  Most lesions are circular 
or oval with clearly demarcated borders.  
Hypertrophied hairs often surround the lesion 
borders and should be distinguished from 
epithelial outgrowths that look like long hairs 
extending from the surface of chronic lesions.  
Chronic lesions without these epithelial 
outgrowths are generally thickened and have a 
granular surface.   
 
Lesions are very tender and even a mild 
disturbance of the inflamed tissue tends to result 
in extreme discomfort and mild to moderate 
bleeding.  Cows will alter their posture and/or 
gait to avoid direct contact between lesions and 
the floor or other objects.  This avoidance behavior is one of the best visual indicators of 
a DD lesion.  These pain avoidance adaptations also lead to abnormal wear of the 
weight bearing surface of affected claws.  Lesions associated with the plantar 
interdigital cleft usually cause the cow to shift weight bearing toward the toe.  This 
results in increased wear at the toe, decreased wear in the heel and an overall 
reduction in the weight bearing surface of the affected claw.  When lesions occur on the 
dorsal (front) aspect of the foot, cows respond by altering posture and weight bearing 
resulting in overgrowth and extension of the toe and greater wear in the heel.  These 
alterations in shape of the claw generally require correction at the time of trimming.    
Figure 1.  Severe lesion associated with the 
planatar interdigital cleft., 
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Atypical (Uncharacteristic) Lesions of Digital Dermatitis 
 
“Invasion of the corium by DD”   
Exposure of the corium, whether 
as a consequence of the normal 
pathogenesis of claw lesions 
(white line disease and ulcers) or 
secondary to corrective trimming 
procedures, is often the prelude to 
development of a very painful DD 
lesion. It shares similar 
characteristics to the more 
frequently observed skin lesion; 
that is, a granular and sometimes 
whitish surface.  Trimmers often 
refer to the condition as “hairy 
attack”, referencing its invasion of 
the corium rather than the skin 
above the claw horn capsule.  
Lesions tend to have well defined 
borders and depending upon 
chronicity may be slightly raised in comparison to adjacent unaffected corium tissues.  
The affected areas are particularly sensitive such that even a mild disturbance results in 
a very overt pain reaction from the cow.  Stained sections of these lesions demonstrate 
large numbers of bacterial spirochetes typical of DD.   
 
The atypical lesion of DD is often observed in association with non-healing claw lesions.  
Experience with treatment suggests that healing, as evidenced by the formation of new 
horn over the affected area, is not likely to occur until the infection is under control.  
Therefore, some form of topical 
antibiotic therapy is necessary to affect 
recovery.  Researchers from 
Tennessee and Iowa have also 
observed that the inflammation 
associated with this condition may in 
itself be a significant complication in 
successful treatment of these lesions.  
Therefore, they suggest that the 
inclusion of an anti-inflammatory agent 
along with the antimicrobial be 
included in therapy of these lesions.      
 
“Udder Sores” also known as bovine 
ulcerative mammary dermatitis, 
mammary necrotic dermatitis, udder 
Figure 2.  Atypical lesion of digital dermatitis on the corium secondary 
to corrective trimming of a claw lesion. 
Figure 3.  Typical udder sore on anterior aspect of the 
mammary gland
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seborrhea, and udder foul are typically observed in the ventral abdominal wall between 
the front quarters of the cow’s mammary gland. It is described as a moist exudative 
dermatitis with a characteristic pungent foul odor.  Researchers report an increased 
prevalence of this condition in herds suffering from severe problems with DD.  This link 
has been strengthened by several studies in recent years that have identified bacterial 
spirochetes similar to those of DD in sections of tissues recovered from these lesions.  
While further research is necessary to definitively establish DD as the most likely cause 
of udder sores, previous work demonstrating transmission of DD from foot-to-foot by 
direct contact suggests that a similar mode of transmission from foot-to-udder is 
possible. Indeed, some theorize that the pathogens causing DD may be transferred 
from an infected foot to the abdominal skin as the downside leg of the cow makes 
contact with the udder and ventral skin when the cow lies down.   
 
Occurrence of the Disease in Herds 
 
Housing, environment and management conditions most consistently identified as 
underlying causes of DD include:  large herd size, wet and muddy corrals, and the 
purchase of replacement animals.  Other factors cited as contributors to DD included:  
use of a footbath, housing on grooved concrete, use of a trimmer who trimmed feet at 
other farms, and failure to clean and sanitize equipment between uses on cows.  
Although the latter study suggested important relationships between the occurrence of 
DD and various management practices, it did not distinguish between cause and effect.  
In other words, considering the relationship of footbaths and DD for example, analysis 
of the data did not establish that DD was caused by footbaths or vice versa.  One would 
have to conclude however, that housing and environmental hygiene are important 
factors in control of this disease.  Furthermore, based on the above studies the 
importance of hygiene could be extended to those who provide foot care services 
(veterinarians and/or trimmers) on dairy farms.   
 
Highest incidence rates of DD are usually observed in early lactation.  In some herds 
this is due to extremely high rates of DD in pre-fresh home-grown or off-site raised 
heifers.  Herds that purchase replacements often fail to request DD-free animals or 
properly inspect purchased animals for the presence of DD lesions before introducing 
them into their herds.  The transition from a non-lactating to a lactating state represents 
one of the more stressful periods in a cow’s life.  She must adapt to the physiological 
changes associated with the initiation of lactation, adjust to changes in housing and 
feeding conditions, and successfully respond to battles for dominance amongst herd 
mates. Finally, some have suggested that one of the potential causes of a higher 
incidence of DD in the early postpartum period may be due to peri-parturient immune 
suppression.  
  
The possible reservoirs and mode of transmission of DD are largely unknown, but 
assumed to be clinically and sub-clinically infected cows and fomites. The plantar 
interdigital cleft between the claw heels provides an excellent environment for the 
bacterial spirochetes most commonly isolated from lesions, and is therefore likely a 
significant reservoir.  Attempts to reproduce the disease under controlled conditions has 
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proven difficult, but has been accomplished in young heifers.  Experimental 
transmission was achieved by the placement of skin scrapings from DD lesions under a 
bandage designed to create an oxygen-depleted and moist micro-environment in the 
intended anatomical site. Typical lesions were observed after a period of several weeks.  
 
Effects of Digital Dermatitis on Performance 
 
Few studies have attempted to assess the effects of DD on performance.  A US study 
found that milk yield in cows affected with DD was 338 lb (153.3 kg) less than that 
produced by healthy cows; however the difference was not significant. An earlier study 
conducted on a 600-cow dairy in Mexico had similar results.  Cows affected with DD 
produced 268 lb (121.6 kg) less milk than their unaffected herd mates; but as in the 
previous study this difference was not significant.  There were, however significant 
effects on reproductive performance.  For cows affected with DD the calving to 
conception interval was increased from 93 to 113 days and average days open were 
increased by approximately 14 days as compared with non-infected herd mates.  
 
Treatment and Control Strategies  
 
Past approaches to therapy included: 1) surgical excision, 2) footbaths 3) topical 
treatment with various disinfectants, and antibiotic solutions, 4) cryosurgery, and 
electrocautery, 5) topical treatment under a bandage, and 6) systemic antibiotic therapy.  
With the possible exception of cryosurgery and electrocautery, most of these treatments 
have a place in the management of this condition.  However, they may not be practical 
in some situations.   
 
Topical spray-on treatment with 
antibiotic and some non-
antibiotic preparations have 
been shown to be effective 
when used in a scheme of 
consistent daily treatment for a 
period of 8-10 days over a 2-
week period.  The major 
disadvantages to topical 
treatment are that it is labor 
intensive and lesions occurring 
in the interdigital space are 
usually missed by spraying 
procedures.  Footbath solutions 
are more likely to reach lesions 
in the interdigital space and 
offer a great deal more 
treatment convenience; but 
footbathing done right also requires some intensive management effort.  Footbathing is 
also quite inefficient and costly.  For example, all cows must parade through the 
Figure 4.  Topical spray application of oxytetracycline for control of digital 
dermatitis. 
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footbath in order to get the 10 or 15% of animals that may need treatment.  Topical 
spray on the other hand, allows treatment of only those affected as long as the lesions 
one is attempting to treat are visible. Response to topical antibiotic treatment (topical 
spray or in combination with topical antibiotics under a bandage) is also influenced by 
the anatomic location of lesions.  A Florida study demonstrated that lesions occurring on 
the plantar interdigital cleft were less likely to respond compared with lesions occurring 
on the heel bulbs or dewclaws. Limited evidence also suggests that response to therapy 
may be influenced by lesion maturity and possibly antibiotic resistance patterns of 
etiologic agents. Topical antibiotic treatment under a bandage is particularly effective 
with most cows showing remarkable improvement within 24-48 hours.  However, 
concerns for the timely removal of bandages have caused some to recommend topical 
antibiotic treatment with a solution or paste without the use of a bandage.  Bandages 
also increase the possibilities of foot injury from wraps that are applied so tight that they 
interfere with normal blood circulation in the foot.  A Canadian study by Higginson and 
co-workers compared topical treatment with topical oxytetracycline under a bandage 
with a topical oxytetracycline paste and no bandage. Results demonstrated a significant 
advantage to treatment versus no treatment but when results between those treated 
topically with a bandage or no bandage there was no statistically significant difference 
between the treatment groups.    
 
Proper application of topical treatments has the potential advantage of reaching lesions 
affecting the interdigital skin and other areas that may not be accessible to topical spray 
or even footbath treatment. But, in the end, most agree that it’s a combination of these 
procedures that is most likely to be effective in managing DD lesions.  
 
Topical Treatment - The European Experience 
 
For many years the recommended therapy for DD was surgical removal of the lesion 
and trimming of the claw as needed. However, the more popular treatment used in 
Europe during the early 1980's was a combination product (not available in the US) 
consisting of topical oxytetracycline hydrochloride and gentian violet. The treatment 
procedure first described consisted of properly restraining the affected animal in a foot-
trimming chute whereby the foot was elevated or situated to permit examination.  Once 
the diagnosis of DD was confirmed, the lesion was thoroughly cleaned and then 
sprayed with the combination product. Efficacy was reported to improve to near 90% if 
the operator allowed the first topical treatment to dry and follow with a second topical 
treatment before turning the cow loose. Subsequent study demonstrated that the active 
ingredient in this combination product was oxytetracycline and that this product alone 
was sufficient to affect recovery. It is this observation that lends support to the idea of 
treating these lesions without the use of a wrap or bandage.   
 
Vaccination for Control of Digital Dermatitis 
 
Because of high recurrence rates and the inability to conveniently treat high risk groups 
of animals (such as growing heifers or feedlot cattle), an effective vaccine for control of 
DD is highly desirable.  Results from early studies of a Treponema bacterin for control 
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of DD in cattle concluded that immunization could reduce clinical disease.  In contrast, 
German researchers found no benefit from a vaccine containing herd-specific 
pathogens including Treponema sp.  Similar results were observed in a recent US field 
trial which found no therapeutic or prophylactic benefit from vaccination with a 
Treponema bacterin.  At the present time, there are no vaccines commercially available 
for control of digital dermatitis.   
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Introduction 
Since the 1990s timed AI protocols have been developed to improve the AI submission 
rate (number of cows that receive AI divided by the number of cows that are eligible to be 
inseminated over a 21 d interval), also known as heat or estrus detection rate, of lactating dairy 
cows. More recently, a better understanding of reproductive physiology has resulted in timed AI 
protocols that may result in pregnancy per AI (P/AI) of up to 45% in high producing lactating 
dairy cows (Santos et al., 2010; Souza et al., 2008). Nonetheless, the greatest benefit of timed AI 
protocols to reproductive performance of dairy herds is increased AI submission rates. Thus, 
often the decision of whether or not to use timed AI protocols is based on the AI submission 
rates achieved when AI occurs based only on estrous detection (ED). Other factors like accuracy 
of ED and compliance to the timed AI protocols chosen are also important to the reproductive 
performance. 
Upon the advent of timed AI protocols many suggested that daily ED of lactating dairy 
cows would no longer be necessary. Timed AI protocols make use of reproductive hormones like 
GnRH, prostaglandin (PG) F2α, and progesterone (P4). The use of these hormones for 
reproductive management of dairy cows may undergo scrutiny by consumers similar to what has 
been observed in regards to the use of antimicrobials possibly limiting their use. The recent 
growth in number of companies commercializing activity monitors for detection of estrus has 
resulted in several companies claiming that the implementation of such activity monitors would 
eliminate the need for timed AI protocols. 
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The goal of this brief review is to evaluate whether reproductive programs of lactating 
dairy cows may be solely dependent on timed AI protocols or AI on detected estrus. A few 
examples of dairies that have attempted to eliminate one or the other will be given, but I caution 
that some of these examples are merely data extracted from on farm software and not the result 
of controlled studies. 
 
The Challenges of Estrous Behavior for Lactating Dairy Cows 
Unquestionably lactating dairy cows have reduced expression of estrus compared with 
dairy heifers and beef animals because of physiological characteristics, often because of 
increased incidence of pathological conditions, and because of management. 
Immediately postpartum, cows undergo physiological anovular condition characterized 
by the lack of ovulation and formation of a corpus luteum (CL) until approximately 25 to 30 
days postpartum (Butler, 2000). However, cows that have postparturient diseases and undergo 
more severe loss of body condition score (BCS) have more prolonged anovular condition. Cows 
that had no change in BCS from calving to first postpartum AI (approximately 65 DIM) and 
cows that lost < 1 unit of BCS from calving to first postpartum AI were 2.0 and 2.4 times more 
likely, respectively, to be cyclic by 65 DIM than cows that lost > 1 unit of BCS during this 
period (Santos et al., 2009). Furthermore, cows diagnosed with mastitis early postpartum 
(mastitis = 39 vs healthy = 32 d; Huszenicza et al., 2005) and cows diagnosed as lame within the 
first 30 DIM (lame =34 vs healthy = 29 d; Garbarino et al., 2006) had prolonged anovular 
condition than healthy cows. Postponed resumption of ovarian cycles results in delayed 
establishment of pregnancy because of reduced AI submission rates and reduced P/AI (Chebel et 
al., 2010; Santos et al., 2009). 
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Limited access to open lots/dirt lots also seems to be a limiting factor for AI submission 
rate among lactating dairy cows. Vallies and Britt (1989) demonstrated that mounting activity 
was 15-fold greater for lactating dairy cows with access to open lots than cows housed solely on 
concrete.  
Onset of lactation affects expression of estrus by reducing concentrations of estradiol. 
Lopez et al. (2004) demonstrated that cows with greater milk yield (102.1 ± 0.9 lb/d) had 
reduced duration of estrus (6.2 ± 0.5 vs 10.9 ± 0.7 h) and reduced number of mounts during 
estrus (6.3 ± 0.4 vs 8.8 ± 0.6 mounts) compared with cows with reduced milk yield (73.7 ± 0.7 
lb/d). Furthermore, the same group demonstrated that high producing dairy cows (103 ± 2.2 lb/d) 
had reduced estradiol concentration on the day of estrus (6.8 ± 0.5 vs 8.6 ± 0.5 pg/ml) despite 
having larger follicles (18.6 ± 0.3 vs 17.4 ± 0.2 mm) compared with low producing dairy cows 
(71.1 ± 1.3 lb/d; Lopez et al., 2004). This resulted in reduced length of estrus (7 ± 1.1 vs 11.9 ± 
1.4 h) and number of mounts during estrus (6.5 ± 0.9 vs 9.8 ± 1) for high producing cows 
compared with low producing dairy cows (Lopez et al., 2004). Even though the reasons for the 
reduced estradiol concentrations of estradiol during estrus in lactating dairy cows are not 
completely elucidated, the currently most accepted hypothesis is that the elevated dry matter 
intake of high producing cows, necessary to meet nutritional requirements of lactation, results in 
greater blood flow through the liver, the most important site of steroidal hormones catabolism. In 
a series of experiments, Sangsritavong et al. (2002) demonstrated that onset of feed intake 
resulted in significant increase in blood flow to the liver and that the increase in blood flow was 
dependent on amount of feed consumed (Figure 1). Furthermore, lactating dairy cows fed 7.8 lb 
of dry matter had greater clearance rate of P4 at 1 and 2 h after feeding compared with unfed 
cows (Sangsritavong et al., 2002). Cows fed 23.4 lb of dry matter had greater P4 clearance rate 
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from 2 to 4 h after feeding than unfed cows, whereas cows fed 33.4 lb of dry matter had greater 
P4 clearance rate from 1 to 4 h after feeding compared with unfed cows (Sangsritavong et al., 
2002). Similarly, lactating dairy cows fed ad libitum had greater estradiol clearance rate from 2 
to 4.5 h after onset of feeding compared with unfed cows (Sangsritavong et al., 2002). 
Clearly, physiological and pathological conditions share the blame for reduced AI 
submission rates among lactating dairy cows. Because of the great importance of AI submission 
rate to the overall reproductive efficiency of lactating dairy cows, in herds where adequate AI 
submission rates are not achieved, different ED and/or AI submission strategies (i.e. timed AI 
protocol) should be implemented. 
 
Estrous Detection and Timed AI protocols: Complementary not Mutually Exclusive 
In one comprehensive survey conducted in 103 dairy herds from at least 12 states, 74.8% 
of the herds indicated that an estrus/ovulation synchronization program for first postpartum AI 
was implemented (Caraviello et al., 2006). When data from 33 million inseminations of Holstein 
and Jersey cows from Dairy Herd Improvement Association herds were analyzed, however, it 
was estimated that the percentage of herds that did not use synchronization protocols was 94.8% 
in 1996 and 72.5% in 2005 (Miller et al., 2007). Thus, it is clear that a lot of variability exists in 
regards to implementation of timed AI protocols let alone the types of timed AI protocols used.  
In general, the implementation of timed AI protocols results in reduced intervals from 
parturition to first postpartum AI, reduced variability in interval to first postpartum AI, and may 
reduce the interval from parturition to establishment of a new pregnancy (Miller et al., 2007). 
These beneficial results, however, are highly dependent on the base line reproductive 
performance of the herd before adoption of such protocols. Simply putting it, herds that achieve 
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good AI submission rates and P/AI without timed AI protocols do not necessitate the latter. In 
the opinion of this author, however, only when P/AI achieved through AI on estrus is extremely 
poor (poor ED accuracy) should programs based 100% on timed AI protocol be recommended. 
This is simply a matter of mathematics. Even though 100% AI submission rate may be achieved 
in the first 21-d cycle after the end of the voluntary waiting period (VWP) when 100% of cows 
are inseminated at fixed time at first postpartum AI, pregnancy diagnosis is not possible to be 
conducted until 25 d after AI at the earliest. Thus, re-insemination of nonpregnant cows could 
only occur as early as 28 d after a previous AI, resulting in the 21-d cycle immediately after AI 
with AI submission rate of 0% and the following 21-d cycle with AI submission rate of 100%. 
Thus, herds with 100% timed AI would struggle to achieve AI submission rate greater than 60%, 
depending on P/AI.  
Therefore, the question that must be answered is: what are the breakeven points in the 
decision for 100% timed AI, 100% ED, or both? To answer that question, we must take into 
consideration published research and the outcomes obtained with different timed AI protocols 
and the reported P/AI following AI on estrus. It is important to remind the readers that the 
numbers presented in peer-reviewed manuscript are often inflated because they result from well 
controlled studies and often sick cows (i.e. extremely lame, low BCS, etc.) and cows that fail to 
receive the appropriate treatments are removed from the study. 
One of the first experiments to evaluate the economic benefits of reproductive strategy 
based on ED or timed AI was conducted in Germany (Tenhagen et al., 2004). In this experiment, 
cows from two herds were either only inseminated based on estrus or were inseminated at fixed 
time until approximately 200 DIM. In the herd in which AI submission rate of cows inseminated 
on estrus was 29%, the timed AI protocol resulted in significant improvements in AI submission 
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rate (65%) and pregnancy rate (14 vs 25%). On the other hand, in the herd in which AI 
submission rate of cows inseminated on estrus was 55%, the timed AI protocol slightly increased 
the AI submission rate (70%), but had no significant effect on pregnancy rate (25 vs 29%). 
Consequently, in the herd with poor AI submission rate of cows in the ED treatment the addition 
of timed AI to the reproductive management resulted in reduced cost per pregnancy generated (€ 
363 vs € 264). On the other hand, the cost per pregnancy generated was similar among cows 
submitted to the ED protocol (€ 251) or the timed AI protocol (€ 272) in the herd in which AI 
submission rate of cows in the ED treatment was 55%. This was one of the first experiments to 
suggest that in herds that only inseminate cows in estrus and have AI submission rate greater 
than 55% the use of timed AI protocols may not be necessary. 
In two recent manuscripts, researchers compared the economic outcomes of reproductive 
strategies based on ED, timed AI, or a hybrid between ED and timed AI. These experiments used 
modeling techniques to simulate the economic return of the different reproductive programs. 
Giordano et al. (2001) evaluated economic return of reproductive programs for lactating dairy 
cows based on ED, the double Ovsynch protocol for first AI and the Ovsynch protocol for 
resynchronization of cows starting 32 d after the previous AI (DO-Res), and the double Ovsynch 
program for first AI and resynchronization (DO-DO). The DO-Res ($ 17 cow/year over the cost 
of the ED program) and the DO-DO ($ 21 cow/year over the cost of the ED program) programs 
were more expensive than the ED protocol. On the other hand, the DO-Res and the DO-DO 
protocols resulted in income per cow/year $ 45 and $ 69 greater, respectively, than the ED 
protocol. The authors, however, based their calculations of economic return on P/AI results from 
one study and on farm data for ED cows. As such, P/AI to first AI and resynchronization were 45 
and 30%, respectively, for DO-Res protocol, 45 and 39%, respectively, for DO-DO protocol, and 
 61 
 
33 and 30%, respectively, for the ED protocol. It is not surprising, therefore, that with such 
differences in fertility, the DO-DO and the DO-Res protocols resulted in greater economic return 
than the ED protocol. Nonetheless, P/AI of cows subjected to timed AI is not significantly 
greater that P/AI of cows inseminated following synchronized estrus based on several published 
manuscripts that did not use the Double-Ovsynch protocol (Chebel and Santos, 2010; Santos et 
al., 2009; Santos et al., 2004a; Tenhagen et al., 2004).  
Galvão et al. (2012) modeled reproductive performance and economics based on the 
adoption of one of ten breeding programs. The breeding programs evaluated were based on ED 
or timed AI and taking into consideration differences in ED efficiency (40 or 60%) and accuracy 
(85 or 95%), compliance to injections of the synchronization protocols (85 or 95%), and milk 
price ($ 0.33 or $ 0.44/kg). The reproductive programs evaluated were ED with differing ED 
efficiency and accuracy, timed AI for all with differing compliance to injections, and timed AI 
for first AI with differing compliance followed by ED with differing ED efficiency and accuracy. 
Pregnancy per AI for first AI was assumed to be 33.9% and P/AI of subsequent AI decreasing by 
2.6% for every AI, pregnancy loss was assumed to be 11.3%, cows were deemed not eligible for 
insemination if nonpregnant after 366 DIM, and were culled by 450 DIM if not pregnant. All 
costs associated with the reproductive programs and feeding were taken into consideration. Milk 
price was set at $0.33 or $0.44/kg, cull cows were sold for $0.65/kg of live weight, and calves 
were sold for $140/calf. Under these assumptions, when the herd used timed AI for first 
postpartum AI with 95% compliance to injections and ED for subsequent AI with ED with 60% 
efficiency and 95% accuracy the greatest 21-d cycle pregnancy rate was achieved (Figure 2A; 
Galvão et al., 2012). Similarly, this reproductive program resulted in the shortest median days to 
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pregnancy (113; Figure 2B) and the greatest profit per cow/year (profit of $375/cow for milk 
price = $0.33/kg; profit of $1,616/cow for milk price = $0.44/kg of milk). 
Therefore, postponing re-insemination of cows that return to estrus in order to submit 
them to timed AI protocols seems illogical because of the consequent increased interval to re-
insemination. As mentioned before, the only reason to avoid insemination and, particularly, re-
insemination in estrus is poor ED accuracy, which results in reduced P/AI of cows inseminated 
in estrus. Dairy farms in the USA commonly utilize timed AI protocols in association with 
insemination on estrus. Approximately 55% of dairy farms rely primarily on detection of estrus 
as the major method to inseminate cows (NAHMS, 2009). Among the winners of the award for 
Excellence in Reproductive Management of the Dairy Cattle Reproductive Council between the 
years of 2009 to 2011, 21 out of 24 used AI on detected estrus associated with timed AI protocol, 
2 out of 24 used only timed AI protocols, and 1 out of 24 used only AI on detected estrus. 
Recently, several companies have started to commercialize in the USA activity monitors 
for detection of estrus. These activity monitors are placed in the collars or legs of cows and 
determine the walking distance and pattern of cows. Once a cow presents an excessively elevated 
walking patter, the system flags the cow as a suspect for estrus. These systems have been used in 
other countries (i.e. Israel) for several years and have presented very good results. Interestingly, 
however, it has been proposed that implementation of electronic methods for detection of estrus 
would eliminate the need of any timed AI protocol because of its efficiency and accuracy. This is 
a somewhat ambitious claim, particularly considering the physiological and pathological 
challenges that affect onset of estrus and estrous behavior of high-producing lactating dairy 
cows. Anovulation, low estrous expression associated with high-production, and other less 
prevalent abnormalities such as persistent corpora lutea or pregnancy loss after day 21 of the 
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preceding AI would all reduce the efficacy of estrous detection and result in more nonpregnant 
cows being diagnosed at the day of pregnancy diagnosis. Some have claimed that electronic 
monitoring systems can detect 99% of the cows that display estrus. This high sensitivity should 
not imply that electronic monitoring systems will result in 99% AI submission rate. The key 
issues here are the cows that remain anovular after the end of the VWP (10 to 50% of cows 
depending on interval from calving, herd, parity, etc.) and cows that are not pregnant from 
previous inseminations that will not return estrus within 21 d after a previous AI. Therefore, 
anovular cows and the cows with abnormal inter-estrus interval would not be detected in estrus 
and AI submission rates, which are calculated using 21-d cycles, would likely be approximately 
50 to 60%, and not any higher. 
Nonetheless, until recently there were no controlled experiments to determine whether 
activity monitors could eliminate the need for time AI protocols completely. Two recent 
experiments, however, indicated that activity monitors are not able achieve AI submission rates 
of 90 to 95% as some companies were claiming for the simple fact that some cows will not 
display estrus. Valenza et al. (2011) fitted 42 cows with an activity monitor system (collar) and a 
mounting detection system (Kamar). The cows were synchronized and allowed to come in estrus. 
Cows were then examined by ultrasound to determine ovarian activity and occurrence of 
ovulation. In this small experiment, according to activity monitor and mounting detector 67 and 
62%, respectively, of cows were observed in heat and ovulated; 7 and 12%, respectively, of cows 
were not observed in heat and ovulated; 5% of cows were observed in heat and did not ovulate; 
and, 21% of cows were not observed in heat and did not ovulate. Therefore, based on an activity 
monitor system and a mounting detection system 28 to 33%, respectively, of cows were not 
observed in estrus. Furthermore, considering ovulation as the ‘gold standard’, cows that ovulated 
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and were in estrus were +/+, cows that did not ovulate and were in estrus were -/+, cows that 
ovulated and were not in estrus were +/-, and cows that did not ovulate and were not in estrus 
were -/-. Thus, the activity monitor system and the heat detection system resulted in sensitivity of 
91 and 84%, respectively, specificity of 81%, positive predictive value of 93%, and negative 
predictive value of 75 and 64%, respectively. Therefore, based on this small experiment the 
activity monitor and mounting detection system had similar performance. 
In a study presented at the 2012 American Dairy Science Association, researchers 
evaluated the insemination pattern and P/AI of cows that were fitted with activity monitors and 
were submitted to the Ovsynch protocol with ED (Ovs), to the Presynch/Ovsynch with ED 
(PresOvs), and to the Presynch/Ovsynch protocol without ED (100%TAI; Fricke et al., 2012). In 
this study, 70% of cows that received the two PGF2α presynchronizing injections were observed 
in estrus, whereas approximately 57% of cows that were not presynchronized with PGF2α were 
observed in estrus. The P/AI of cows inseminated in estrus was 30% and the P/AI of cows 
inseminated at fixed time was 36%. These numbers are very similar to those reported by 
Stevenson and Phatak (2005), Chebel et al. (2006), Lima et al. (2009), and Chebel et al. (2010). 
In these studies the percentage of cows that were inseminated in estrus after two 
presynchronizing injections of PGF2α ranged from 50 to 62%. On the other hand, P/AI of cows 
inseminated in estrus ranged from 27 to 44% and P/AI of cows inseminated at fixed time ranged 
from 21 to 41%. The results from these studies suggest that activity monitors may perform just 
as well as detection of estrus based on tail paint removal and that P/AI of cows inseminated in 
estrus based on activity or tail paint removal may be similar, these being extremely dependent on 
farm and personnel.  
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Field observations of two herds that adopted the activity monitor systems for estrus 
detection and abolished the use of fixed time AI for first postpartum AI demonstrate that there is 
a significant risk of increasing significantly the variability in interval to first AI, increasing 
interval to first postpartum AI, and reducing AI submission rate and pregnancy rate. In figure 3A 
and 3B, the patterns of first postpartum AI of herds that started using timed AI protocols for first 
postpartum AI are depicted. In figure 3C and 3D, the patterns of first postpartum AI of herds that 
stopped using timed AI protocols once they implemented activity monitoring systems are 
depicted. Although this is not data from controlled studies, it is possible to observe that once 
timed AI protocols stopped being used in the herds that adopted the activity monitoring system 
their pattern of first postpartum AI started to resemble the pattern of first postpartum AI before 
timed AI protocols were widely adopted. 
 
Conclusions 
It is widely known that estrous expression and estrous detection of lactating dairy cows 
are compromised by several physiological, pathological, and managerial factors. The advent of 
timed AI protocols has resulted in significant improvements AI submission rates, a very 
important component of reproductive efficiency and perhaps the easiest parameter manipulate 
with different managerial strategies. Activity monitoring systems are also an exciting tool for the 
reproductive management of dairy cows that has significant value. Nonetheless, the selection of 
reproductive strategies should be made in light of estrous detection efficiency and accuracy and 
in light of availability of facilities and personnel. 
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Figure 1. Effect of feed intake on liver blood flow. Adapted from Sangsritavong et al. (2002). 
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Figure 2A. 
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Figure 2B. 
Figure 2. Profits per cow per year ($/cow/year) of cows subjected to 1 of 10 breeding programs: 
1) ED at 40% efficiency and 85% accuracy; 2) ED at 40% efficiency and 95% accuracy; 3) ED 
at 60% efficiency and 85% accuracy; 4) ED at 60% efficiency and 95% accuracy; 5) timed AI 
for all AI (85% compliance); 6) timed AI for all AI (95% compliance); 7) timed AI for first AI 
(85% compliance) followed by ED at 40% efficiency and 85% accuracy;  8) timed AI for first AI 
(95% compliance) followed by ED at 40% efficiency and 85% accuracy; 9) timed AI for first AI 
(85% compliance) followed by ED at 60% efficiency with 85% accuracy; and 10) timed AI for 
first AI (95% compliance) followed by ED at 60% efficiency with 95% accuracy. In panel A, 
bars represent the profit per cow per year calculated using milk price at $ 0.33/kg and dashed 
lines represent the 21-day cycle pregnancy rate. In Panel B, bars represent the profit per cow per 
year using milk price at $ 0.44/kg (panel B). Dashed lines represent either the 21-day cycle 
pregnancy rate (panel A) or median days open (panel B). Courtesy of Ribeiro et al. (2012): 
Adapted from Galvão et al. (2012). 
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Figure 4A. Pattern of first postpartum AI of a dairy herd in CA (1,600 lactating cows) that 
implemented timed AI starting December of 2003. 
 
 
Figure 4B. Pattern of first postpartum AI of a dairy herd in CA (2,300 lactating cows) that 
implemented timed AI starting August of 2002. 
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Figure 4C. Pattern of first postpartum AI of a dairy herd in MN (3,100 lactating cows) that 
implemented the activity monitoring system without timed AI starting January of 2011. 
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Figure 4D. Pattern of first postpartum AI of a dairy herd in MN (800 lactating cows) that 
implemented the activity monitoring system without timed AI starting May of 2011. 
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New developments in pregnancy diagnosis 
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Introduction 
 
Pregnancy testing in dairy cattle has evolved over time.  The simplest and most definitive test for 
pregnancy is to wait until the cow gives birth to the calf. This approach is perhaps acceptable for 
extensive systems but for intensive systems waiting until calving to identify the pregnant or 
nonpregnant (open) cows takes too long. The desire for an earlier pregnancy diagnosis led to the 
routine use of rectal palpation of the uterine contents for the purpose of detecting the pregnancy. 
Although traditionally practiced from 40 to 60 days after insemination or later, pregnancy 
diagnosis by rectal palpation can be pushed to its limit of detection (30 to 35 days after 
insemination) to identify open cows sooner. Additional sensitivity can be achieved by using 
transrectal ultrasound for pregnancy detection. Transrectal ultrasound can be used as early as 25 
days after insemination but is more typically applied after day 30 (Fricke, 2002). If performed 
later (60 to 80 days) then the sex of the calf can be determined when ultrasound is used. 
Although ultrasound represents a definitive test for pregnancy and can be used to determine the 
sex of the calf, it requires specialized equipment. The examination generally requires more time 
than rectal palpation. Regardless of whether rectal palpation or ultrasound is used, an individual 
with highly specialized training performs the diagnosis. This individual is typically a veterinarian 
or, in some cases, may be a reproductive specialist that is an employee of the farm. 
 
A changing cattle industry may affect how pregnancy diagnoses are performed in the future. 
Intensification of reproductive management in dairy herds and the implementation of 
resynchronization programs are creating the need for more accurate and timely diagnoses of 
pregnancy. At the same time, there is a shortage of large animal veterinarians in some regions 
(Jensen et al., 2009). The shortage of large animal veterinarians has put pressure on a limited 
number of experienced veterinarians to complete a large number of pregnancy diagnoses. 
Collectively, these factors are creating an opportunity for the application of chemical pregnancy 
testing (for example, blood and milk-based tests for pregnancy). The cattle industry is clearly 
moving toward alternative methods of pregnancy diagnosis that do not require skilled 
practitioners or specialized equipment. 
 
Physiological and theoretical aspects of four tests 
 
If cattle were people then the solution would be simple. The human pregnancy produces a large 
amount of a hormone called hCG (human chorionic gonadotropin) that passes into the urine and 
can be detected by a simple lateral flow ELISA test. This test is done by women in their homes. 
Unfortunately cows do not make bovine chorionic gonadotropin (or any such molecule that is 
readily detectable in the urine) so a simple test that is similar to the human test is not available. 
There are, however, a series of candidate molecules associated with pregnancy in cattle (Figure 
1). These molecules include: “early pregnancy factor”, interferon-stimulated genes (ISGs), 
progesterone, and pregnancy-associated glycoproteins (PAGs).   
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Figure 1. Four chemical tests for pregnancy.  Pregnancy can be detected at different intervals 
after insemination by measuring different chemicals in the blood or milk. In this figure, the 
uterus, embryo (grey structure within the uterine horn), and ovary (ovoid structure with circular 
corpus luteum) are depicted. The ECF test (left-most depiction) was reported accurate on day 2 
but the test was later shown to be inaccurate at any time. Other tests measure the biological 
response to interferon-τ (day 16 to 18), progesterone in blood or milk (day 18 to 23), or 
pregnancy associated glycoproteins in blood or milk (PAG; after day 25). See text for details on 
the individual tests.  
 
Early Pregnancy Factor 
 
A chemical test for pregnancy termed Early Pregnancy Factor (EPF) or Early Conception Factor 
(ECF) was proposed and marketed in the 1990’s (Concepto Diagnostics, Knoxville,TN). This 
molecule was supposedly present in the blood of pregnant cattle within two days after 
conception. The exact nature of this molecule (an immunosuppressive glycoprotein protein) and 
how it got into circulation were not well defined but nonetheless it could be assayed by using a 
rosette inhibition test (Nancarrow et al., 1981).  A kit for pregnancy diagnosis reached the market 
but studies found that the kit was unreliable for pregnancy diagnosis (Cordoba et al., 2001; 
Gandy et al., 2001). 
 
The possibility of performing an early pregnancy diagnosis (within one day after insemination) 
is, of course, intriguing in as much as it may be possible to resynchronize open cows within one 
week after insemination. To our knowledge, very little is known about the secretions of the early 
bovine embryo (within one week after conception). Detection of these secretions in blood, milk, 
or urine for the purpose of pregnancy diagnosis is an interesting area for investigation. There 
would theoretically be a large amount of embryonic loss after the diagnosis but the truly 
nonpregnant cow could be dealt with in a timely manner (within one week after insemination).  
 
  
77 
 
Interferon-stimulated gene expression 
 
The early embryo forms a blastocyst and hatches out of the zona pellucida at approximately one 
week after fertilization. During the second week, it continues to grow, becomes spherical, and 
during the third week elongates to form the filamentous embryo. It is during this transition from 
the spherical to elongated form that the embryo produces interferon-τ (INFT). The INFT is 
produced in large amounts by the embryo after day 14 to signal the mother and establish the 
pregnancy (Roberts, 2007). The INFT secretion is transitory. It reaches a maximum by 20 to 24 
days and is completely gone by day 30 of pregnancy. The IFNT is unlike hCG because its 
expression is transitory and it does not accumulate in the blood or urine. Thus, IFNT cannot be 
used for a pregnancy test in the blood or urine of the cow. 
 
Although the INFT cannot be assayed directly in blood, its presence can be detected through its 
action on leukocytes (white blood cells). Interferon-τ is a cytokine, a class of molecules that has 
the capacity to stimulate leukocyte function. The leukocyte response to INFT can be monitored 
by measuring the expression of secondary proteins that are called “interferon-stimulated genes” 
(ISGs) within leukocytes (Gifford et al., 2007). Examples of ISGs are MX2, ISG15 and OAS1. 
An example of the ISG response is shown in Figure 2 (data for MX2). In this experiment, dairy 
cows were blood sampled on days 14, 16, 18, and 20 after insemination and were later diagnosed 
as either pregnant or open by ultrasound. The RNA from the leukocytes was extracted from the 
blood and analysed by using a process called “reverse-transcriptase PCR” (RTPCR). The graph 
shows that the expression of MX2 increases in the leukocytes of pregnant cows particularly on 
days 18 and 20. This increase in the MX2 represents the leukocytes responding to the IFNT 
produced by the embryo.  
 
Figure 2. Ratio of MX2 to cyclophilin gene expression 
in leukocytes isolated from cows on days 14, 16, 18, 
and 20 after insemination. Compared with open 
(nonpregnant) cows, the pregnant cows have an 
increase in the ratio. The increase in MX2 relative to 
cyclophilin (control gene) can be used as an indication 
or pregnancy. 
 
 
 
 
Despite their promise as a diagnostic tool for pregnancy detection, the ISGs have not seen 
commercial application. The current and most reliable assay method involves RNA extraction 
and RTPCR. The RNA in leukocytes is a highly labile molecule and blood samples would 
theoretically require special handling before analysis. The RTPCR is a cumbersome and time-
consuming laboratory process (relative to ELISA, for example). Although individual cows may 
give a strong signal by day 18, our experience is that a consistent signal is not achieved until day 
20 after insemination. This is only five days earlier than the simpler and perhaps more reliable 
PAG test (see below). A breakthrough in this area may come if the protein instead of the RNA 
for ISGs could be measured in blood or milk or if IFNT itself could be measured in blood or 
milk.  
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Progesterone monitoring 
 
Measuring progesterone in blood or milk as a method to identify open (nonpregnant) cows was 
perhaps the first true example of chemical pregnancy testing. If a cow is not pregnant then she 
will theoretically have a decrease in progesterone at approximately 21 days after insemination. If 
she is pregnant then her progesterone concentrations will remain elevated. There is excellent 
physiological underpinning for the progesterone test because cows cannot be pregnant if they 
have low (less than 1 ng/mL) progesterone 21 days after insemination. The test can be done on 
the farm (milk progesterone test for dairy cows) or in the laboratory. When done on the farm and 
with a single sample (for example on day 21) progesterone testing is an excellent method for 
identifying a truly open cow. If a cows tests low for progesterone then she is not pregnant 
(progesterone testing has a high negative predictive value). If a cow tests high for progesterone 
then she may be pregnant (progesterone has a low positive predictive value). The low positive 
predictive value arises from a number of reproductive cycle-related issues that cannot easily be 
resolved if a single measurement for progesterone is made.  
 
DeLaval recently introduced a new system (Herd NavigatorTM; http://www.delaval.com/en/-
/Product-Information1/Management/Systems/herdnavigator/Heat-detection/) that automatically 
samples cows for milk progesterone. This new system is not available in the United States but is 
currently in use within Europe and Canada. Milk from cows is sampled automatically based on 
the reproductive status of the cow. When multiple days are sampled and displayed graphically, 
estrous cycles are detected (Figure 3; the successive increases and decreases in progesterone are 
estrous cycles that occur during the postpartum period). It is possible to link the progesterone 
measurements to activity monitoring so that periods of estrus can be accurately identified. With 
this system, progesterone can be used to diagnose pregnancy. If a cow is inseminated and her 
milk progesterone concentrations remain elevated beyond 21 days then she is in all likelihood 
pregnant. There is limited published data on this new system for its use in pregnancy diagnosis 
but milk progesterone monitoring within the Herd Navigator system should theoretically be 
accurate. False positives would occur in cows with persistent corpora lutea; a phenomenon that is 
relatively rare in cows that are cycling normally.   
 
Figure 3. Screen shot of 
progesterone plot from a 
postpartum dairy cow (DeLaval 
Herd Navigator System). A 
series of estrous cycles are 
displayed. The cow has an 
increase in activity (triangles) 
when progesterone 
concentrations decrease. A 
sustained increase in 
progesterone (final cycle) 
indicates that the cow is 
pregnant after AI. 
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Pregnancy-associated glycoproteins (PAGs) 
 
Binucleate cells are specialized cells of the placenta that migrate and fuse with the epithelium 
that lines the uterus. Placental proteins synthesized by binucleate cells are secreted into the blood 
and circulate throughout the cow. One type of placental protein secreted by the binucleate cells is 
the pregnancy-associated glycoprotein (PAG). The PAGs consist of a large family of more than 
20 closely related proteins that are only produced by the placenta (Telugu et al., 2009).  They can 
be detected in the blood of pregnant cows beginning at approximately 25 days after insemination 
(Green et al., 2005). This family of proteins is expanding in the bovine genome but their function 
is unknown. Monitoring the concentrations of PAGs in blood or milk is an effective method of 
pregnancy detection. 
 
The original work on PAGs was done by Sasser et al. (1989) in which they described proteins in 
the blood of pregnant cows. The protein that they isolated was called “pregnancy-specific protein 
B” or PSPB. The PSPB is a member of the PAG family of proteins produced by the placenta.  
The original PAG (PSBP) test is commercially available through BioTracking, LLC (Moscow, 
ID) or through one of the commercial labs affiliated with BioTracking. The test is trade-named 
“BioPRYN”. Blood samples are collected from cattle that are approximately 30 days after 
insemination and shipped at room temperature. Data (pregnancy status of individual animals) are 
returned to the producer via telephone, mail, fax, or email. The test has an extremely high 
negative predictive value (99.9%; data provided on company website). The high negative 
predictive value means that if a cow is diagnosed open than she is definitely open. The positive 
predictive value is also extremely high (approximately 95%) but slightly lower than the negative 
predictive value. The slightly lower positive predictive value is caused by a small percentage of 
pregnant cattle that undergo embryonic loss after testing. Pregnant cattle that undergo embryonic 
loss will initially test positive (pregnant) but will later be found open because the embryo died 
(Figure 4). The PAGs from the previous pregnancy are found within the blood stream for several 
months after calving. There is a 2 to 3 month waiting period, therefore, before testing a cow for 
pregnancy (Figure 4). Virgin heifers can be tested at any time because a positive result cannot be 
confused with a previous pregnancy. 
 
Figure 4. Conceptual diagram of the 
blood PAG concentrations in 
postpartum cattle. At calving, the blood 
PAG concentrations are extremely 
high. For boPAG-1 (PSPB), 60 to 90 d 
are required for the PAG from the 
previous pregnancy to entirely clear the 
blood stream. In this example, the AI is 
65 days postpartum and cows are tested 
at 95 days. Pregnant cows have 
elevated PAG whereas open cows do 
not. A cow that undergoes embryonic loss (Em loss) will have an increase in PAG until the 
embryo dies. The PAG will decrease in blood after the embryo dies and will require 1 to 2 weeks 
to clear from the blood stream.   
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In addition to the BioPRYN test there are two additional commercially available PAG tests. 
Conception Animal Reproduction Technologies (Beaumont, Quebec, Canada) has partnered with 
AgSource Cooperative Services and Genex Cooperative (Cooperative Resources International, 
CRI, Shawano, WI) to market a test called DG29. The second commercially available test is 
being marketed by IDEXX laboratories (Westbrook, ME). The results for the IDEXX test and 
BioPRYN test are essentially the same (Figure 5; blood samples collected 25 days after AI). The 
IDEXX test takes less time to complete (about 3 h) when compared with the traditional 
BioPRYN test (overnight). Both product inserts state that cows can be tested 28 days after AI. 
There are differences in terms of when the test can be used. The cows should be at least 60 days 
postpartum for the IDEXX test and at least 73 days postpartum for the BioPRYN test. We 
mistakenly tested cows too early with BioPRYN and had two “false positive” diagnoses that 
were not seen with IDEXX (wells A6 and H1; Figure 5). 
 
Figure 5. Side by side comparison of IDEXX and BioPRYN pregnancy tests for blood samples 
collected 25 days after AI. Dark color indicates pregnancy. The tests perform nearly identically. 
The only difference was for two cows (A6 and H1) where the IDEXX diagnosis was negative 
and the BioPRYN diagnosis was positive. These two cows were 61 and 70 days postpartum 
(below the established cut-off for BioPRYN but after the established cut-off for IDEXX). 
 
IDEXX has recently release a milk PAG test. The product insert for the milk test states that it can 
be used 35 days after AI. Like the blood test, cows should be at least 60 days postpartum. In a 
recent study, the milk test had a positive predictive value of 99.8% when used in cows that were 
at least 60 days pregnant (LeBlanc, 2013).  The recommendation from the study was that the test 
can be used to confirm pregnancy in cows that were previously diagnosed pregnant. Any cow 
with a negative test should be checked by using traditional palpation or ultrasound before 
additional action is taken. We have tested the IDEXX milk test in our lab (Figure 6). Our 
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preliminary data indicate that the milk test is equivalent to the blood test in terms of the intensity 
of the signal and the days after AI that cows can be tested. 
 
Figure 6. Results from an IDEXX milk pregnancy test. 
The milk test is based on PAG (the same placental protein 
that is tested when the blood test is performed). Results 
from the IDEXX milk test are shown to the left. Dark 
color indicates a positive test. The cows on d 27 after AI 
had not been pregnancy diagnosed at the time of the milk 
test. The cows tested in E1, H1, A2, B2, and E2 where 
subsequently diagnosed pregnant. The d 34, d 41, d 48, d 
55, and d 62 cows were known to be pregnant. There were 
“open” cows in the pregnancy test as well. There was one 
open cow that tested positive. She was presumably 
undergoing embryonic loss.  
 
 
 
 
 
 
 
The advent of reliable and affordable PAG assays for pregnancy testing in cattle creates options 
for early pregnancy diagnosis (25 to 30 days after insemination).  Transrectal ultrasonography 
can be used within approximately the same time frame as the PAG test (Fricke, 2002). There are 
advantages of ultrasonography when compared with the PAG blood test. For example, 
ultrasound provides an instantaneous diagnosis of pregnancy and the ability to evaluate uterine 
and ovarian morphology of nonpregnant animals. It may also be possible to identify dead 
embryos and nonviable pregnancies when the ultrasound is used. These advantages must be 
weighed against the cost of ultrasound equipment, the technical skill required when performing 
the ultrasound procedure, and whether or not the farm has access to someone who can do early 
pregnancy diagnosis with ultrasound (Fricke, 2002).  
 
Integrating pregnancy tests into a reproductive program 
 
Pregnancy diagnosis from a blood sample enables the detection of nonpregnant (open) cows 
sooner after insemination. Commercially available blood PAG tests can reliably be performed at 
28 days after insemination. We routinely perform PAG tests at 25 days after insemination (3 
days earlier than the recommended minimum). In all likelihood, future tests for pregnancy will 
decrease further the interval between insemination and pregnancy detection. For example, if the 
ISGs are used then an interval as short as 18 to 20 days may be achievable (Figure 2).  
Shortening the interval between insemination and pregnancy detection enables a shorter interval 
between successive inseminations for herds performing synchronization and resynchronization 
without estrous detection. Giordano et al. (2013) concluded that a shorter interval between AI for 
non-pregnant cows yielded the greatest economic return regardless of the level of estrous 
detection. Using a chemical test for pregnancy may enable a shorter interval between AI.  
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A perceived downside of earlier pregnancy diagnosis is that some cows diagnosed pregnant will 
later be found open because pregnancies are lost over time when embryos die. Most cows are 
pregnant shortly after insemination but there are sequential periods of embryonic loss until the 
end of pregnancy. Most of the embryonic loss occurs before the placenta is fully formed at 
approximately 60 days after insemination (Santos et al., 2004). If cows are checked too early 
then a high percentage of the cows diagnosed as pregnant will later be found open because they 
have lost their pregnancies through the natural process of embryonic loss (Figure 7). If the cows 
are checked too late then open cows go undiagnosed for too long. In these open cows, earlier 
pregnancy detection could enable corrective intervention (for example resynchronization) so that 
they have an additional opportunity for a pregnancy to AI. In their economic analyses, Giordano 
et al. (2013) found that the advantage of using a chemical test to decrease the intervals between 
AI outweighed the potential disadvantage of diagnosing a pregnancy in a cow that will later 
undergo embryonic loss. 
 
 
 
Figure 7.  Conceptual diagram showing important considerations when making a decision about 
when to perform pregnancy diagnosis after an AI. A high percentage of cows are pregnant soon 
after insemination (top panel, left part of graph). The percentage of pregnant cows decreases over 
time because of the natural process of embryonic loss. If cows are pregnancy diagnosed (“Preg 
checked”) too early then many cows that are correctly diagnosed as pregnant will lose their 
pregnancies during the embryonic loss period. The losses may diminish the value of the early 
diagnosis. If the preg check is scheduled too late (after most of the loss is completed) then an 
open cow may not be identified until too late.  
 
Conclusions 
 
Dairymen have options for pregnancy diagnosis. The traditional method of manual palpation is 
widely practiced. In some areas, ultrasound is performed so that more information is collected 
and pregnancies are detected sooner after insemination. In some geographical regions, there are 
too few skilled practitioners that can perform pregnancy diagnosis by manual palpation or 
ultrasound. In these places, blood and milk pregnancy tests for PAGs are a viable option for 
pregnancy diagnosis that can be used at any time after 28 days of pregnancy. The PAG tests are 
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based on well-understood physiology and are commercially available from at least three 
suppliers at competitive prices.  There is also the possibility of ISG tests that could determine 
pregnancy by 18 to 20 days after insemination. If cows are checked too early, however, then a 
high percentage of the cows that are diagnosed as pregnant will later be found open because they 
have lost their pregnancies through the natural process of embryonic loss. An appropriate method 
for pregnancy diagnosis depends on the objectives of the reproductive program and 
considerations that are unique to each individual farm. 
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The power of genomic evaluations for herd improvement.  
C. G. Sattler, Select Sires, Inc.  
Introduction 
Rapid developments in DNA‐testing technology have led to dramatic changes in genetic improvement 
practices in the dairy industry in recent years. DNA marker information can now be used in genetic 
evaluations and this provides us with more accurate genetic information on young animals than what 
was previously available. Use of these methods has been widely applied by AI companies over the last 
five years which has led to more advanced genetics being provided by today’s AI sires. Continued 
advances in DNA‐testing technology have reduced the cost of DNA tests and there now may be 
opportunities for practical use of genomic evaluations in managing heifers and cows in commercial 
dairies. 
The old adage of “mate the best to the best and hope for the best” is the general approach used in 
cattle breeding schemes. Since the 1970’s, this practice was followed up with progeny testing of dairy AI 
sires to identify which individuals inherited a favorable set of genes from its parents. Once identified, 
these individual bulls were then made available to the industry for wide‐scale AI use. This process takes 
over three years, is expensive and limits the number of animals that are “tested” to see if they inherited 
a favorable set of genes. 
Today, the process begins the same way. But, with genomic evaluations, a DNA test can be run at birth 
to see if the resulting animal received a favorable set of genes from its parents. This allows AI companies 
to “test” hundreds of thousands of bulls rather than the couple of thousand bulls that previously had 
the opportunity to be progeny tested. This same approach, on a smaller scale, may provide some new 
opportunities to improve the management of herd replacements. 
How do genomic evaluations work? 
The cattle genome contains 30 chromosomes, 3 billion base pairs and 10,000+ genes. For decades, the 
dairy industry, through the DHI system, has been accumulating a large and powerful database of 
individual animal performance information. The sequencing of the bovine genome, published in 2006, 
directly led to the development of DNA chips that allowed affordable testing of a large number of 
markers. The dairy industry then invested in an effort to run these comprehensive DNA tests on a wide‐
range of historical bulls with completed progeny tests. The combination of comprehensive DNA 
information on a large number of reliably progeny‐tested bulls provided the resource needed to identify 
associations between sections of chromosome and important performance traits that make genomic 
evaluations effective. 
Table 1. Number animals in the April 2013 genomic evaluation reference population. 
  Holstein  Jersey  Brown Swiss Ayrshire
Progeny‐tested bulls  21,904  2,855  5,381  639 
Cows with lactation records  38,042  10,186 575  3 
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Genomic evaluations improve the accuracy of genetic evaluations in two ways. First, it helps us more 
accurately track the pedigree makeup of an individual. DNA testing allows us to identify the parents and 
grandparents with virtually 100% accuracy. In addition, there is no longer an assumption that an 
individual’s DNA is equal 25% portions from each of its grandparent. The DNA information can be used 
to adjust these percentages based on the sections of chromosome the animal actually inherited. 
Knowing the contribution of the grandparents with more precision is helpful because the grandparent’s 
genetic merit is often known with fairly high accuracy (especially the males). 
The second way genomic evaluations improve accuracy is that with a large enough reference population 
the evaluations are able to identify relationships between sections of chromosomes and the traits that 
are evaluated. A lot of research has been done over the years to identify major genes and how they 
relate to economically important traits but, at this point, the genomic evaluations use none of that 
information. The methods rely on a dense set of DNA markers evenly scattered across all the 
chromosomes to capture a large percentage of the sequence variation that exists in our cattle. Then, 
with a large enough database, it can be determined how the parts of the chromosome affect the 
measured traits. Animals’ evaluations are adjusted based on the sum of the chromosome effects it 
received from its parents.  
Figure 1. Chromosome map for net merit dollars (NM$) of 7HO11351 Supersire. 
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Our current state of knowledge about individual genes and how different genes interact with each other 
is still very crude. Because of this, the accuracy of genomic evaluations is far from perfect. However, by 
using the DNA marker information available with current tests and using this to make better use of the 
large historical database of performance records that’s available, the genetic merit of young animals is 
estimated more accurately than with traditional evaluations. Table 2 shows the accuracy improvement 
of genomic evaluations in heifers.  
Table 2. Comparison of April 2013 genomic and traditional evaluations. 
Trait  Breed 
Genomic 
Reliability
Traditional
Reliability  Difference
Daughter 
Equivalents 
Milk  Holstein  71  28  +42  24.9 
Jersey  61  32  +29  11.3 
Brown Swiss  58  33  +25  9.2 
Somatic 
Cell 
Score 
Holstein  67  25  +42  54.5 
Jersey  54  27  +27  26.3 
Brown Swiss  54  29  +25  24.4 
Daughter 
Pregnancy 
Rate 
Holstein  62  22  +40  133.3 
Jersey  45  23  +22  51.8 
Brown Swiss  41  24  +17  37.6 
Productive 
Life 
Holstein  63  22  +41  70.7 
Jersey  47  23  +24  28.9 
Brown Swiss  49  26  +23  29.5 
Overall 
Conformation 
Holstein  70  25  +45  25.5 
Jersey  57  29  +28  11.4 
Brown Swiss  57  32  +25  10.8 
  
One of the real benefits of genomic evaluations is that it provides more accurate genetic information on 
the health and fertility traits earlier in an animal’s lifetime. For instance, with a trait like daughter 
pregnancy rate (DPR), without genomic evaluations, a bull would reach eight years old until 133 
daughters‐worth of DPR information was gathered. While the genomic evaluations for DPR are only 62% 
reliable, it provides enough genetic information on both males and females to make useful decisions 
when animals are in their prime reproductive years.  
The values in Table 2 are theoretical estimates of improved accuracy based on the statistical 
assumptions used in the genomic evaluation model. USDA does historical analyses to check the 
assumptions and they adjust the assumptions as needed. It still is useful, though, to check whether the 
published values are delivering improved accuracy in practice. Table 3 compares the genomic 
predictions of AI sires when they were young calves to the actual yield differences seen in their 
daughters after they completed their progeny test.  
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Table 3. Genomic and traditional evaluations of AI sires compared to actual progeny milk production. 
 
No. of  
Bulls 
Correlation 
Apr. ’10 Genomic Prediction to
Dec. ’12 Dtr. Yield Deviation 
Correlation 
Apr. ’10 Parent Average 
Dec. ’12 Dtr. Yield Deviation 
Holstein  1,484  0.75  0.55 
Jersey  305  0.69  0.57 
 
The improvements in accuracy seen in practice don’t quite match theoretical estimates. However, there 
are some key factors to keep in mind when making this comparison. The December 2012 progeny test 
results shown in Table 3 are based on a daughter group size of roughly 100 daughters. These are enough 
daughters to detect genetic differences between bulls but not nearly enough daughters to estimate the 
genetic merit of each bull with 100% accuracy. So, the standard of accuracy used in Table 3 may change 
as more daughter data on these bulls is gathered. Also, the accuracy values in Table 2 reflect the 
accuracy in today’s genomic evaluations while the genomic evaluations used in Table 3 were from 2010 
which may not have been as accurate. As animals with performance information and DNA test results 
are added to the database, the accuracy of the genomic evaluations gets incrementally more accurate. It 
is comforting to see that actual results experienced by AI companies show that genomic evaluations are 
significantly more accurate than the traditional genetic evaluations. 
Table 4. Current genomic testing options 
Chip Type 
No. of 
Markers 
Genomic 
Evaluation
Reliability  Price 
Low density  6,000 – 10,000  72%  $37 ‐ $50 
High density  50,000 – 80,000  75%  $75 ‐ $125
 
With strong evidence showing that genomic evaluations deliver improved accuracy the challenge then 
becomes how should breeding programs be adjusted to best take advantage of this increased accuracy? 
Table 4 displays the current genomic testing options and their prices. Prices can vary depending on the 
size of the chip and the number of animals being tested. This is a rapidly developing area and we’re 
likely to see a steady stream of testing options becoming available. Recent advances include expanding 
the low density chip to gain an improvement in genomic evaluation reliability. Also, several chips are 
available that combine genomic testing with testing for individual traits. Breeders can now get 
information about an animal’s genotype for coat color, horned/polled and a variety of genetic defects at 
the same time as they are running a genomic test. The low density chip is used for almost all the testing 
done by commercial herds. The high density test is used for AI bulls and for elite females.  
How this new tool should be used in a breeding program is a more difficult question. Let’s follow the 
paths of selection, in their order of importance, to discuss the opportunities. 
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Sires of bulls 
Because of the heavy use of AI in the dairy industry, this is the most powerful selection step in 
generating genetic improvement. Prior to the availability of genomic evaluations and the increasing 
attention given to health and fertility traits, the tendency of the industry was to use older bulls that had 
an established track record of transmitting both improved production as well as improved fitness traits 
as sires of the future AI bulls. This trend has shifted back to using younger sires as bull fathers because 
of the improved accuracy delivered by genomic evaluations. In fact, over 50% of today’s AI bulls are 
results of matings to bulls that don’t yet have progeny test results. Because of this the real evaluation 
accuracy of sire fathers is slightly lower today with genomic evaluations. But, the bulls with the best 
genetics are being used at much younger ages than previously. It is believed that this advance in 
generation interval will overcome the slight reduction in selection accuracy and the next generation of 
AI sires will be superior to today’s offering.  At this point, time will tell us whether this is an effective 
strategy and what is the best balance between generation interval and selection accuracy. 
Dams of bulls 
Genomic evaluations have delivered a big improvement in our capability to select the best cows to work 
with to produce the next generation of AI bulls. Traditionally we’ve relied on production records and 
classification scores to help us identify the cows with the best genetics. This process was complicated by 
the commercial reality that it was important to make sure cows with marketing potential also had good 
performance. Genomic evaluations provide better capabilities to separate out whether superior 
performance is due to genetics or management.  
In addition, the affordability of DNA testing has expanded the pool of cows that are now eligible to 
become bull mothers. Geography was a key limiting factor for a sire analyst in tracking potential bull 
mothers prior to genomic evaluations. Genomic evaluations now provide a new common standard that 
makes it easier for breeders from all corners of the globe to establish credibility of their cows and get on 
AI companies’ radar screens. 
Many AI companies have taken a more hands‐on approach in developing the cow families used in 
producing AI sires. Because of the improved accuracies of genomic evaluations, it is more valuable than 
ever to make sure that the heifers with the best genetics have full opportunity to generate pregnancies 
using advanced reproductive technologies. Use of in‐vitro fertilization and embryo transfer in heifers has 
greatly expanded since the introduction of genomic evaluations. Many AI companies also own a herd of 
donor females so that they have more control and influence over the timing of embryo production and 
the mating combinations that occur in those critical early stages of the heifer’s reproductive career. 
Sires of cows 
Due to the changes in AI Company practices mentioned above, the genetic level of AI sires available to 
dairy producers is higher than ever. The number one priority for dairy producers is to fine‐tune their 
breeding practices and make sure they are maximizing the number of cows getting pregnant to AI sires. 
A variety of programmed breeding protocols, heat detection aids and activity monitoring systems are 
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available today that are very effective to assure the proper timing of AI breeding. Poor heat detection 
can no longer be used as an excuse not to use AI. 
In addition, it is more costly than ever to feed a bull and it’s important to keep in mind that dairy bulls 
are dangerous animals. Putting yourself, family members and employees in harm’s way just doesn’t 
make sense when there are a variety of tools available that make AI practical. 
Today’s dairy herd managers have access to a wider variety of AI sires than ever before. One area to 
assess is the producer’s comfort level with using genomic‐tested young sires at 70% reliability compared 
to progeny‐tested bulls at 85% reliability. Key factors in this decision are semen price, size of the herd 
and the herd’s breeding goals. Generally, the genomic‐tested young sires will deliver better genetics on 
average but some individual bulls will not live up to their genomic prediction. For larger herds that can 
manage around some individual bull disappointments and are disciplined in using a variety of bulls 
without overusing individual bulls then genomic‐tested young sires can be an effective option. If 
consistent and predictable performance is more critical than being on the leading edge of genetics, then 
using the more reliable progeny‐tested sires may be a better option. There is no clear‐cut answer on this 
question and the bottom line is that it comes down to producer preference.  
The single most important on‐farm management decision in guiding the genetics of a dairy herd is 
choosing which AI sires to use. With the improved accuracy delivered by genomic evaluations, producers 
are more likely to get what they select for. So, it’s important to decide up front what traits are important 
to your herd and use that in deciding which bulls to use. Key factors in deciding which traits are 
important include how the producer is paid for the milk, what are the key limiting factors that are 
causing cows to leave the herd and what traits are needed for efficient operations of the milking herd. 
The list of traits should be comprehensive but not so long that it prevents meaningful progress in any 
one area. Focusing on five to ten priority traits is a reasonable target. 
Once a list of priority traits is established, the most effective way to use this in selecting AI sires is to 
develop a selection index that includes these traits. There are a variety of websites and tools out there 
that can assist producers in developing a customized selection index. These tools will then help 
producers sort the list of currently available AI sires based on their own index. This will take a little time 
to set up initially but, once built, it becomes a very efficient way to sort through the mountain of 
available information every four months when the genomic evaluations are updated.  
 Dams of cows 
The combination of improved reproductive performance, availability of sexed semen, high feed costs 
and high beef prices have caused dairy herd managers to look closer at being more selective in how they 
manage their heifers. Running a DNA test and obtaining an indication of the genetic capability of 
replacement heifers can be useful way to manage this valuable herd resource more efficiently. 
Developing a strategy of how to use this genetic information in making better management decisions 
before initiating the DNA testing is critical. Key items to review would include whether producers have 
plans for expanding, have surplus heifers and what options exist for marketing surplus calves. 
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One strategy producers might consider would be an aggressive genetic improvement approach. This 
strategy would include routine genomic testing of all heifer calves as they are born. As genetic 
information is gathered about the herd then the top 5% of animals would be used as embryo donors, 
the remainder of the top 25% would be bred to sexed semen, the middle two quartiles would be bred 
with conventional semen or be used as embryo recipients and the bottom 25% would be sold. This 
strategy would mean that more of the future replacements would come from the best members of the 
herd and would eliminate replacements coming from the bottom of the herd. This strategy would 
involve a fair amount of investment and is mainly for those herds that have a strong interest in 
generating a significant portion of their revenue from selling breeding stock.  
Commercial operations may be more interested in minimizing the cost of raising replacements. The 
situation where dairies have surplus replacement heifers is much more common today than it was ten 
years ago. In this situation producers may want to consider a genomic testing strategy where 
replacements are screened based on the pedigree information that is available. The bottom 15% of 
heifers would be genomic tested with plans to sell the bottom 5% based on the resulting genomic 
evaluations. A general rule of thumb would be to test 3 animals for every one that you plan to sell.  
An interesting strategy that is emerging is one where the herd is sorted based on their genetic merit and 
the top portion of the herd is bred to dairy bulls using a combination of sexed and conventional semen. 
The bottom portion of the herd is bred to beef bulls. This is a strategy seen more often in Jersey herds 
but is also may be an effective strategy for Holstein herds. Genomic testing a portion of the herd to help 
identify the ones to breed to beef bulls would help make the selection process more accurate.  
Summary 
1. Genomic evaluations are now available in Holsteins, Jerseys, Brown Swiss and Ayrshires that 
provide more accurate genetic information for young animals. 
2. Improved accuracy of selection will accelerate genetic improvement for health and fertility traits 
particularly in Holsteins. 
3. It’s more valuable than ever for producers to make full use of AI in their dairy herds. 
4. Commercial animals can be genomic tested for $37 to $50. 
5. Genomic testing can provide some new options for herds to more effectively manage their 
replacement heifers. 
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Key Performance Indicators for Improving Milk Quality 
Pamela L. Ruegg, DVM, MPVM, University of WI, Madison 
 
Introduction 
Increased involvement in the design and implementation of mastitis control programs is a 
potential growth area for many dairy veterinarians.  As farms have expanded, the detection, 
diagnosis and administration of treatments for clinical mastitis has become the responsibility 
of farm workers.  On many farms veterinarians are rarely consulted for mastitis unless an 
affected cow is near death. There are ample reasons for veterinarians to increase involvement 
in mastitis control programs.  The occurrence of mastitis reduces milk production, increases 
the amount of milk discarded and increases premature culling and production costs.1  
Additionally, both clinical and subclinical mastitis have been demonstrated to reduce 
reproductive efficiency.2,3  The prevalence of contagious pathogens has decreased as herds 
have modernized and adopted mastitis control practices.4   Milk quality programs now tend 
to be focused on prevention of mastitis caused by environmental pathogens and other issues 
that influence consumer perceptions of milk quality. The purpose of this paper is to describe 
key performance indicators that dairy practitioners can use to monitor mastitis, milk quality 
and milking performance.   
 
Defining and Detecting Clinical Mastitis   
Clinical mastitis is technically defined as the production of abnormal milk with or without 
secondary symptoms but the working definition of clinical mastitis varies greatly among 
farm personnel.  On large farms, detection of mastitis is usually dependent on the 
observational skills of the milking technicians.  Veterinarians must actively communicate 
with milking technicians and farm managers to be sure that the definition of clinical mastitis 
and intensity of detection are consistent with farm goals. Mastitis case definitions should be 
simple and easily understood by all farm workers.  Mastitis severity scores should be 
recorded in the permanent cow treatment records for each case.5   Use of a 3-point severity 
scoring scale (1 = abnormal milk only; 2 = abnormal milk & abnormal udder;  3 = systemic 
symptoms)  based on clinical symptoms is practical, simply recorded and can be an important 
way to assess detection intensity.6,7   When using this scale, if the proportion of severe cases 
exceeds about 20% of all cases it is a signal that detection intensity and case definition 
should be investigated. 
 
Monitoring clinical mastitis.   
Animal health recording systems should consist of both temporary cow-side records (often 
used for day to day decision making) and permanent records (such as cow cards or 
computerized records) that are used to summarize trends over time.8  The ideal system for 
recording clinical mastitis will allow the practitioner to evaluate important cow factors that 
define the probability of treatment success and to assess epidemiological trends.9  To begin 
involvement in mastitis control programs,  veterinarians should ensure that the following 
questions can be answered:  1)  What is the incidence (rate of new cases) of clinical mastitis? 
2)  What proportion of cases are severe (severity score 3)?  3)  What are the most common 
bacteria that are causing clinical mastitis? 4)  What are the current treatment protocols? 5)  
How many days is milk discarded as a result of treatment?  6)  How many cases:  a)  require 
changes to the original treatment protocol and b)  experience recurrence of the case within 
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the same lactation?  7)  What percent of lactating cows are being milked on less than 4 
quarters? 8)  What percent of cows that experience clinical mastitis are culled in the same  
lactation or die?   
 
Practitioners who work with small herds, generally need to review data found in paper 
treatment diaries and will need to include data collected over longer time periods (3-4 month 
periods) to discern trends.  For larger herds, computerized dairy management record systems 
can be configured to allow practitioners to rapidly review appropriate data.8  Data entry 
should be structured to avoid redundancy, and only one mastitis event should be entered for 
each discrete case (defined at the cow level).9  Researchers generally define separate cases of 
clinical mastitis based on an interval of 14-21 days between occurrences but this time period 
is not based on sound research and may be adapted  to meet the needs of the farm.  Key 
performance indicators that are defined at the cow-level (occurrence of  mastitis in 1 or more 
quarters of a cow) rather than the individual quarter are easier to record and may better 
reflect the important economic consequences of mastitis (Table 1).  Goals for key 
performance indicators (KPI) are derived from populations of herds and may need to be 
adjusted for individual herd circumstances. 
Monitoring Subclinical Mastitis    
Prevalence of mastitis is a function of incidence (development of new subclinical cases) and 
duration.  For some herds, prevalence of subclinical mastitis may exceed goals even when 
relatively few new infections are occurring because of chronic infections caused by 
contagious pathogens.  Alternatively, goals may be exceeded because of environmental 
mastitis problems that are characterized by high incidence of new infections of relatively 
short duration.  The first step in monitoring subclinical mastitis is to ensure that SCC values 
are routinely obtained from all cows on a regular basis.  Generally all cows with SCC  values 
>200,000 cells/ml (linear somatic cell score of approximately 4.0) are considered to have 
subclinical mastitis.  Assessments of subclinical mastitis should begin with the following 
questions:  1)  What is the prevalence of subclinical mastitis (defined based on SCC)?  2)  
What is the incidence of subclinical mastitis (defined based on SCC)?  3)  What are the most 
common bacteria recovered from cows with SCC values >200,000 cells/ml? 4)  What 
proportion of subclinical cases are chronic (persist more than 2 months)?  5)  What is the 
prevalence of subclinical mastitis by days in milk and parity? 6)  What proportion of cows 
have subclinical mastitis at the first test and the last test?  Data to answer these questions can 
often be found in summarized reports available from DHIA testing centers or the data can be 
downloaded and manipulated in customized spreadsheets or dairy management programs.  
Common KPI for subclinical mastitis are:  85% cows with somatic cell counts <200,000 
(prevalence) and less than <5% of cows developing new subclinical mastitis infections per 
month (incidence) (Table 2). 
 
Measuring and monitoring bacteriological quality of bulk milk.   
Many processors measure bacteriological quality of milk on every tanker load of milk and 
provide online access to daily milk quality reports.  Bacteriological contamination of raw 
milk can occur from 2 basic sources: 1)  organisms can  contaminate milk from 
environmental sources (especially contamination during the milking process) or 2) via 
mastitis organisms from within the udder.10 Raw milk from healthy udders normally contains 
< 1,000 total bacteria per ml; and therefore do not significantly contribute to total numbers of 
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microorganisms in bulk milk, or to a potential increase in bacterial numbers during 
refrigerated storage.11  It is unusual for mastitis to contribute to increased total bacteriological 
counts in raw milk but occasionally cows with mastitis can shed large numbers of 
microorganisms. Investigations of bacteriological quality of raw milk begin with the 
following questions:  1)  How many tests of bacteriological quality have been performed and 
do the counts demonstrate a trend or a “spike?”  2)  What is the average, minimum and 
maximum standard plate count?  3)  What other diagnostic tests of milk quality have been 
performed and how do they compare?12  4)  If available, what are the values for:  a)  
laboratory pasteurized count (LPC);  b)  preliminary incubated count (PIC);  and c)  coliform 
count (CC)?  The SPC is an overall measure of milk quality but a single SPC value is not 
very useful diagnostically.  Consistently increased values for SPC are an indication of a milk 
quality problem and the best diagnostic strategy is to perform strategic sampling of milk at 
various points throughout the milking process.  Comparison among the values of diagnostic 
counts (SPC, LPC, Coliform count, and SCC) can give valuable clues as to the likely source 
of the problem.10 The LPC is basically a SPC performed on milk that has been heated to 
145F (62.8C) and held for 30 minutes (low temperature-long time pasteurization).  The 
objective of performing the LPC is to identify organisms that survive pasteurization 
(thermoduric bacteria).  Typical mastitis causing organisms do not survive pasteurization. 
Thermoduric bacteria may include Micrococcus, Microbacterium, Lactobacillus, Bacillus, 
Clostridium and occasional Streptococci.  Increased LPC are often associated with the 
development of biofilms on unclean equipment.  The LPC should be less than 100 to 200 
cfu/ml and a LPC below 10 cfu/ml indicates excellent equipment hygiene.10,12 Goals for high 
performing herds are set by processors and are not uniform across the industry but SPC of 
<5,000 cfu/ml and LPC of < 200 cfu/ml are reasonable goals for high performing herd (Table 
3).   
 
Conclusion 
The delivery of milk quality programs by veterinarians is an important overall component of 
a dairy production medicine program.  Preventing mastitis and improving milk quality is 
vitally important role that contributes to improved animal wellbeing, enhanced farm 
profitability and better assurances that food is being produced in a safe and sustainable way.   
Dairy veterinarians should seek out involvement in continuing education programs that focus 
on research based methods and advancements in mastitis control.  Milk quality programs 
must continue to advance with changes in pathogens, changes in milking equipment and cow 
housing systems and as societal expectations evolve. 
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Table 1.  Calculation of suggested key performance indicators for clinical mastitis.  For ease 
of interpretation, a case is defined as the occurrence of mastitis in 1 or more quarters of a 
cow. 
Indicator Calculationa Suggested Goal 
Incidence Rate Sum of first cases occurring in the 
appropriate time perioda  divided by 
average number of lactating cows in 
the same time periodb 
< 25 new cases per 100 
cows per year (about 2-3 
cases per 100 cows per 
month) 
Proportion of cases 
scored 3 (severe) 
Number of severity score 3 cases 
occurring divided by the total number 
of cases occurring  
5-20% of total cases 
Proportion of cases 
that die 
Number of cows experiencing mastitis 
cases that resulted in death divided by 
the total number of cows experiencing 
mastitis  
2% 
Proportion of cases 
requiring treatment 
changes 
Number of cases where the initial 
protocol is changed or supplemented 
because of non-response divided by 
the total number of detected casesc 
<20% 
Proportion of cases 
that are recurrent 
(second or greater 
treatment) 
Number of cows with second or 
greater case of mastitis occurring >14 
days post treatment divided by the 
total number of cases of mastitis 
<30% 
Proportion of cows 
with > 1 quarter 
affected 
Number of cases with 2+ quarters 
affected divided by the total number of 
cases 
<20% 
Number of days milk 
discarded (per case) 
Sum of the number of discard days for 
the time period divided by the total 
number of cases 
4-6 days (unless many 
cows are receiving 
extended therapy because 
of a high prevalence of 
Staph aureus) 
Percent of herd 
milking with <4 
quarters 
Number of cows milking with < 4 
quartersd divided by the number of 
lactating cows 
<5% 
anumerators and denominators should include the statement “in the appropriate time period.”  The appropriate 
time period will vary depending on herd size.;b a more correct denominator would exclude cows that had 
previously experienced a clinical case within that lactation; ccases  which are detected but do not receive initial 
antimicrobial treatments should be included in this calculation;  dherds that use quarter milkers to discard milk 
from selected quarters should include those cows in the numerator 
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Table 2.  Calculation of suggested key performance indicators for subclinical mastitis. 
Indicator Calculation Suggested Goal 
Prevalence Number of cows with SCC >linear score 4a 
divided by the number of cows with somatic 
cell counts 
<15% of the herd 
   
Incidence Number of cows with SCC > linear score 4a 
for the first time in the time period of 
interestb divided by the number of cows with 
SCC below the threshold in the previous 
time period 
<5% if incidence is 
determined based on 
the first SCC above 
threshold in the 
lactation;  up to 8% 
if calculated based 
on month to month 
changes in SCCb 
   
Prevalence at 1st 
DHIA Test 
Number of cows with SCC >linear score 4a 
at the 1st DHIA test divided by the number of 
cows with first test DHIA somatic cell 
counts  
<5% of 1st lactation 
<10% of lactation 
2+ 
   
Prevalence at last 
DHIA Test 
before dry off 
Number of cows with SCC >linear score 4a 
at the last DHIA test before dry off of the 
lactation divided by the number of cows with 
last test DHIA somatic cell counts  
<30% of cows with 
last test days before 
dry off 
afor the purpose of herd monitoring, linear somatic cell score of 4 is used interchangeably with somatic cell 
count of >200,000 cells/ml;  bThe appropriate time period will  vary depending the intended use of this index.  
Many DHIA centers & computer management programs will calculate this index based on changes between 2 
months.  Others may calculate it based on the SCC values available in the current lactation.  
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Table 3.  Key performance indicators and sources of typical bacteria used to troubleshoot 
problems with bacteriological quality of raw bulk milk. 
Indicator Type of Bacteria Detected Common Sources Suggested Goal 
Standard Plate 
Count 
Quantifies most viable, 
aerobic bacteria found in milk 
Contamination 
during milking; 
problems with 
milk cooling; 
cleaning failures 
<10,000 cfu/ml 
Laboratory 
pasteurized count 
Thermoduric bacteria (such as 
bacillus, clostridia etc.) 
Biofilm 
development on 
milking equipment 
as a result of 
cleaning failures; 
occasional 
problems with 
contamination 
<200 cfu/ml 
Preliminary 
incubated count 
Psychrotrophs (such as 
pseudomonas and others) 
Contamination 
during milking; 
cooling problems 
<10,000 cfu/ml 
Coliform count Coliform bacteria (such as 
E.coli and Klebsiella) 
Contamination 
during milking 
rarely mastitis 
<100 cfu/ml) 
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ABSTRACT 
Mastitis due to Gram‐negative bacteria is a common occurrence in dairy farms with a low bulk 
somatic cell count. All Gram‐negative bacteria have lipopolysacharides as a major part of their 
outer membrane. The biological activity of LPS resides predominantly within the lipid A fraction 
that anchors LPS in the bacterial outer membrane. E. coli and particularly Klebsiella spp. 
intramammary infections cause a severe inflammatory response, while Serratia spp. 
intramammary infections are usually associated with less severe clinical signs. Gram‐negative 
intramammary infections are often environmental in nature but may occur in within farm clonal 
outbreaks, suggesting contagious transmission. Severity of infections with Gram‐negative 
bacteria may be reduced by vaccination with a core antigen vaccine. Treatment of coliform 
intramammary infections may result in an important increase in bacterial cure compared to 
untreated controls. 
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Introduction 
 
Gram-negative bacteria are an important cause of bovine mastitis throughout the world. With the 
advance of our understanding of the main risk factors for classical contagious bacteria such 
Streptococcus agalactiae and Staphylococcus aureus, we have observed a decrease in the 
prevalence of these two mastitis pathogens. However, this decrease has gone hand in hand with 
an increase in the incidence of intramammary infections (IMI) due to Gram-negative bacteria 
(Barkema et al. 1998, Olde Riekerink et al. 2008).  Gram-negative bacteria, mostly coliforms (E. 
coli, Klebsiella spp. and Enterobacter spp.), cause 40% of all clinical mastitis (CM) cases 
(Erskine et al., 1988; OldeRiekerink et al. 2008) and up to 25% of cows in well-managed herds 
are annually diagnosed with CM caused by coliforms (Erskine et al., 1988). The most common 
coliform species are Escherichia coli and Klebsiella spp. (Todhunter et al. 1991. Barkema et al. 
1998, OldeRiekerink et al. 2008). The incidence of CM arising from gram-negative bacterial 
infection is inversely related to bulk milk SCC (Barkema et al., 1998), economic losses attributed 
to intramammary gram-negative infection can therefore be expected to increase as dairymen 
continue to strive for lower bulk milk SCC.  Here we present a discussion on Gram-negative 
bacteria, their bacterial characteristics and immune response patterns. Then we will discuss some 
new findings with regard to Gram-negative mastitis causing bacteria. 
 
 
Gram-negative bacteria 
 
Enterobacteriaceae 
Some of the more common clinically important genera of the family Enterobacteriaceae include: 
Salmonella, Shigella, Proteus, Escherichia, Citrobacter, Enterobacter, Serratia, Klebsiella, 
Morganella, Yersinia, Edwardsiella, Providencia. These genera include recognized mastitis 
pathogens such as E. coli, and Klebsiella spp. but also the less well know but known mastitis 
causing organisms such as Raoutella spp., Pseudomonas spp, Enterobacter spp., Shigella spp 
and Citrobacter spp. The Enterobacteriaceae are rod shaped, are all gram-negative and are 
typically diagnosed in the  laboratory with the use of the MacConkey agar plates (NMC 1999). 
Lactose fermenters such as E. coli, Enterobacter and Klebsiella will produce acid, which lowers 
the pH of the MacConkey agar below 6.8 and results in the appearance of red/pink colonies. 
Some organisms ferment lactose slowly or weakly. These include Serratia spp. and Citrobacter 
spp. (NMC 1999).  One of the several unique characteristics of Gram-negative bacteria is the 
structure of the outer membrane. The outer membrane consists of a complex lipopolysaccharide 
(LPS) whose lipid portion may act as an endotoxin. This lipopolysacharide structure is present in 
all Gram-negative bacteria but is structurally different between and within Gram-negative 
bacterial species (Caroff et al. 2002). 
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Lipopolysacharides 
Bacterial lipopolysaccharides (LPSs) are the major component of the outer membrane of Gram-
negative bacteria. They have a structural role since they contribute to the cellular rigidity by 
increasing the strength of cell wall (De Castro et al. 2010). The LPS structure also mediates 
contacts with the external environment and will allow different species to live under different 
environmental conditions. The low permeability of the outer membrane acts as a barrier to 
protect bacteria from a number of environmental stressors, including antimicrobial compounds. 
The lipopolysaccharides also have an important role in the activation of the host innate immunity 
(De Castro et al. 2011,). For that reason, LPS are considered pathogen-associated molecular 
patterns (Schukken et al. 2011). The LPSs are macromolecules generally with three defined 
components: the lipid A fraction, the inner and out core oligosaccharide and finally a 
polysaccharide portion, the O-chain (Caroff and Karibian 2003). In some Gram-negative 
bacterial strains, there is no O-chain and these strains are identified as ‘rough-types’ as opposed 
to the ‘smooth types’ when the O-chain is present. The O-chains are in direct contact with the 
host during infection and form the basis for serotype classification (Caroff and Karibian 2003).  
Figure 1 shows a schematic representation of the Gram-negative cell wall. Although LPS is not 
actively secreted by the bacterial cells, small amounts of the LPS are released into the bacterial 
environment under circumstances such as cell division. Larger amounts are released when the 
bacteria are killed by antibiotics, phagocytosis, or the complement complex.  
The role of LPS in the activation of the host immune response is dose dependent. Small amounts 
of LPS can be used as a protective compound by stimulating the immune system (Petzl et al. 
2011, Gunther et al., 2012). Large amounts of LPS, however, induce high fever, increase heart 
rate, and lead to septic shock and death by lung and kidney failure, intravascular coagulation, and 
systemic inflammatory response (Caroff and Karibian 2003). The biological activity of LPS 
resides predominantly within the lipid A fraction that anchors LPS in the bacterial outer 
membrane. Lipid A differs between species in acyl-side chain number and length; however, the 
overall structure and synthetic pathway is conserved between gram-negative bacteria. The lipid 
A structure of E. coli consisting of six acyl chains and two phosphate groups and is one of the 
most potent stimulators of the innate immune system through it binding to Toll-like receptor 4  
(TLR-4) in a tight connection to the LPS binding protein (Schukken et al. 2011). Deleterious 
effects of LPS on the mammalian host, such as fever, inflammation, acute phase response, and 
multiple organ failure, are generally attributed to lipid A fraction of LPS (Caroff  et al. 2002). It 
has been suggested that the variability in lipid A structure between bacterial species explains the 
difference in the biological activity of LPS (Caroff et al. 2002). Changing the number of acyl 
groups from six to five decreases the biological activity of LPS approximately 100-fold. With 
regard to the main mastitis pathogens, E. coli has six acyl groups, whereas Serratia marcescens 
has five acyl groups and Klebsiella pneumonia has been reported to have 7 acyl groups (Llobet et 
al. 2011). This difference in the structure of the lipid A portion of LPS may partly explain the 
difference in immune response patterns and clinical presentation that is observed between these 
three important mastitis pathogens. 
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Immune response patterns 
The innate immune response is characterized by the rapid activation of antimicrobial host 
defense mechanisms in the mammary gland of the cow (Schukken et al. 2011). The ability to 
respond to a large number of pathogens is possible through evolutionary conserved pattern 
recognition receptors. These receptors are capable of recognizing molecular patterns that are 
shared by bacterial pathogens. Toll-like receptor 4, which is expressed on a wide array of cell 
types including macrophages, neutrophils, and epithelial cells, is one such pattern recognition 
receptor (Bannerman 2009). The TLS-4 receptor recognizes bacterial LPS, particularly the lipid 
A fraction of LPS. Activation of TLR-4 and other pattern recognition receptors leads to the 
generation of an inflammatory response that is modulated, in part, by cytokine production 
(Schukken et al. 2011). In a series of experimental IMIs, Bannerman and co-workers provided a 
unique insight in the comparative activation of the innate immune response after a challenge with 
a number of Gram-negative bacterial species (Bannerman et al. 2004a,b,c). Since these scientists 
were using similar methodologies throughout the challenge trials, it is now possible to compare 
the innate immune response of the host to IMIs with these Gram-negative bacteria. Figure 2 
shows the response of the challenged cows to an experimental IMI with E. coli, Klebsiella 
pneumonia and Serratia marcescens. The results in this figure make it very clear that the innate 
response between these three pathogens differs sharply, with the most sever response observed 
after Klebsiella pneumoniae IMI and the more modest response observed after an IMI with 
Serratia. marcescens. This difference in response was apparent in both the pro-inflammatory 
response as shown by the concentration of TNF- (Figure 2, top) as well as in the regulatory 
immune response as shown by the concentrations of the cytokine IL-10 (Figure 2, bottom). 
Although the precise mechanism of the difference in innate immune response are not fully clear, 
the functional form of LPS in these three organisms is likely to play a role in the observed 
pathogenicity. 
 
E. coli and Klebsiella spp. Mastitis 
Differences in the pathogenicity of E. coli, Klebsiella spp. and Serratia spp. as mastitis 
pathogens have been noted (Bannerman 2009, Grohn et al. 2005). These differences include a 
longer duration of infection for Klebsiella spp. and Serratia spp compared to E. coli (Todhunter 
et al., 1991). Also, Klebsiella spp. IMIs appear to be more severe than E.coli IMIs and Serratia 
spp. IMI appear to be less severe compared to E. coli IMIs. Severity of clinical episodes, poor 
response to vaccination, and the paucity of effective treatments make Klebsiella mastitis 
especially troublesome when compared with E. coli (Erskine et al., 2002; Roberson et al., 2004). 
The severity of clinical mastitis due to coliforms was highlighted in a series of papers from our 
research team. In a paper on the effect of pathogen specific clinical mastitis on milk production 
of CM affected cows (Grohn et al. 2004), a difference in milk production loss between E. coli 
and Klebsiella spp. IMI became clear (Figure 3, top). The duration of milk production loss was 
substantially longer in cases of Klebsiella spp. compared to clinical cases due to E. coli. 
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Similarly, the risk of culling (Grohn et al. 2005) after a case of clinical mastitis was substantially 
larger in cases of Klebsiella spp mastitis compared to E. coli clinical mastitis (Figure 3, bottom). 
These findings were in line with observations of others where Klebsiella CM turned out to be 
more severe compared to E. coli mastitis (Erskine 2002, Roberson et al. 2004). 
 
Epidemiology 
Classically, coliform IMIs are considered to be of environmental origin and improving 
environmental hygiene and optimizing the cow’s immune response would prevent therefore aid 
in the prevention of these infections. Environmental infections are considered to be not 
contagious, and the practical implication of that is that every IMI would be associated with its 
own bacterial strain (Paulin-Curlee et al. 2008). This is in stark contrast to contagious infections, 
where many IMIs share the same strain (or clone) of a bacterial species (Zadoks and Schukken, 
2008). With the advance of molecular diagnostic techniques, the differentiation between clonal 
and non-clonal outbreaks of intramammary infections on dairy farms has become possible for 
routine outbreak evaluations. Recently, Munoz et al. (2007) described the occurrence of two 
Klebsiella spp. mastitis outbreaks on a single dairy farm. Klebsiella isolates from milk, feces, 
and environmental sources were compared using random amplified polymorphic DNA (RAPD). 
The first mastitis outbreak on the described farm was caused by a single strain of Klebsiella 
pneumoniae, which was detected in milk from eight cows. In figure 4, an example of a clonal K. 
pneumoniae outbreak on a New York dairy farm is shown. This RAPD type was also isolated 
from the rubber liners of milking machine units after milking of infected cows and from bedding 
in the outbreak pen. This observed predominance of a single strain would indicate contagious 
transmission of the organism or exposure of multiple cows to an environmental point source. 
When the authors implemented intervention methods that targeted the prevention of transmission 
via the milking machine as well as improvement of environmental hygiene, no new cases with 
the initial RAPD type were observed (see also figure 6). A second outbreak of Klebsiella mastitis 
that occurred several months later on the same farm was caused by multiple RAPD types, which 
rules out contagious transmission and indicates infections originating from the environment 
(Munoz et al. 2007). Using the RAPD technique has shown to be useful in distinguishing clonal 
versus non-clonal outbreaks across several Gram-negative mastitis pathogens (Zadoks et al. 
2011). 
 
Vaccination and Treatment 
A mutant Escherichia coli O111:B4 known as J5 (Teng et al. 1985) has been used for the 
development of a bacterin to reduce mastitis severity due to coliform organisms.  This mutant 
is deficient in the enzyme uridine 5'-diphosphate-galactose 4-epimerase so that it cannot attach 
the 0 side chains of LPS (see figure 1). Without the O side chains, the core oligosaccharide 
with the bound lipid A becomes exposed and can stimulate antibody response by the host. The 
induced antibodies may react with the core region and lipid A of all LPSs, regardless of bacterial 
species. Commercial vaccines developed against the J5 core antigen of coliform bacteria have been in 
use for approximately 15 years (González et al., 1989).  Reduction of coliform CM in vaccinates 
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compared with controls has been reported (González et al., 1989).  However, more often, J5 vaccination 
is associated with a reduction in severity and improved herd survival (González et al., 1989, Wilson et al. 
2007). Wilson et al. (2008) showed that the milk loss due to clinical mastitis was substantially less among 
J5 vaccinates compared to controls; however, this protective effect of vaccination waned with increasing 
time since the last vaccination. It was also reported that J5 vaccination was also associated with survival 
advantages after a case of clinical coliform mastitis (Wilson et al. 2007). Particularly, Wilson et al. 2007 
reported that vaccinates with Klebsiella CM were less likely to be culled for mastitis compared to 
unvaccinated controls. Together these data indicate that J5 vaccination is one of the tools available to 
reduce losses due to clinical coliform mastitis. 
 
Studies reporting on treatment efficacy of antibiotic treatment of Gram-negative mastitis have 
generally shown a very limited efficacy of antibiotic treatment (Roberson et al. 2004). A field 
study of naturally occurring severe CM caused by coliform organisms showed that intramuscular 
treatment with ceftiofur reduced the risk of death or culling (Erskine et al., 2002). A proportion 
of approximately 50% cure, was observed after intramuscular ceftiofur treatment of 8 animals 
with severe CM, while cure in controls animals was approximately 25% (Erskine et al., 2002). In 
a recent study on mild and moderate clinical coliform mastitis in six large dairy farms, it was 
reported that across farms and coliform species, 5-day treatment with intramammary ceftiofur 
resulted in a significantly higher probability of cure compared to no treatment (Figure 5, 
Schukken et al. 2011). Across herds and bacteriological species, bacteriological cure was 73% in 
the treated animals and 38% in control animals. Although treatment of Gram-negative mastitis is 
not as successful as treatment of most Gram-positive bacteria, the availability of third generation 
cephalosporins for clinical mastitis treatments appears to provide an important tool for the 
treatment of clinical mastitis caused by this organism. An important benefit of successful 
treatment of Gram-negative bacteria is the reduction in the duration of infection. Shorter duration 
infections will have a lower probability of transmission to other cows (Figure 6). Successful 
treatment is therefore not only of benefit to the cured cow, but also to the herd (Halasa et al. 
2012). 
 
Prevention 
Identification of potential sources of E. coli and Klebsiella is important for implementation of 
preventive measures that decrease exposure and limit the risk of udder infections. Bedding 
materials can be important sources for both E. coli and Klebsiella organisms on dairy farms 
(Munoz et al. 2006). Furthermore, fecal shedding of these bacteria by healthy dairy cows has 
been documented recently (Munoz and Zadoks, 2007). Consequently, feces and manure also 
constitute sources of exposure for dairy cows (Munoz et al., 2007, Verbist et al. 2011).  Direct 
contact of the teat ends with materials that contain coliforms, such as bedding, feces, manure 
splash,  water, milk, mattresses, legs or liners may provide the bacteria with access to the udder 
(Zadoks et al. 2011), which may ultimately result in IMI and subsequent CM.  Dirty udders were 
a significant risk factor for presence of Klebsiella after udder preparation (Munoz et al. 2006). In 
summary, prevention of coliform IMI appears to be possible through careful monitoring and 
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improving of hygiene in the environment of the cow.  
Another component of prevention is improvement of cow susceptibility to intramammary 
infection. There are a number of factors that affect the cow’s susceptibility. This includes the 
quality of the innate immunity, such as teat-end quality, nutritional status and genetic ability to 
combat infections. Important nutritional components include minerals such as Selenium and 
Copper and Vitamins such as Vitamin E, finally the presence of a negative energy balance puts a 
cow at risk for more severe inflammatory responses to a coliform infection.  
 
Discussion and Conclusions 
Mastitis by Gram-negative infections is of increasing importance on modern and well-managed 
dairy farms. Without a doubt, E. coli tends to be the most important cause of these Gram-
negative infections when the data are tallied across farms (Barkema et al. 1998). However, more 
precise investigation of individual farms often reveals a farm-specific infection pattern where a 
single Gram-negative bacterial species predominates. Here we have shown the presence of 
outbreaks on individual dairy farms with Klebsiella pneumoniae. It is quite surprising to identify 
the difference in host immune response pattern and the associated clinical and subclinical 
presentation of intramammary infections due to the different Gram-negative organisms. 
Experimental and field observations would suggest that among the Gram-negative bacterial 
causes of mastitis, Klebsiella spp. are causing the most severe cases, closely followed by E. coli 
and then much less clinical severity is observed in Serratia spp. and Enterobacter spp cases. The 
precise mechanisms that would explain the difference in clinical severity are not known, but the 
most likely explanation appears to be the structure of the lipid A fraction of the LPS of the 
bacterial species. Important differences in the lipid A fraction of LPS between and within 
bacterial species are observed. 
Prevention of IMIs with Gram-negative bacteria has components that are generic across species 
and components that are species specific. Generic prevention may be obtained by improving 
hygiene and reducing exposure of teat ends to environmental contamination. Also the use of a J5 
bacterin is expected to provide some reduction in severity of Gram-negative IMIs across 
bacterial species. Specific prevention programs will depend on the actual transmission behavior 
of the dominant species causing IMIs in the herd. Several clonal outbreaks of Gram-negative 
bacterial species have been described. In such situations, optimal milking procedures, 
segregation and culling of infected animals and targeted treatment would be advisable. 
Antimicrobial treatment of Gram-negative bacteria has often considered to be of limited value 
and treatment should be more targeted towards cow survival and reduction of clinical symptoms. 
More recently, extended treatment with a third generation cephalosporin was reported to be 
efficacious in the treatment of E. coli and Klebsiella spp., but not of Enterobacter cloacae. 
Further investigations in effective treatment protocols for Gram-negative IMIs are warranted. 
A herd characterized by a stable healthy udder health status will need to have three components 
of management in excellent working order (figure 6). These three components are 1) a low risk 
of new IMI, 2) a short duration of IMI that are occurring and 3) a low risk of on-farm infection 
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transmission. These three components are important irrespective of the causal organisms and will 
guarantee that the herd is not in a situation characterized by either a contagious or environmental 
transmission pattern. 
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Figure 1. Schematic representations of the enterobacterial Gram-negative cell wall(left), a 
lipopolysaccharide structure (right), R, SR, and S indicate the structures of rough-type, semi-
rough type (with only one O-chain subunit) and smooth-type lipopolysaccharides, respectively. 
Reproduced with permission from Caroff and Karibian (2003). Copyright 2003 by Elsevier Ltd. 
All rights reserved. 
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Figure 2. Cytokine profiles after experimental challenge infections with three different Gram‐negative 
bacterial species. In the top graph, milk Tumor Necrosis Factor – alpha (TNF‐) concentrations (in ng/ml) 
and in the bottom graph milk IL‐10 concentrations after intramammary challenge infection with E. coli, 
K. pneumonia and S. marcescens are shown. Data from Bannerman  2009. 
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Figure 3. Milk production effects (top) of an E. coli and a Klebsiella spp. case of clinical mastitis compared 
to milk production of healthy herd mates. The milk production loss pattern in Klebsiella spp. indicates an 
earlier onset and a longer duration of milk production loss compared to E. coli, whereas the severity of 
loss (indicated by the nadir) is approximately similar (data from Grohn et al. 2004). Hazard rate ration of 
cows with a case of E. coli or Klebsiella spp. in early lactation (data from Grohn et al. 2005). 
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Figure 4. An electrophoresis gel depicting the result of an RAPD analysis of the DNA of K. pneumoniae 
isolates from 10 cases of clinical mastitis on a single dairy farm. The text above the gels indicate the cow 
number, quarter and date of the clinical case, (+) and (‐) for positive and negative controls, W for a 
water control and  L for DNA ladder. The figure shows that 9 out 10 clinical cases were caused by the 
same clone of K. pneumoniae. 
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Figure 5. Least square means of bacteriological cure, clinical cure and clinical improvement by bacterial 
species and treatment arm. Cows with non‐severe clinical coliform mastitis were randomized to obtain a 
5‐day ceftiofur treatment or remained untreated as a control group. Data from Schukken et al. 2011. 
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Figure 6. Components of infection biology and management practices that make up a herd that has a 
healthy udder health status. 
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Improving Mastitis Treatments by Targeted Antimicrobial Therapy 
Pamela L. Ruegg, DVM, MPVM, University of WI, Dept. of Dairy Science, Madison WI   
 
Introduction 
Control of mastitis caused by Streptococcus agalactiae and Staphylococcus aureus has 
resulted in reductions in bulk tank somatic cell count (SCC) but many herds continue to 
struggle with treatment of clinical mastitis caused by environmental pathogens.  On many 
modern dairy farms, mastitis is caused by an increasingly diverse group of opportunistic 
pathogens (Figure 1).   Common environmental mastitis pathogens include both Gram 
negative bacteria and Gram positive bacteria (Figure 1). The presentation of the symptoms 
and duration of infection is associated with the degree of host adaptation of the pathogen.  
Some environmental pathogens (such as most E. coli), are truly opportunistic and the immune 
response successfully eliminates them after a brief period of mild clinical disease.  Other 
environmental pathogens (such as Streptococci spp.) have become more host adapted and 
may present as mild clinical cases that erroneously appear to resolve when the case has 
actually returned to a subclinical state.  Both of these scenarios make it very difficult to 
determine success of mastitis treatments.  While farmers often remember the most severe 
cases of mastitis, research demonstrates that the majority of clinical mastitis cases are mild to 
moderate in severity. The purpose of this presentation is to review research based principles 
that can help improve treatment of clinical mastitis.  
 
Figure 1.  Results of milk samples submitted from 793 cases of clinical mastitis occurring on 
51 large Wisconsin dairy farms in 2010.1 
 
 
 
DETERMINING RELEVANT OUTCOMES OF MASTITIS THERAPY 
It is often difficult to determine if mastitis treatments are successful because there is no 
standard outcome that is used to evaluate outcomes.  The detection of mastitis is based on 
recognition of the immune response that is a result of the infection.  Thus, interpretation of 
treatment outcomes can be confusing because, clinical signs will normally resolve within 4-6 
days, regardless of treatment.  This is expected, as the response of immunologically 
competent cows will often successfully reduce the number of bacteria infecting the gland.  
However, disappearance of clinical signs does not always indicate that the infection has been 
successfully eliminated.  As the immune response lessens, the milk may return to normal 
appearance, however many of these cases may have simply regressed to a subclinical state 
and maintain increased SCC.  This occurrence is especially true for Gram positive pathogens. 
 
The ability to achieve a bacteriological cure depends on the pathogen, case severity, variation 
in immune response among cows, efficacy of the treatment protocol (when needed) and the 
promptness of initiating treatment.2  Even in the absence of mastitis caused by Staph aureus, 
bacteriological cures are almost always greater for Gram negative as compared to Gram 
positive pathogens (Figure 2).1 
 
Figure 2.  Treatments outcomes based on comparison of microbiological results of Milk 
samples collected at detection of clinical case and follow-up samples collected 3 weeks later.1 
 
In one study, bacteriological cure was 7 times more likely for first cases of mastitis as 
compared to  
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recurrent cases.3  Definition and interpretation of bacteriological cure also depends on 
laboratory procedures as differences in laboratory protocols can influence the probability of 
recovering bacteria from milk samples.  Issues such as the frequency of sampling, the volume 
of milk that is inoculated, the time period after therapy until sampling and time between 
collection of consecutive samples all contribute to the wide variation in bacteriological cure 
rates noted in the literature.4  
 
On a practical basis, farmers often assess clinical efficacy based on  the appearance of the 
milk or other indicators such as recurrence of another clinical case, reduction in SCC, return 
of milk yield to normal, retention of the cow within the herd and number of days milk is 
discarded (because of abnormal appearance or the presence of antibiotic residues).  
Recurrence of another case of clinical mastitis is one of the least desirable outcomes after 
treatment and may be more likely for cases that occur early in lactation as compared to cases 
that occur later (Figure 3)3.  This may indicate the need for more aggressive treatment 
protocols (for example, longer duration therapy) for cows experiencing mastitis in early 
lactation as compared to treatments for cases that occur later. 
 
 
Figure 3. Recurrence of clinical mastitis (CM) by stage of lactation3 
 
Somatic cell reduction below 200,000 cells /mL is another desired outcome but occurs slowly 
and this outcome is highly influenced by pathogen.  Of cases caused by Gram-negative 
pathogens or no growth 63% resulted in somatic cell reductions to  less than 200,000 cell/mL 
within 21-55 days after treatment in contrast to only 44% of cases caused by Gram-positive 
bacteria.3 While long-term reductions in SCC should occur after successful therapy, short-
term changes in SCC should not be used to determine when to stop therapy nor to determine 
if therapy has been effective.  Likewise, the use of cowside tests like the California Mastitis 
Test should not be used to determine when to stop treatment. 
 
Cow Factors Influencing Treatment Outcomes.   
Host factors are well known to influence the probability of success responses to mastitis 
infections.5  Older cattle have a greater risk of both subclinical and clinical mastitis and 
several studies have indicated that older cattle have poorer responses to treatment as 
compared to younger cattle.6  Deluyker et al., used  a rigorous definition of clinical cure 
(normal milk by 5 d and no relapse within 3 weeks post-treatment) and reported a reduction 
in combined “clinical & bacteriological cure rates” from 39% (lactation 1) to 26-30% for 
older cattle.7  Other researcher have reported that bacteriological cure after mastitis therapy 
were less for older cows.8-11  Age has also been associated with reduced clinical responses to 
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therapy.  Hektoen et al.,  measured responses to treatment by comparing scores for both acute 
and chronic symptoms obtained before treatment and at various periods post-treatment.12  
While parity was not associated with differences in acute symptoms, the reduction in chronic 
symptoms (changes in the milk, gland or inflammatory response) were markedly greater in 
first lactation as compared to older cattle.  The effect of parity should be considered by 
practitioners before initiating mastitis treatments.  For example, when IMM compounds are 
approved for extended duration therapy, veterinarians may want to consider using use longer 
duration of treatment for cases occurring in older cows.  Likewise, older cows (>3 lactation) 
may not be good candidates for withholding treatment if that option is used for managing 
some cases of mastitis on particular farms.   
 
Differences Among Pathogens   
It is well known that mastitis is caused by a diverse group of bacteria and the probability of 
cure is highly influenced by the characteristics of the pathogen.  The pathogenesis, virulence 
and prognosis of IMI is influenced by important characteristics that vary among pathogens. 
Depending on specific virulence factors, organisms infect different locations in the mammary 
gland, have differing abilities to cause systemic symptoms, vary in the expected duration of 
subclinical phases of infection and differ in the expected rate of spontaneous bacteriological 
cure.  Understanding these differences is fundamental to development of effective control 
programs.  For example, expectations for spontaneous bacteriological cure of subclinical and 
clinical mastitis caused by Staph aureus are essentially zero13 while the expectation for 
spontaneous cure of E coli is quite high.14  While a few cases may result in spontaneous cure, 
therapeutic cure rates for several mastitis pathogens (yeasts, pseudomonas, mycoplasma, 
prototheca etc.) are essentially zero, regardless of treatment.  Even among Gram-positive 
pathogens, outcomes vary.  The following typical differences among pathogens in 
bacteriological cure after treatment have been noted:  Strep uberis (89%, n = 488 cases);  
Strep dysgalactiae (69%, n = 32 cases),  Staph aureus (33%, n = 40 cases), and CNS (85%, n 
= 71).9  On farms that have controlled contagious mastitis, approximately 25-40% of clinical 
cases are microbiologically negative before treatment.  Clinical and spontaneous cure rates 
for these “no-growth” samples are often very high with or without treatment.15,16   
 
Most cases of clinical mastitis caused by E coli are detected well after the immune response 
of the cow has been initiated and the immune response is usually successful in eliminating 
IMI caused by E coli.  However, the duration of IMI caused by other coliforms (such as 
Klebsiella or Enterobacter) is much longer.   After coliform bacteria infect the mammary 
gland, they multiply rapidly but most do not adhere to or invade the epithelial cells.5  If the 
cow's immune response is rapid and efficient, infection will be quickly eliminated and there 
will be little long-term impact on cow health or productivity.   The outcome of clinical 
mastitis caused by coliform bacteria depends on the severity of the case, which is usually 
dependent on the balance between the dose (relative degree of exposure to bacteria) and the 
ability of the cow to response immunologically.  Severe cases of mastitis occur most 
frequently in the periparturient period and early lactation and are  primarily associated with 
characteristics of the cow that influence her ability to respond to the infection.5,17-19 When 
influx of neutrophils is delayed or phagocytosis or intracellular killing mechanisms of 
neutrophils impaired, bacterial multiplication continues, resulting in greater concentrations of 
inflammatory mediators and more severe clinical disease 
 
In contrast, mastitis caused by environmental Streptococci typically respond well to 
IMM antimicrobial therapy but have a low spontaneous cure rate and high rate of recurrence 
when antimicrobials are not administered.16  These differences among pathogen demonstrate 
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that identification of pathogen considerably improves mastitis treatment protocols.  With 
current laboratory methods, it is not feasible for all farms to achieve a microbiological 
diagnosis before beginning therapy but guiding treatment by use of on-farm culture systems 
(OFC) has been shown to be economically beneficial.20,21  The use of OFC to direct treatment 
of clinical mastitis gives farmers the opportunity to make better treatment decisions and 
reduce costs associated with milk discard and treatment of microbiologically negative cases.  
A positively controlled clinical trial evaluating OFC demonstrated that there were no 
significant differences in either long-term or short-term outcomes for cases of mastitis that 
received treatment based on results of OFC as compared to cases treated immediately without 
regard to diagnosis.20,21 In this study, antimicrobials were not administered to cases that were 
culture negative or Gram negative thus the use of intramammary antimicrobials was reduced 
by approximately 50% as compared to cases which were treated without prior diagnosis. 
Most smaller herds cannot adopt OFC and an alternative is to encourage veterinary clinics to 
offer in-veterinary clinic culturing (IVCC).  In these instances, farmers initiate treatment 
immediately but may modify treatment duration or drug after receiving a preliminary 
microbiological diagnosis within 24 hours.  Development and oversight of a culture program 
(either OFC or IVCC) is an ideal way for veterinarians to increase involvement in mastitis 
control programs.  The use of veterinary technicians to supervise these programs may also 
increase veterinary involvement and oversight of mastitis treatments.  Veterinary technicians 
can visit farms to restock supplies, train farm personnel and provide oversight and quality 
control.   
 
Duration of Therapy    
In general, duration of antibiotic treatment should be kept as short as possible to minimize the 
economic losses associated with milk discard while maximizing the probability of achieving 
bacteriological cure.  The appropriate duration of antibiotic treatment for clinical mastitis has 
not been well-defined and varies depending on the causative pathogen.  There is considerable 
evidence that extended administration of antibiotics increases cure rates for pathogens that 
have the ability to invade secretory tissue (Staph aureus and some environmental Streps).  For 
example,  bacteriological cure for subclinical mastitis caused by Staph aureus treated with 
IMM ceftiofur were 0 % (no treatment), 7% (2 days), 17% (5 days) and 36% (8 days).13  Cure 
rates reported for clinical mastitis caused by β-lactamase negative Staph aureus were 
significantly greater when extended duration therapy was used (50%) versus administration 
of 3 treatments over 36 hours (38%).8  Likewise, bacteriological cure rates for experimentally 
induced Strep uberis infections increased from 58% (2-d treatment) to 69-80% for treatments 
of 5 or 8 days.22  Therefore, for mastitis caused by potentially invasive pathogens, the 
duration of therapy should be 5 to 8 days.  Research to support use of extended duration 
therapy to treat pathogens that infect superficial tissues (for example coagulase negative 
staphylococci or most E. coli) has not been published and the use of extended duration 
therapy to treat these pathogens significantly increases costs without improving treatment 
outcomes.23  When extended therapy is considered, veterinarians should assess the ability of 
the herd personnel to perform aseptic infusions as extended intramammary treatment is 
associated with an increased risk of infection from opportunistic pathogens, and herds with 
poor infusion techniques are not good candidates for multiple doses of intramammary tubes.     
 
Conclusion 
Veterinarians should be involved in developing and implementing mastitis treatment 
protocols and should work with farm personnel and other professionals to actively monitor 
outcomes of treatments that farm personnel administer.  Research evidence is available to 
help guide mastitis treatment decisions and to better select animals that will benefit from 
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specific treatments.  There is sufficient research evidence to help develop mastitis treatment 
protocols that vary depending on animal characteristics and the history of subclinical disease.  
The use of OFC or IVCC is an ideal way for veterinarians to become more involved in 
helping farmers make rational decisions about antimicrobial therapy used for treatment of 
mastitis.   
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Continuity of business during a FMD outbreak: Secure milk supply project  
Timothy J. Goldsmith, DVM, MPH, Dipl. ACVPM 
University of Minnesota 
 
Introduction  
  In the event Foot and Mouth Disease (FMD) is diagnosed in the United States, a national animal 
health emergency will be declared and livestock and allied industries will feel the immediate impact of 
animal and animal product quarantine and movement restrictions. Quarantine, managed movement 
and mandatory biosecurity protocols are designed to contain and control the disease and minimize virus 
spread.  However in the dairy industry, the just‐in‐time supply practices of milk movement in the U.S. 
could be significantly impacted by managed movement and the need for additional biosecurity at farms 
and processing facilities. This could lead to a disruption of the provision of milk and milk products to 
consumers, along with the potential for significant milk disposal and animal welfare issues on dairies. 
  Most dairy operations and processing plants do not have the capacity to store milk for more 
than 48 hours; some have less than 24 hours storage capacity. Hence, preplanning for safe, timely, risk‐
based, permitted movement of animals and animal products will be critical to maintaining the business 
continuity of the dairy industry while controlling and containing the outbreak. 
 
Goals 
  The goals of the national Secure Milk Supply (SMS) Plan are to maintain business continuity for 
dairy producers and processors during an FMD outbreak, to minimize disease spread, and to assure a 
continuous supply of milk and milk products to consumers. The specific aims of the SMS Plan are to 1) 
Engage stakeholders in the planning process for an FMD response, 2) Develop and socialize tools and 
guidance documents that support business continuity within the dairy industry, and 3) Ensure that 
producers, processors, federal and state agency personnel agree the proposed guidelines are feasible, 
implementable, and effectively enable critical movements of animals and animal products with minimal 
risk of further FMD spread during an outbreak response. 
 
Focus  
  Initial the project is focusing on the movement of raw milk from farm to commercial processing, 
and the development of resources and tools to facilitate this type of movement while minimizing the 
risk of FMD spread.  The development of these tools and resources is being done through Public‐Private 
Partnerships that involve stakeholders from the dairy industry, State and Federal agencies, and 
academia working through working groups.   Current components being developed include: 
 
Biosecurity Performance Standards 
National biosecurity performance standards for dairy premises, milk haulers, and processing plants have 
been developed for implementation during an FMD outbreak. Compliance with these performance 
standards is intended to significantly reduce the chance of spreading FMD virus while facilitating the 
ability to permit raw milk movement from dairy premises (not known to be infected with FMD) in a 
Control Area to processing where it can be pasteurized for commercial consumption. The dairy industry 
and Animal Health Officials in each state are encouraged to develop pre‐event, standard operating 
procedures that meet the national performance standards while accounting for the local climate and 
industry practices.  
Decision Support Tools 
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As an aid to timely decision making at the onset of an FMD outbreak, a proposed framework for 
classification of an outbreak response based on the phase (time course of the event) and type  
(scale or magnitude of the event) has been developed to facilitate response planning.   In addition a set 
of recommendations pertaining to raw milk handling and processing has been drafted for pre‐event 
review, discussion, and ideally agreement with incorporation into local/regional/national response 
plans.   
 
Active Observational Surveillance (AOS) Training Materials 
AOS as part of the SMS Plan is “an active process for the detection of foot‐and‐mouth disease on dairy 
premises, utilizing trained observers (herd managers or workers) who are routinely monitoring animals 
on a daily basis for abnormal or increased occurrence of clinical signs compatible with FMD, or changes 
in food or water consumption, or milk production.  AOS does not replace the need for periodic 
inspection of the herd by animal health officials; it increases the likelihood of early detection of FMD by 
trained Herd Health Monitors. 
 
Proactive Risk Assessment   
Risk assessments support managed movement and permitting of animals and animal products during 
disease outbreaks.   As part of the SMS Plan, proactive risk assessments are being conducted to evaluate 
the risk that the transport of raw milk from an FMD infected, but undetected, dairy farm to further 
processing poses to the spread of FMD. The initial risk assessments consider current Grade A milk 
production practices as well as proposed mitigations developed through the SMS effort and the risk of 
virus spread through identified pathways onto or off of a farm via the transport of raw milk to further 
processing. The results of the proactive risk assessments will help inform movement and permitting 
decisions in the event of an outbreak.   
 
Summary   
  The national SMS Plan has made significant strides in the development of a framework and 
support tools to facilitate decision making and timely permitting for raw milk movement during an FMD 
outbreak response. However, these tools need to be tailored to specific states and regions, discussed 
and agreed upon by those responsible for decision making at that level, and then incorporated into state 
and regional FMD response plans. 
  Raw milk movement is just one of a number of critical movements needed for a dairy to remain 
in business and be economically viable. Future planning efforts should focus on other priority movement 
areas, such as contingency planning for dairies which utilize off‐site calf rearing.  
  If FMD is diagnosed in the U.S., it will be a major animal health emergency and severely impact 
the daily activities and economic viability of all livestock sectors of the U.S. economy. With enhanced 
contingency planning and clear communications between industry and government prior to an 
outbreak, we can ensure significant improvements in the national resiliency of U.S. livestock industries 
to transboundary animal diseases and hence enhance the security of U.S. livestock and food production 
systems. 
 
For more information, visit the Secure Milk Supply website at www.securemilksupply.org 
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Objective:  The main goal of USDA and MN FMD response plans is disease eradication.  The 
objective of this study was to evaluate emergency vaccination control strategies for a simulated 
FMD outbreak in Minnesota. 
 
Methods:  The North American Animal Disease Spread Model (NAADSM) was used to develop 
and compare scenarios that varied based on whether vaccination was utilized, the time to deliver 
vaccine, the capacity to administer the vaccine and the time to develop immunity. Output data 
analyzed included the mean number of infected herds and animals, mean duration of active FMD 
disease, mean duration of outbreak, and mean number of herds and animals vaccinated.  
Important elements included movement restrictions, depopulation, and surveillance, using MN-
specific direct and indirect contacts between herds, and airborne spread.  Simulated FMD 
outbreaks (1,000 model iterations) began in and were limited to MN. Vaccine related variables 
explored included time to deliver vaccine (7, 14 and 21 days), time to develop immunity from 
vaccine (4 and 7 days), and number of herds vaccinated per day (two levels: 50 (assumption with 
federal/state veterinarian applied vaccination) and 1,500 (assumption with industry vaccinators 
under the supervision of accredited veterinarians) herds per day). 
 
Results:  Our study described the implications of emergency vaccination and compared the 
epidemiological results of FMD in MN with and without emergency vaccination. Results 
suggested that vaccination had important implications in a MN outbreak and was associated with 
large differences in disease and outbreak duration and number of animals/herds infected. These 
results were more striking for scenarios in which disease begins in a dairy. Assuming a dairy 
herd was initially infected, the mean number of animals infected ranged from 30,000 to 88,000 
with 50 herds per day vaccinated and varying delivery and immunity time. However, when 
vaccination capacity was increased to 1,500 herds per day and other conditions held constant, the 
mean number of animals infected was consistently below 20,000. Variability around means also 
decreased with vaccination. 
 
Conclusions:  Models that began in a Dairy Index herd showed greater response to vaccination 
effect across all measured outputs.  The application of a large scale, rapidly administered, 
emergency vaccination program (1500 herds vaccinated per day) greatly diminished the duration 
and severity of an FMD outbreak, assuming a Dairy Index Herd. 
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Update on Milk Residues 
Nicole Neeser, Minnesota Department of Agriculture 
Dairy Inspection Program Manager 
 
Milk residues continue to be a hot topic among dairy industry personnel and within veterinary 
circles.  As the industry and government await the results of FDA’s sampling surveillance project, 
questions continue to circulate regarding the impacts of the project, future actions and changes in 
residue testing and the regulatory requirements.  Almost certainly, the results of a small sampling 
surveillance project designed to address a specific risk factor on dairy farms, tissue residue violations, 
will have a much wider impact when the results are released.   
Traditionally, drug residue testing on milk has been limited to the beta lactam testing 
requirements explicitly stated in the Pasteurized Milk Ordinance (2011 PMO, Appendix N, p. 342):  
“Industry shall screen all bulk milk pickup tankers, regardless of final use, for Beta lactam drug 
residues.”   
In Minnesota, the results of this testing program have shown steady reductions in the number of 
violations obtained each year (Table 1).   
Table 1.  MN Drug Residue Summary 2007‐2012 
Year  2007  2008  2009  2010  2011  2012 
Number of 
Residues  133  97  81  92  89  56 
Average Number 
of Farms  5067  4864  4689  4511  4333  4090 
Percent of Farms 
with Violations  2.62%  1.99%  1.73%  2.04%  2.05%  1.37% 
 
The current testing regimen has been consistent for many years and is a very predictable, very 
structured process which allows dairy producers and industry to understand exactly what is being tested 
for, when tests are occurring and allows them to put standard procedures in place to avoid residues. 
  The potential addition of testing requirements is a very real possibility.   This requirement may 
come from additional government regulations; however, it is much more likely that the first testing 
programs outside of the stated regulatory requirements will be performed at the initiative of the 
industry in response to the expectations of other countries or customers.  In fact, some of this testing is 
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already beginning to take place.  The additional testing creates an environment which is much less 
predictable for the dairy producer, processor and those veterinarians serving the dairy industry.   
  Additional testing protocols are not as well defined as those that exist to meet the prescribed 
regulatory requirements.   Testing may be done for a wider variety of drugs, on a longer timeline, and 
using tests which have not been officially approved by the FDA.  All of these factors make it much more 
difficult for producers to predict when testing is occurring, what drugs are being tested for, the 
implications of a positive result and how to prevent a violation.   In general, these factors create an 
environment in which producers and veterinarians must be extremely vigilant about how they are using 
drugs on their farm, following the proper withdrawal times and ensuring they have the proper controls 
in place to prevent a residue for a drug, regardless of which drugs they are using.   Judicious drug use 
and drug treatment protocols on farms will continue to be critical to ensuring a safe milk supply and 
preventing drug residues.      
 124 
 
Johne’s disease: A zoonosis? 
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Assistant Professor of Dairy Production Medicine 
College of Veterinary Medicine 
University of Minnesota 
St. Paul, MN 55108 
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Most cattle veterinarians are familiar with Johne’s disease (JD). The disease is caused by 
Mycobacterium avium subspecies paratuberculosis (MAP) and has been described worldwide. 
The infection progresses slowly so that most infected cows do not show clinical signs of this 
granulomatous enteritis, chronic diarrhea and wasting, until they are 2-4 years of age. The 
predominant transmission route is fecal-oral and infected cows shed the bacterium through 
manure, milk, and colostrum. It is estimated that 70% of dairy herds in the United States are 
infected with a within-herd prevalence of 3-5% test-positive animals1. Johne’s disease has an 
economic impact on infected farms through premature culls and reduced milk production.  
 
While Johne’s disease is primarily a ruminant disease (i.e., cattle, small ruminants, camelids, 
cervids), clinical disease after natural exposure has also been described in a donkey2 and MAP 
was isolated from other monogastric animals such as bears and cats3. A human disease that is 
often compared to JD is Crohn’s disease (CD) as the gross pathology of both diseases looks very 
similar. It has been speculated whether MAP is a zoonosis and could be a potential cause of CD. 
Both is unclear at this point. However, the hypothesis cannot be completely dismissed with the 
current knowledge as MAP belongs to the genus Mycobacterium, which includes severe human 
diseases such as M. tuberculosis (human tuberculosis), M. bovis (bovine tuberculosis, zoonotic) 
and M. leprae (leprosy). Therefore, the dairy industry is concerned that consumers could 
perceive a causal relationship between MAP and CD - whether a causality is actually 
scientifically proven or not. The biggest problem is that MAP can survive for long times in the 
environment and is furthermore very heat resistant. Pasteurization does only reduce its numbers4 
and viable MAP has been isolated from environmental5 and drinking water6, infant formula7, 
pasteurized shelf milk4 and beef8. Only thorough cooking of beef (to well done) will kill viable 
MAP in meat9.  
 
Crohn’s disease and JD are both chronic diseases and the onset of clinical disease is most 
commonly after puberty, i.e., at 15-30 years and 50-70 years of age in humans and 2 years in 
cattle. However, unlike JD, CD can affect any portion of the gastrointestinal tract from mouth to 
anus and even inflammation of skin, joints and eyes are common. Most patients with CD suffer 
from severe abdominal cramps, nausea, chronic diarrhea, vomiting, fever, ulcers in mouth or at 
anus. The disease is a transmural inflammation of the intestine.  It is generally recognized that 
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there are 5 different types of CD, depending on the affected portion of the intestinal tract, and 
that Crohn’s disease should therefore be more appropriately used only as an umbrella term for 
“Crohn’s diseases”10. Ulcers, fistulas or strictures of the gut are common, which require a 
surgical resection of parts of the intestine in roughly 75% of Crohn’s patients. The diagnosis of 
CD is based on a battery of tests (blood tests for anemia and inflammation, liver function tests, 
stool analysis, endoscopy and gut biopsy, x-rays with barium contrast) and other exclusion 
criteria. A differential diagnosis of CD is ulcerative colitis (UC) that also belongs to the 
inflammatory bowel disease (IBD). In 10% of patients the features are undistinguishable 
between UC and CD and no clear diagnosis can be made10. The prevalence of CD patients has 
been estimated at 1 in 694 people in the United States has the disease. Manitoba, Canada, has the 
highest CD prevalence with 1 in 428 people. However, over the recent years the incidence of 
IBD has increased significantly11. 
 
The etiology of CD is still not fully understood despite the fact that CD was already first 
described in 1904. The different forms of CD and the fairly unspecific diagnosis might 
contribute to this dilemma. Although CD was first thought to be an autoimmune disease12, now it 
is generally accepted that CD is a multifactorial disease. Factors that are associated with the 
disease include genetic susceptibility, westernization of the lifestyle, dietary changes towards 
fast-food, changes in alimentary microbiota, hygiene, various possible pathogens and treatment 
with antibiotics in the first year of life11,12.  
 
The genetic component of CD has been established based on the observation that certain 
ethnicities have a higher incidence of CD than others, that the odds to get CD are higher if a 
family member has CD and specific gene defects were discovered in some patients with CD13. 
For example, defects of the NOD2 receptor have been described by 3-43% of CD patients 14 - as 
well as in cows with JD15. However, the genetic susceptibility alone does not produce IBD and it 
also cannot explain the relatively quickly rising incidence of IBD over the past decades as the 
genetic pool was relatively stable16. Therefore, the role of various “environmental” factors needs 
to be discussed11,13. In particular the role of a changed gut microbiota in the disease etiology is 
more and more under investigation. Although, it is currently still unclear if general changes in 
the gut microflora or specific pathogens are the major contributor to CD pathogenesis13. 
  
Factors that were identified to be associated with an increased incidence of IBD and CD in a 
population include increased stress levels, smoking, obesity, westernization of society and 
changes in diet to include more fast-food, dairy products, meat and fatty acids11,16. Furthermore, 
studies have found that children treated with antibiotics in their first year of life were 5.3 times 
more likely to develop CD17. As the microflora well as the immune system of the GI tract 
develop in the first 5 years of life in humans, both will likely been altered by antibiotics in early 
childhood11,13. Contrary, poor domestic hygiene, parasitism, and overcrowding reduce the risk of 
CD. In particular the latter supports the hypothesis regarding a change in the general gut 
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microbiom and contradicts theories of a specific pathogen as those circumstances would support 
the involvement of a transmissible factor13. Nevertheless several pathogens are being discussed 
in association with CD. They include MAP, Yersinia ssp., Mycobacterium tuberculosis, 
Helicobacter hepaticus, Adherent-Invasive Escherichia coli (AIEC), Listeria ssp., Entamoeba 
histolytica, Campylobacter, an early measles (Paramyxovirus) infection and more12,13. The 
diversity of pathogens under investigation shows that at this point no single pathogen has been 
identified the cause of CD in humans and many questions remain. In the case of MAP, there are 
studies that found higher presence of MAP in CD patients. For example, Bull et al.18 found MAP 
in up to 92% of CD patients compared to 23% of controls. However, other studies were unable to 
find MAP in Crohn’s patients or to determine an association between MAP with CD19. 
Therefore, one might speculate that MAP is a part of the causal mix in some cases of CD. 
However, unless more specific tests for the diagnosis of CD and its types are developed this is 
difficult to prove. Crohn’s disease is not a homogeneous disease but rather an umbrella-like term 
of several multifactorial diseases and trying to explain MAP as cause for all CD cases is 
comparable to saying that all calfhood diarrhea cases are attributable to e.g. Salmonella.   
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Temporal and spatial patterns of cattle imports to Minnesota for the years 2009 and 2011: 
Identifying cattle farms and zones for risk-based surveillance 
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In this study we propose to develop a risk-based surveillance system for MN cattle herds by creating a 
risk profile of each import cattle movement to the state of MN. We hypothesize that by doing so, we will 
identify high risk herds and zones for BTb introduction into the state of MN, which can direct resource 
allocation for the state animal health agency.  
Data on import interstate cattle movements was obtained from the Minnesota Board of Animal Health 
(MNBAH) for the years 2009 and 2011. Descriptive analysis was performed for 2009 and 2011. 
Movement data was summarized at the premise and county level and for both levels the distribution of 
cattle moved and number of movements was evaluated. In order to develop a strategy for a targeted 
surveillance system at the herd level for BTb in MN, each import movement was risk profiled based on 
known risk factors. The data was analyzed by fitting a linear regression model at the county level, to 
determine which variables might be affecting higher number of movements at the regional level.  
In each year, about 1500 herds had import movements to MN. Most of the cattle imported were in the 
categories of beef and feeder cattle, mostly originated from bordering US states. The peak season for 
incoming cattle and import movements was the fall season for both years. The risk model identified four 
risk groups with about 500 (~2% of total cattle farms in MN) cattle premises in the Very High and High 
risk group for each year. The southeast and southwest zones of the state had the highest density of cattle 
premises with movements and also cattle premises in the higher risk groups.  
In this abstract an approach for risk-based surveillance for BTb is presented using available data from the 
MNBAH, which outlines a method that can be used in the US for BTb and other disease scenarios. 
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 Effect of Using the Perfect Udder® System to Heat-Treat Colostrum on Passive Transfer 
of IgG in Neonatal Jersey Calves 
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Heat-treating colostrum using batch pasteurizers has been proven effective to reduce bacterial 
contamination while protecting immunoglobulins, and enhancing passive transfer and health in 
calves.  The Perfect Udder® bag (Dairy Tech Inc., Windsor, CO) is designed to heat-treat 
colostrum (then store and feed) one gallon at a time.  However, this system requires 
validation.  The study objective was to describe the effect on passive transfer of IgG in neonatal 
calves when using the Perfect Udder® heat-treatment system as compared to a negative control 
(fresh refrigerated or fresh frozen colostrum) and a positive control (batch heat-treated 
colostrum).  
The study was conducted in summer, 2012, on a large commercial Jersey farm in Minnesota.  
First milking colostrum was pooled each day to achieve a unique batch. The batch was then 
divided four ways with 3.8 L allocated to each treatment group: 1. Heat-treat in Perfect Udder® 
bag at 60°C for 60 minutes (PU); 2. Batch heat-treat at 60°C for 60 minutes and store in Perfect 
Udder® bag (BT; positive control); 3. Fresh frozen in Perfect Udder® bag (FF; negative 
control); 4. Fresh refrigerated at 4°C in Perfect Udder® bag (FR; negative control).  Colostrum 
from all treatments was sampled for IgG concentration and bacterial culture testing immediately 
after assembly, post processing, and post thawing/prior to feeding.  Newborn calves were 
removed from the maternity pen within 20-30 minutes of birth and before suckling. The calf was 
weighed and an 8 mL blood sample was collected from the calf’s jugular vein prior to feeding.  
Singleton calves were randomly assigned to one of four treatment groups (PU, n=28); (BT, 
n=28); (FF, n=29); (FR, n=27).  At 24 hr of age, a second 8 mL venous ‘postfeeding’ blood 
sample was collected. Paired serum samples collected at 0 and 24 hrs were analyzed for IgG 
(mg/ml) using RID analysis. 
Mean dystocia score, calf weight, and quality of colostrum fed (g/L IgG) were not different 
among colostrum treatment groups.  The mean age at feeding in minutes was shorter for calves 
fed FR colostrum (69 min), as compared to PU (79 min), BT (83 min) and FF (88 min) groups.   
However, age at feeding was not associated with IgG absorption in this study. Final analysis of 
variance models showed a significant effect of treatment on IgG absorption when comparing 
fresh (FF or FR) versus heat-treated (PU or BT) treatment groups, but no difference between FF 
and FR treatments and no difference between PU and BT treatments.  The mean apparent 
efficiency of absorption of IgG (%) was 37%, 37%, 32%, and 32% for the PU, BT, FF and FR 
groups, respectively.  The mean final serum IgG value at 24 hrs was 41.1, 40.0, 35.2, and 35.7 
mg/ml for PU, BT, FF, and FR groups, respectively. Secondary analysis indicated that enhanced 
efficiency of absorption of IgG and final serum IgG concentrations for calves in the PU and BT 
groups was likely attributed to the fact that lower bacteria counts in heat-treated colostrum, and 
particularly lower coliform counts, are associated with enhanced IgG absorption.  Pre-feeding 
total plate count (log TPC, cfu/ml) was significantly different for all 4 treatments, with mean 
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values of 4.23, 3.63, 5.68, and 6.53 for PU, BT, FF and FR groups, respectively.  Total coliform 
count (log TCC, cfu/ml) was also significantly different for all 4 treatments, with mean values of 
0.45, 1.08, 3.82, and 4.80 for PU, BT, FF and FR groups, respectively. 
Calves fed colostrum processed using the Perfect Udder® heat-treatment system had improved 
efficiency of IgG absorption and final serum IgG concentrations as compared to fresh colostrum 
groups. However, efficiency of IgG absorption and final serum IgG concentrations were not 
different for calves fed colostrum heat-treated using the Perfect Udder® system as compared to 
batch heat-treated colostrum.  The Perfect Udder® colostrum heat-treatment system can be 
useful to dairies desiring to heat-treat 1 gallon aliquots of colostrum at a time. 
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INTRODUCTION 
One of the most commonly experienced stressors in livestock is caused by fluctuations in 
environmental temperature that extend beyond the thermonuetral zone for the animal.  The 
reported lower critical temperature (LCT) for a newborn dairy calf ranges from 13 °C (Curtis, 
1974) to 8°C (Young, 1981).  Limited data are available evaluating impact of supplemental fat 
for nursery calves fed accelerated milk replacer during cold stress.  Questions remain regarding 
when to feed and amount of supplemental fat to optimize calf nutrient intake for calf growth and 
health.  Numerous studies have investigated effects of varying the fatty acid profile of calf milk 
replacer; however, we are unaware of studies designed to specifically target amount of 
supplemental fat fed during the early nursery phase (Jenkins et al., 1985; Piot et al., 1999; Gaulet 
et al., 2000; Hill et al., 2007; Mills et al., 2010).  Increasing rates of milk replacer feeding have 
been shown to reduce starter intake and delay rumen development (Bar-Peled et al., 1997; Jasper 
and Weary, 2002; Terré et al., 2007).  Supplemental fat may be optimally positioned early in the 
nursery phase (first three wk) when nutrient intake from starter is expected to be low.  Khan et al. 
(2007) found that providing calves a large amount of milk early in life and then reducing milk 
intake before weaning (step-down method) caused a surge in solid feed consumption.  Removing 
supplemental fat from milk replacer could be considered as an alternative approach to inducing a 
similar step-down effect on starter intake without altering the amount of milk replacer fed.  Cold 
stressed calves may benefit from supplemental fat by sparing glucose and amino acids which are 
used for thermoregulation when calves are managed in conditions below the thermal neutral 
zone. Composition of maternal transition milk indicates that calves are naturally programmed to 
consume high fat milk during the early days of life.  Increasing amount of fat fed to calves in the 
beginning of the nursery phase may replicate added energy from milk fat which is typically at an 
elevated concentration in early lactation.  Supplemental fat may spare amino acids (alanine) by 
reducing amount of amino acids catabolized for energy resulting in a greater proportion of 
dietary energy available for lean growth.  In order to test this hypothesis milk replacer must be 
fed that provides sufficient amounts of protein to meet the amino acid requirements of nursery 
calves for growth and maintenance (Bartlett et al., 2006; Donnelly and Hutton, 1976).  
Supplemental fat also spares energy that can be used for functions beyond growth including 
immune function.  Reducing effects of cold stress on nursery calves may also reduce stress 
which has been shown to reduce efficiency of growth.  Enhanced early nutrition capitalizes on 
growth performance early in life being driven more by increasing protein and lactose intake than 
by increasing fat intake (Tikofsky et al., 2001; Hill et al., 2008).   Objectives of this experiment 
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were to determine if increasing fat intake during the first 21 d of the nursery phase alters growth 
rate, efficiency of growth, voluntary starter intake and nutrient intake in nursery calves fed 
accelerated MR and to determine if response in calf performance is altered by supplemental fat 
amount.  We hypothesized that supplemental fat will decrease starter intake during the first mo 
of the nursery phase but energy available for growth will be greater resulting in increased calf 
growth.   
MATERIALS AND METHODS 
Animals 
Experimental protocol was reviewed and approved by the University of Minnesota Institutional 
Animal Care and Use Committee.  Eighty-one (n = 27 per treatment) Holstein and Holstein-cross 
calves born at the University of Minnesota Dairy Teaching and Research Center, St. Paul, MN 
were enrolled in the study.  At birth, calves were removed from their dams, identified with a 
unique ear tag, birth body weight (BBW) was recorded, navels were dipped, and each calf 
remained in a heated indoor pen for the first 48 h after birth.  Calf BBW averaged 41.8 ± 1.6 kg.   
Calves received approximately 1.9 L of colostrum at each of the first three feedings (within 2 h 
after birth and again approximately 12 and 24 h after the first feeding) and were trained to drink 
MR from buckets during the first 4 d of life.  A blood sample was collected via jugular 
venipuncture into evacuated serum collection tubes (SST; Beckton Dickenson Vacutainer 
Systems, Franklin Lakes, NJ) 24 h after birth and centrifuged at 2,000×g for 20 min.  Serum was 
separated and analyzed for total serum protein concentration using a refractometer (Reichert 
Rhino VET360, Reichert, Depew, NY).  Serum total protein averaged 5.8 ± 0.1 mg/dL.  Each 
calf was placed in a calf hutch (PolyDome, Litchfield, MN) bedded with wheat straw.  
Throughout the experiment the mean temperature was 1.7°C and the average low temperature 
was -3.9°C (Figure 1).    
Assignments to Treatments and Feeding 
Experimental design was a randomized block design with 3 treatments.  Calves were assigned to 
treatment at birth and treatments were balanced by BBW, gender, breed, and serum total protein.  
Calves were fed one of three treatments; 1) Low fat (LF) (28:15 MR); 2) Medium fat (MF) 
(28:15 MR + 113 g/d commercial fat supplement (FAT) (60% fat); 3) High fat (HF); 28:15 MR 
+ 227 g/d FAT. MF and HF calves received FAT 1 to 21 d.   
All calves were fed LF 22 to 49 d. Calf milk replacer was fed at 1.4% of BBW 1 to 10 d and then 
1.8% of BBW 11 to 42 d, and 0.9% of BBW 43 to 49 d and CMR was reconstituted to 13% 
solids.  Calves were fed CMR twice d at 0630 and 1730 in hutches. Intake of CMR was similar 
(P = 0.41) among treatments and averaged 34.2, 32.6, and 33.5 kg/calf for LF, MF and HF 
respectively.  Calves were weaned on day 49 and remained in hutches to day 56.  Calves were 
fed a commercial texturized starter grain ad libitum (19.2% CP on a DM basis) (Table 1).  
Approximately 4-10 L of drinking water was provided daily.  Starter refusals were recorded 
daily and refusals of MR were recorded at each feeding.  Calf BBW averaged 42.0 ± 1.1 kg/d 
and were similar among treatments (P = 0.41).  Calves were born over a 5-mo period (October 
through January) however; ambient temperature 5.3 ± 1.1°C at birth was similar (P = 0.82) 
across treatments.  Quality of calf bedding was evaluated using nesting scores when calves were 
lying down in hutches (1 = calf legs are completely nestled into straw; 2 = calf legs are partially 
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nestled into straw; 3 = calf legs are resting on top of straw).  Nesting scores were similar (P = 
0.65) among treatments. 
Nutrient composition of milk replacers and starter is listed by treatment in Table 1.  Milk 
replacer was formulated to contain 28% CP and 15% fat on an as-fed basis and actual analyzed 
CP and fat on a DM basis was 30.9% and 15.7%, respectively.  Supplemental fat contained 7.7% 
CP and 57.4% fat on a DM basis.  Fat supplement contained 25.4% palmitic, 12.6% stearic and 
42.2% oleic acid (Table 2).  Starter was prepared to contain 18% (as-fed basis) CP and was 
21.8% on a DM basis.   
Body Growth and Health Monitoring  
Calves were weighed at birth and weekly thereafter each Friday at 0900 h.  Body length (BL), 
heart girth (HG) (dairy calf weigh tape, Fort Atkinson, Nasco, WI), hip width (HW), withers 
height (WH) and hip height (HH) (measuring stick, Fort Atkinson, Nasco, WI), were also 
measured.  Calculations of average daily gain (ADG) of body weight (BW) and stature were 
made from these measurements.  Calves were observed at least twice daily from 1 to 56 d of age 
for general health, including appearance (alertness), and appetite (ability to consume feed).  
Fecal scores (FS); 1 = normal, firm and well formed, 2 = semi-formed, pasty, 3 = loose, but stays 
on top of bedding, and 4 = watery, readily absorbed into bedding, were recorded daily from 1 to 
56 d of age.  Scours were defined as FS ≥ 3.  Scours were treated with oral electrolytes (Bounce 
Back, Manna Pro, Chesterfield, MO) and continued CMR feeding. 
RESULTS 
Calf management 
 
There was no treatment effect on nesting score, fecal score or weekly measures of rectal 
temperature (Table 3).  Nesting score decreased (P < 0.001) over time as initial straw bedding 
was compacted with use.  Consistently low fecal scores were observed during this study and 
were similar among treatments. Rectal temperature tended (P = 0.09) to be highest on week 3 
with an average of 38.3°C.       
Starter and nutrient intake 
 
Starter intake was lower (P = 0.038) for MF vs. LF and HF (Table 4; Figure 1).  As expected, 
starter intake increased (P < 0.001) with increasing age (Table 4).  Starter intake on d 21, when 
the fat supplement was discontinued, was greater (P < 0.003), and on d 42 was greater (P = 
0.009) for LF vs. MF and HF.  Starter intake on d 49, when calves were weaned from CMR, was 
greater (P = 0.032) for LF vs. HF with starter intake by MF being intermediate.  By d 56, when 
the study ended, starter intake per day was similar (P =0.646) across all treatments.  Starter 
intake expressed as a percentage of body weight was affected by treatments similarly as was 
starter intake.  Total DMI (starter intake + CMRI + FAT) from d 3-49 tended (P = 0.062) to be 
greater for LF vs. MF and HF.  Total DMI from d 3-56 followed a similar trend.  Feed efficiency 
(gain:feed) through d 49 was greater for MF and HF compared with LF, but gain:feed through 56 
d was similar among treatments.  Day of age in which calves were consuming at least 250, 500, 
1000 and 2000 g/d was calculated to determine if there were differences not only in amount of 
starter intake but also age in which calves consumed these targeted amounts of starter.   Calves 
fed LF ate the targeted 250 g/d of starter intake 5.5 and 6.4 d earlier than MF and HF, 
respectively.  Mean separation in starter intake was observed as early as day 14 of the trial, but 
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interestingly by d 56 all calves were consuming a similar amount of starter grain.  Peak starter 
intake was defined as the greatest amount of starter consumed per d during the 56 d nursery 
phase.  Starter intake peaked at 3.5, 3.3, and 3.2 ± 0.1 kg/d for LF, MF and HF, and was similar 
(P = 0.233) among treatments.  Calculated metabolizable energy intake from CMR was similar 
(P = 0.775) across treatments.  As expected, MEI increased with fat supplementation by 0.28 and 
0.59 ± 0.06 Mcal/d for MF and HF during the first 21 d in which fat was added to CMR (Figure 
3).  Metabolizable energy intake was greater on wk 1, 2 and 3 for HF vs. LF and MF.  On wk 6 
LF MEi was greater than MF and on wk 7 LF MEi was greater was greater than LF.  Despite 
higher starter intake by LF, supply of MEI from calf starter was not different (P = 0.221) among 
treatments.  Due to greater starter intake by LF and higher energy intake through fat 
supplementation by MF and HF, total MEI through 56 d was similar (P = 0.332) among 
treatments.       
Calculated intake of crude protein from CMR and starter grain from day 3 to 49 and day 3 to 56 
was similar (P = 0.323) among treatments; however calculated fat intake was increased (P < 
0.001) from LF to MF and MF to HF (Table 5).  Intake of C16:0 and C18:1 from CMR was 
similar among treatments.  Calculated intake of C16:0 from fat supplement was 0.36 and 0.73 kg 
and intake of C18:1 was 0.60 and 1.21 kg during the first 3 wk for MF and HF respectively.  
Total intake of both C16:0 and C18:1 from CMR and FAT was increased (P < 0.001) by fat 
supplementation HF > MF > LF.  Post-weaning measures of apparent total tract DMd was 
similar across all treatments.   
 
Growth and structural development  
       
 Calves fed MF and HF had greater (P < 0.05) BW gain during wk 1 and 2 than LF.  Very few 
calves lost weight during week 1 (n = 6); however, of those losing weight during the first wk, 4 
were LF and 1 calf each were fed MF and HF.  Body weight gain and ADG through 21 d 
continued to be greater (P < 0.009) for MF and HF compared with LF (Table 6).  Average daily 
gain during wk 1-3 tended (treatment × wk, P = 0.077) to be greater for MF and HF vs. LF 
(Figure 2).  There were no differences in growth measures of HH, WH, BL, HG, or HW among 
treatments.  Differences in total gain and ADG observed in calves at 21 d were no longer 
apparent by 42 d.  By 56 d, there were no differences in total BW gain among treatments, 
however, LF had greater (P < 0.029) hip height and tended (P = 0.053) to have greater WH 
compared with MF and HF.  Interestingly, there were no differences in rates of growth between 
MF and HF.        
DISCUSSION 
 
Supplementing fat during the early nursery phase provides additional nutrients that more closely 
mimic fat concentration found in transition milk of the dam.  Calculated as-fed protein to fat 
ratio for treatments employed in this study were 28:15, 26:20, and 24:25 for LF, MF, and HF 
respectively.  The HF treatment most closely represents the protein:fat typically found in cow’s 
milk.  Although amount of fat supplied by HF is similar to that from cow’s milk, fatty acid (FA) 
profile is considerably different lacking short (< 6 carbon) and medium chain (6 to 12 carbon) 
FA found in milk fat.      
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Starter and nutrient intake and feed efficiency 
 
Lower starter intake by calves fed FAT through d 49 is not surprising as these calves likely 
experienced greater satiety with chemical and physical factors.  Calves fed an enhanced-growth 
feeding program usually have lower starter intakes during the preweaning period compared with 
conventionally-fed calves.  Calves consuming appreciable amounts of starter at a younger age 
may have advantages in gastrointestinal tract maturation, greater capacity for nutrient absorption, 
and increased gut integrity (Hill et al., 2010; Sweeney et al., 2010).  An alternative view is a 
greater supply of energy and nutrients from higher milk intake could contribute directly to 
development of rumen papillae through metabolic axis (Shen et al., 2004).  Interestingly, 
changes in endocrine factors (insulin and IGF-1) in relation to higher milk intake may also 
promote development of ruminal epithelium (Gerrits et al., 1998; Shen et al., 2004).  Post-
weaning measures of total tract apparent DMd were similar across all treatments.  We anticipated 
that greater rumen development associated with greater amounts of starter intake for LF would 
result in greater DMd, however, greater starter intake and likely increased rates of passage of 
digesta resulted in similar DMd.  Apparent DM, OM, NDF, CP, and gross energy digestibility 
was greater in control fed compared with accelerated fed calves one wk after weaning (Terré et 
al., 2007).  Greater feed efficiency for fat supplemented calves is not surprising given greater 
MEI and the higher coefficient of digestibility for supplemental fat vs. starter grain.  Perhaps 
supplemental fat also increased efficiency of growth by supplying greater amounts of energy 
during the first three wk and therefore reduced the impact of mild cold stress on nutrient used for 
growth.  Effects of supplemental fat on day of age to consistently consume targeted amounts of 
250, 500, 1000 and 2000 g/d starter grain is intriguing and warrants further investigation to 
determine impact of reducing day of age to consume benchmark amounts of starter.   
 
Supplemental fat increased intake of C16:0 and C18:0.  In preruminant calves, high fat diets 
stimulate secretion of triglyceride rich lipoproteins such as chylomicrons and very low density 
lipoproteins (Piot et al., 2000).  Metabolism of FA and their subsequent mitochondrial oxidation 
depends on coordinated induction of enzymes activities involved in FA metabolism at both 
extramitochondrial level (FA uptake) and mitochondrial level (flux of FA through beta-
oxidation) and some of these steps have been shown to be regulated by dietary FA (Pilot et al., 
2000).  Fatty acids are biologically active molecules that can regulate gene expression, enzyme 
activities, binding proteins and other cellular processes.  Hepatocytes from 7- to 10-d-old calves 
exposed to 2 mM palmitic acid and 1mM palmitic acid plus 1 mM stearic acid had greater rates 
of oxidation and ketogenesis of FA compared with all other treatments which included 
polyunsaturated FA (Mashek and Grummer, 2003).  In neonates, FA oxidation rapidly increases 
after birth to meet energy demands (Girard et al., 1992).  Capacity for FA oxidation and ketone 
body production increases rapidly during the first 24 h after birth (Oden and Treen, 2003;Odle et 
al., 1995).  Plasma concentrations of β-hydroxybutyrate in neonatal calves are low but increase 
after intake of milk (Senn et al., 2000).  Milk intake and carnitine supply is also important for 
long-chain FA oxidation in brown adipose tissue to ensure heat production by mitochondria 
uncoupling proteins for thermogenesis and body temperature regulation in neonates of species 
that contain appreciable amounts of brown fat such as in ruminants (Girard et al., 1992; 
Hondares et al., 2010).   
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During trial planning we discussed potential impact of sudden decrease in dietary energy from 
supplemental fat at completion of the third wk.  Previous work has suggested that consistency of 
milk feeding programs has an impact on calf health and growth (Quigley et al., 2006).  Perhaps a 
gradual decrease in supplemental fat feeding during the second or third wk of the trial may have 
resulted in more gradual change-over to consuming more starter grain especially for HF calves.                            
Lower border of the zone of thermoneutrality is called the lower critical temperature below 
which, the animal must increase its rate of heat production to maintain homeothermy.  Plane of 
nutrition likely has a marked effect on thermoneutral heat production and consequently on lower 
critical temperature.  Research reports investigating importance of modulating the environment 
and diet to prevent cold stress in nursery pigs has shown a clear impact of nutrient use for growth 
and immune system function (Salak-Johnson and McGlone, 2007).  Supplemental energy for low 
birth weight infants resulted in greater weight gains and greater increases in lean tissue growth 
than that of control fed infants (Costa-Orvay et al., 2011).  There is a paucity of data examining 
impact of nutrition on growth and health in nursery calves.  Work described by Young, (1981) 
indicated that cold stress was associated with increased resting metabolic rate associated with 
increased energy requirement for maintenance and stimulation of appetite resulting in an 
increased rate of passage of digesta resulting in a decrease in digestive efficiency.  As a result, 
cold stressed calves should consume more starter grain, but have a lower efficiency of growth.  
Net effect of cold stress should be a decrease in efficiency of growth due to a decrease in 
efficiency of use of dietary energy.  Marked changes in efficiency of growth across seasons is 
likely a result of hormonal and adaptive changes occurring as a result of cold stress.   
 
Dry matter digestibility 
 
Varying the approach to liquid feeding nursery calves, including milk replacer (with or without 
sodium butyrate vs. whole milk) affected reticulo-rumen and small intestine development, calf 
growth, and starter intake (Górka et al., 2011).  We hypothesized that calves fed supplemental fat 
would have a less developed rumen at weaning and therefore we anticipated lower apparent total 
tract starter digestibility in MF and HF compared with LF.  Interestingly, apparent starter grain 
digestibility was 7.0 and 1.6 ± 3.9% greater for MF and HF compared with LF and is possible 
due to differences in amount of starter intake and thus rate of passage.  Development and 
function of pregastric fermentation was not measured in this study.    
     
Growth and structural development        
 
One objective of feeding supplemental fat is to increase energy intake during the first wk of age 
when starter intake is expected to be low and not make a substantial contribution towards 
meeting energy requirements for maintenance and growth.  Supplemental fat nearly doubled 
body weight gain during the first week and differences between control and fat supplemented 
calves remained through 21 d.  Differences in starter intake likely explain a lack of difference in 
BW gain among treatments prior to weaning and at end of trial.  There were essentially no 
differences in calf structural measurements among treatments except for small but significantly 
greater hip height and withers height gain through d 56 by LF vs. MF and HF.  Balancing dietary 
energy and protein supply to maintain both body weight gain and structural growth are hallmarks 
of a successful nursery calf feeding program.  These data are in agreement with the review by 
Khan et al. (2011) which suggest that the optimal milk ration is greater than that used in 
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conventional practice (restricted feeding) but less than ad libitum energy intake.  Younger calves 
benefit from increased milk rations by being able to express more natural feeding behavior, 
reduced signs of hunger, improved growth and likely improved health (Khan et al., 2011).    
            
CONCLUSION 
 
Supplemental fat fed during the first 3 wk of the nursery phase in addition to an accelerated 
feeding program during mild cold stress increased energy intake and gain during the first three 
weeks but reduced starter intake until weaning.  Starter intake by LF calves was greatest until 
beginning of weaning after which starter intake was similar among treatments. Due to higher 
starter intake, total intake of metabolizable energy was similar among treatments.  Average daily 
gain during fat supplementation was greater for MF and HF than LF.  Lack of increase in BW 
gain and feed efficiency between MF and HF treatments indicated that HF did not result in 
advantages over MF.  Future research should investigate slower removal of supplemental fat 
from the milk replacer to prevent large changes in energy intake and evaluate impact of 
supplemental fat for low birth weight calves.  
 
Table 1.  Nutrient composition of milk replacer, fat supplement and starter grain fed to nursery 
calves during mild cold stress.   
 Milk replacer (28:15) Fat supplement  Starter grain 
 % DM 
Crude protein, % 30.9 7.7 21.8 
Ether extract, % 15.7 57.4 3.8 
ME, Mcal/kg 4.6 6.5 2.8 
aNDF, % <0.01 <0.01 30.1 
Ash, % 8.3 4.2 4.23 
Calcium, % 1.0 0.3 1.0 
Phosphorous, % 0.8 0.3 0.5 
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Table 2.  Fatty acid composition of milk replacer and fat supplement for calves fed 0, 113, or 
227 g/d supplemental fat d 2-21 of age. 
          Milk replacer      Fat supplement  
Fatty acid g/100 g fatty acids 
C14:0 1.6 3.0 
C15:0 0.28 0.20 
C16:0 24.6 25.4 
C16:1 3.0 3.0 
C17:1 0.28 0.30 
C18:0 12.9 12.6 
C18:1 44.4 42.2 
C18:2 10.2 9.8 
 
Table 3.  Description of calves fed 0, 113, or 227 g/d supplemental fat d 2-21 of age. 
 Treatment1  P-value 
 LF MF HF SEM TRT week TRT*week 
n 27 27 27     
Birth body weight, kg 42.9 41.0 42.1 1.1 0.41 --- --- 
Ambient temp. at birth, °C 5.5 5.3 5.0 1.1 0.82 --- --- 
Serum total protein, mg/dL 5.7 5.8 5.8 0.1 0.67 --- --- 
Parity of dam 1.6 1.8 1.8 0.1 0.28 --- --- 
Milk replacer offered, kg DM 34.2 32.6 33.5 0.8 0.41 --- --- 
Total offered (MR + fat), kg DM 34.2a 35.1a 38.3b 0.8 < 0.05 --- --- 
Nesting score 1.58 1.61 1.64 0.05 0.65 < 0.001 0.95 
Fecal score 1.29 1.17 1.24 0.04 0.13 0.13 0.99 
Rectal temperature, °C 38.25 38.22 38.25 0.03 0.76 0.09 0.96 
1Nursery calves were fed one of three treatments; 1) Low fat (LF) (28:15 MR; 2) Medium fat 
(MF) (28:15 MR + 113 g/d commercial fat supplement (FAT) (60% fat); 3) High fat (HF); 28:15 
MR + 227 g/d FAT. MF and HF calves received FAT d 1-21. All calves were fed LF d 22-49. 
Milk replacer was fed at 1.4% of birth body weight (BBW) d 1-10 and then 1.8% of BBW d 11-
42 and 0.9% of BBW d 43-49.  Calves were weaned on d 49 and remained in hutches to d 56.   
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Table 4.  Mean intakes of starter, peak starter intake, starter intake expressed as a percentage of 
body weight, total dry matter intake, feed efficiency and days of age in which calves were 
consuming selected amounts of starter intake.   
 Treatment1  P-value 
 LF MF HF SEM TRT Wk TRT×Wk 
Starter intake, kg/day, d 1-56 1.2a 1.0b 1.1ab 0.06 0.038 <0.001 0.423 
Peak starter intake, kg/d 3.5 3.3 3.2 0.1 0.233   
Starter intake, kg/d        
21 d 0.4a 0.2b 0.1b 0.04 0.003   
42 d 1.6a 1.3b 1.2b 0.09 0.045   
49 d 2.3a 2.1ab 2.0b 0.09 0.032   
56 d 3.0 2.9 2.9 0.09 0.646   
Starter intake, % of BW        
21 d 0.7a 0.4b 0.3b 0.07 <0.001   
42 d 2.1a 1.7b 1.6b 0.01 0.009   
49 d 2.9a 2.6b 2.4b 0.1 0.014   
56 d 3.5 3.4 3.3 0.1 0.273   
DMI, kg d 3-492 78.3 70.6 70.6 2.6 0.062   
DMI, kg d 3-562 97.8 90.8 90.5 3.1 0.183   
Gain:feed, kg/d d 3-49 0.52a 0.58b 0.57b 0.02 0.032   
Gain:feed, kg/d d 3-56 0.67 0.69 0.61 0.03 0.175   
Day of age consuming 
varying amounts of starter  
       
250 g/d 16.3a 21.8b 22.7b 1.5 0.005   
500 g/d 21.0a 26.1b 27.9b 1.3 0.005   
1000 g/d 31.2a 34.4b 36.0b 1.2 0.012   
2000 g/d 42.9 44.8 45.3 0.8 0.08   
MEI CMR4, Mcal/d 2.74 2.69 2.75 0.06 0.775 <0.001 0.999 
MEI fat5, Mcal/d 0a 0.28b 0.59c 0.04 <0.001 <0.001 <0.001 
MEI CSI6,Mcal/d 3.16 2.74 2.84 0.2 0.221 <0.001 0.487 
Total MEI7, Mcal/d 5.87 5.73 6.11 0.2 0.332 <0.001 <0.001 
1Nursery calves were fed one of three treatments; 1) Low fat (LF) (28:15 MR; 2) Medium fat 
(MF) (28:15 MR + 113 g/d commercial fat supplement (FAT) (60% fat); 3) High fat (HF); 28:15 
MR + 227 g/d FAT. MF and HF calves received FAT d 1-21. All calves were fed LF d 22-49. 
MR was fed at 1.4% of birth body weight (BBW) d 1-10 and then 1.8% of BBW d 11-42 and 
0.9% of BBW d 43-49 Weaned on d 49 and remained in hutches to d 56.   
2DMI = (starter intake + Milk replacer DM + fat supplement) 
5Metabolizable energy intake from fat supplement.   
6Metabolizable energy intake from CSI. 
7Total metabolizable energy intake per d. 
 
 
 140 
 
 
Figure 1.  Starter intake during the first 56 d for calves fed milk replacer (MR) with 0, 114 or 
227 g/d supplemental fat containing 60% fat, DM basis 
1Nursery calves were fed one of three treatments; 1) Low fat (LF) (28:15 MR; 2) Medium fat 
(MF) (28:15 MR + 113 g/d commercial fat supplement (FAT) (60% fat); 3) High fat (HF); 28:15 
MR + 227 g/d FAT. MF and HF calves received FAT d 1-21. All calves were fed LF d 22-49. 
MR was fed at 1.4% of birth body weight (BBW) d 1-10 and then 1.8% of BBW d 11-42 and 
0.9% of BBW d 43-49 Weaned on d 49 and remained in hutches to d 56.   
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Table 5.  Least squares means of estimated intakes of crude protein, fat, metabolizable energy 
and apparent total tract nutrient digestibility from day 2 through day 49 for calves fed increasing 
amounts of supplemental fat during mild cold stress.  
 Treatment1  P - value 
 LF MF HF SEM TRT 
d 3 to 49      
Total CP intake, kg 18.4 17.1 17.2 0.73 0.323 
Total fat intake, kg 6.5a 7.7b 9.1c 0.13 < 0.001 
d 3 to 56      
Total CP intake, kg 22.6 21.5 21.5 0.91 0.55 
Total fat intake, kg 7.2 8.5 9.9 0.16 < 0.001 
C16:0 intake from CMR, kg 1.23 1.21 1.24 0.03 0.856 
C18:1 intake from CMR, kg 2.2 2.2 2.2 0.06 0.852 
C16:0 intake, kg (CMR + suppl. fat) 1.23a 1.57b 1.96c 0.03 <0.001 
C18:0 intake, kg (CMR + suppl. fat) 2.22a 2.80b 3.44c 0.06 <0.001 
Total tract apparent DMd, %, day 50-52 73.5 80.5 75.1 3.9 0.242 
1Nursery calves were fed one of three treatments; 1) Low fat (LF) (28:15 milk replacer (MR); 2) 
Medium fat (MF) (28:15 MR + 113 g/d commercial fat supplement (FAT) (60% fat); 3) High fat 
(HF); 28:15 MR + 227 g/d FAT. MF and HF calves received FAT d 1-21. All calves were fed LF 
d 22-49. MR was fed at 1.4% of birth body weight (BBW) d 1-10 and then 1.8% of BBW d 11-
42 and 0.9% of BBW d 43-49 Weaned on d 49 and remained in hutches to d 56.   
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Table 6.  Least square means for BW and body measurements during the supplemental fat 
feeding period (1 to 21 d), at the start of weaning (42 d) and at the end of the trial (56 d) for 
calves fed increasing amounts of supplemental fat during mild cold stress.      
 Treatment1  P-value 
 LF MF HF SEM TRT 
d 2-7 BW gain, kg 2.6a 4.4b 4.6b 0.6 0.026 
d 8-14 BW gain, kg 7.5a 9.5b 9.9 b 0.7 0.025 
      
d 21      
BW gain, kg 12.4a 14.5b 15.1b 0.7 0.009 
Hip height gain, cm 3.2 3.0 2.6 0.4 0.525 
Withers height gain, cm 3.7 2.9 3.4 0.5 0.426 
Body length gain, cm 1.7 1.3 1.4 0.3 0.698 
Heart girth gain, cm 2.7 2.8 2.3 0.3 0.581 
Hip width gain, cm 1.5 1.3 1.2 0.3 0.851 
ADG, kg/d 0.50a 0.82b 0.73b 0.1 0.022 
      
d 42      
BW gain, kg 33.3 33.1 34.0 1.2 0.855 
Hip height gain, cm 8.0 7.4 7.4 0.4 0.551 
Withers height gain, cm 7.8 6.7 7.3 0.4 0.215 
Body length gain, cm 4.4 3.5 3.7 0.3 0.133 
Heart girth gain, cm 6.2 6.5 5.7 0.4 0.289 
Hip width gain, cm 3.7 3.6 3.8 0.4 0.979 
ADG, kg/d 0.73 0.82 0.82 0.1 0.248 
      
d 56      
BW gain, kg 45.7 46.0 46.1 1.5 0.979 
Hip height gain, cm 12.3a 10.7b 10.3b 0.5 0.029 
Withers height gain, cm 11.2 9.4 9.9 0.5 0.053 
Body length gain, cm 6.2 5.4 5.3 0.4 0.177 
Heart girth, gain, cm 8.9 8.5 8.3 0.4 0.510 
Hip width, gain, cm 4.5 3.9 3.9 0.4 0.595 
ADG, kg/d 0.85 0.82 0.85 0.1 0.821 
      
d 56 total      
BW, kg  89.0 86.0 87.6 2.2 0.60 
Hip height, cm 86.5 86.0 86.2 0.6 0.817 
Withers height, cm 82.8 83.0 83.0 0.4 0.926 
Body length, cm 29.0 29.3 29.3 0.2 0.56 
Heart girth, cm 38.2 38.1 38.0 0.3 0.87 
Hip width, cm 19.7 19.8 19.8 0.2 0.95 
1 Nursery calves were fed one of three treatments; 1) Low fat (LF) (28:15 MR; 2) Medium fat 
(MF) (28:15 MR + 113 g/d commercial fat supplement (FAT) (60% fat); 3) High fat (HF); 28:15 
MR + 227 g/d FAT. MF and HF calves received FAT d 1-21. 
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Figure 2.  Least squares means for weekly ADG of calves fed one of three treatments; 1) Low 
fat (LF) (28:15 milk replacer (MR); 2) Medium fat (MF) (28:15 MR + 113 g/d commercial fat 
supplement (FAT) (60% fat); 3) High fat (HF); 28:15 MR + 227 g/d FAT. MF and HF calves 
received FAT d 1-21. All calves were fed LF d 22-49. MR was fed at 1.4% of birth body weight 
(BBW) d 1-10 and then 1.8% of BBW d 11-42 and 0.9% of BBW d 43-49 Weaned on d 49 and 
remained in hutches to d 56.  The largest SEM = 0.08.  Effects in model: Treatment P = 0.430; 
week, P < 0.0001; treatment × week, P = 0.077. 
 
Figure 3.  Least squares means of weekly calf body weight.  Treatment P = 0.938, Week P < 
0.001, treatment × week P = 0.533  
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Figure 4.  Metabolizable energy intake during the first 56 d for calves fed milk replacer with 0, 
114 or 227 g/d supplemental fat containing 60% fat, DM basis.  Treatment, P = 0.330; week P < 
0.001; treatment × week P < 0.001.  
a,b,cMeans with different superscripts indicate a P < 0.05.     
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Effect of stocking density in the prepartum period on health and productive parameters 
Objectives were to evaluate the effect of different stocking densities during the prepartum period on 
incidence of diseases and milk yield. Four pens were used in this experiment. Within each replicate 
(n=3), 2 pens were assigned to 80% stocking density (80D; 38 animals/48 headlocks) and 2 pens were 
assigned to 100% stocking density (100D; 48 animals/48 headlocks). Nulliparous and parous animals 
were housed separately pre and postpartum. Animals were scored for body condition and locomotion at 
enrollment, within 1 d postpartum (DIM), and at 35 and 56 DIM. Cows were examined within 1 DIM for 
retained placenta; 4, 7, 10, and 14 DIM for metritis; and, 35 DIM for endometritis. Data regarding 
displacement of abomasum, mastitis, and culling were recorded up to 60 DIM. Cows were milked thrice 
daily. Data regarding energy corrected milk yield in the first month postpartum is reported. Pen was 
considered the experimental unit (n=6/treatment). Dichotomous data were analyzed by logistic 
regression using the GLIMMIX procedure and continuous data were analyzed by ANOVA using the 
MIXED procedure for repeated measures. Pen was included as the random effect. Treatment was nested 
within pen and replicate and cows were nested within treatment. Stocking densities were 74.0 and 
94.3% (±0.3) of headlocks and 80.7 and 102.8% (±0.4) of stalls for 80D and 100D, respectively. There was 
no effect of treatment on incidence of stillbirth (80D=3.9 vs 100D=3.4%; P=0.50), retained placenta 
(80D=4.4 vs 100D=7.4%; P=0.13), and endometritis (80D=7.4 vs 100D=7.1%; P=0.65). There was a 
tendency (P=0.10) for incidence of metritis to be greater for 80D (21.5%) than 100D (13.9%). Treatment 
did not affect percentages of cows with locomotion score > 2 at 35 (P=0.94) and 56 (P=0.77) DIM. Body 
condition score was not affected by treatment (80D=2.97±0.02 vs 100D=2.97±0.01; P=0.91). Percentage 
of cows removed from the herd within 60 DIM (80D=4.4 vs 100D=3.0%; P=0.42) and yield of energy 
corrected milk (80D=27.56±1.52 vs 100D=27.98±1.50 kg/d; P=0.85) were not affected by treatment. In 
conclusion, reducing stocking density did not improve health and productive parameters and 
surprisingly tended to increase incidence of metritis. 
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Introduction: 
 
The transition period is a stressful period for the dairy cow.  Up to 25 percent of cows leave the herd or 
die within the first 60 days of milk (Godden et al., 2003).  Using social rank may be beneficial in 
identifying individuals at risk for health and subsequent production problems.  Social rank has been 
associated with the incidence of lameness with low- ranking animals having the greatest risk (Galindo and 
Broom, 2000).  Additionally, low-ranking heifers had a shorter length of estrus and fewer mounts than 
middle and high-ranking animals which may lead to fewer animals visually observed in estrus (Elkins and 
Rorie).  The objective of this study was to examine social rank during the close up prepartum period and 
its association with health, reproduction, and milk production during early lactation. 
 
Material and Methods: 
 
The study included 190 prepartum Jersey cows (average lactation 1.7±0.9) and was conducted in a 
commercial freestall sand-bedded dairy farm in south-central Minnesota for 10 weeks from June to 
August 2011.  Cows were enrolled in the study 4 weeks prior to expected calving date and were balanced 
for body condition score and those cows with locomotion score > 2 were not included in the study.  
 
Displacements from the feed bunk were measured during 3 h on the day of move-in (d0) at 13:00±1:00 
and following fresh feed delivery (05:00±1:00) on d 1, 2, 3 and 7 of each of the wk.  A displacement 
index (Galindo and Broom, 2000) was calculated as the number of displacements initiated by a cow 
divided by the number of displacements initiated plus number of displacements received by a cow.  An 
averaged displacement index was calculated for each day the cow was observed.  Cows with a 
displacement index of < 0.4 were categorized as low-ranking, 0.4 to 0.6 middle-ranking, and > 0.6 were 
considered high-ranking.  Health events for the first 100 DIM, milk production and composition for the 
first 3 DHIA tests, and first breeding pregnancy rate were recorded for each cow.  
 
All analysis was conducted with SAS version 9.2.  The Logistic procedure was used to evaluate 
associations of social ranking to health and reproductive events.  The Mixed procedure was used to 
analyze milk and milk composition.  Animal was used as a random effect.  Least square means were 
separated with the PDIFF statement.  Other covariates tested in all models included lactation and pen.   
 
Results: 
 
Eighty-nine animals were considered low-ranking with 59 and 42 in the middle and high-ranking groups, 
respectively.   There was no association of social rank with retained placenta, metritis, death, displaced 
abomasum, and mastitis events.  Displacement index was associated with first breeding pregnancy rate (P 
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< 0.01).  Middle-rank cows were 3 times more likely to become pregnant after first AI than low-ranking 
cows with no differences between low ranking and high ranking cows.  
 
There was no association between milk production and social rank.  Percent milk fat from the second test 
was associated with social rank (P = 0.04).  Milk fat percentage was greater in low-ranking cows than 
high-ranking cows (4.1±0.13 vs. 3.7±0.16%, respectively).  Middle-ranking cows, however, had similar 
milk fat percentage to low and high-ranking cows.  
 
In conclusion, social rank in the prepartum period was only associated with pregnancy status and 2nd test 
milk fat percentage in early lactation dairy cows.  There were no associations of social rank and examined 
health parameters. 
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